TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-422475	Axon guidance	6.06815754449426e-06	-12.0124555336485	551	47	0.104212860310421	451	10391	83464,7010,1272,2263,161,4897,200734,6091,5519,214,5291,9723,285643,6092,10371,2932,4254,161742,2534,3791,285704,10507,284,3084,2042,1956,6456,2045,5594,9353,7903,10486,8817,9462,2043,7223,2047,5788,4651,287,91584,80031,6197,137970,1630,1297,1946	APH1B,TEK,CNTN1,FGFR2,AP2A2,NRCAM,SPRED2,ROBO1,PPP2R1B,ALCAM,PIK3CB,SEMA3E,KIF4B,ROBO2,SEMA3A,GSK3B,KITLG,SPRED1,FYN,KDR,RGMB,SEMA4D,ANGPT1,NRG1,EPHA3,EGFR,SH3GL2,EPHA7,MAPK1,SLIT2,ST8SIA4,CAP2,FGF18,RASAL2,EPHA4,TRPC4,EPHB1,PTPRC,MYO10,ANK2,PLXNA4,SEMA6D,RPS6KA3,UNC5D,DCC,COL9A1,EFNA5
R-HSA-1500931	Cell-Cell communication	1.8515772623316e-05	-10.8968876148817	134	18	0.0399113082039911	451	10391	2534,56288,1015,3655,1630,1000,101928583,23607,1308,5291,1006,1005,9459,64398,1007,253559,1010,6251	FYN,PARD3,CDH17,ITGA6,DCC,CDH2,SLC7A14-AS1,CD2AP,COL17A1,PIK3CB,CDH8,CDH7,ARHGEF6,PALS1,CDH9,CADM2,CDH12,RSU1
R-HSA-446728	Cell junction organization	2.64797964904333e-05	-10.5391285123316	89	14	0.0310421286031042	451	10391	1308,1000,101928583,56288,1015,3655,253559,1007,1010,6251,1006,1005,64398,9459	COL17A1,CDH2,SLC7A14-AS1,PARD3,CDH17,ITGA6,CADM2,CDH9,CDH12,RSU1,CDH8,CDH7,PALS1,ARHGEF6
R-HSA-418990	Adherens junctions interactions	0.000293944940529266	-8.13211808527548	31	7	0.0155210643015521	451	10391	1010,1007,253559,1000,1005,1006,1015	CDH12,CDH9,CADM2,CDH2,CDH7,CDH8,CDH17
R-HSA-1630316	Glycosaminoglycan metabolism	0.000298500903030147	-8.11673759990957	124	15	0.0332594235033259	451	10391	57214,337876,9957,83539,3037,10090,3074,411,1462,2239,64579,51000,2262,9061,11046	CEMIP,CHSY3,HS3ST1,CHST9,HAS2,UST,HEXB,ARSB,VCAN,GPC4,NDST4,SLC35B3,GPC5,PAPSS1,SLC35D2
R-HSA-421270	Cell-cell junction organization	0.00030340690767332	-8.10043572376347	62	10	0.0221729490022173	451	10391	101928583,1000,253559,1007,1010,1015,1006,56288,1005,64398	SLC7A14-AS1,CDH2,CADM2,CDH9,CDH12,CDH17,CDH8,PARD3,CDH7,PALS1
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.000314462808114502	-8.0646447460043	4	3	0.00665188470066519	451	10391	9353,6091,6092	SLIT2,ROBO1,ROBO2
R-HSA-373752	Netrin-1 signaling	0.000379807988325419	-7.87584472682829	42	8	0.0177383592017738	451	10391	7223,6091,2534,137970,1630,9353,285704,4651	TRPC4,ROBO1,FYN,UNC5D,DCC,SLIT2,RGMB,MYO10
R-HSA-112315	Transmission across Chemical Synapses	0.000482354812040987	-7.63683059015411	217	21	0.0465631929046563	451	10391	2890,5594,6857,406974,114,161,6507,2898,22999,590,2897,2770,8825,2566,8499,9568,83988,108,781,2555,6197	GRIA1,MAPK1,SYT1,MIR197,ADCY8,AP2A2,SLC1A3,GRIK2,RIMS1,BCHE,GRIK1,GNAI1,LIN7A,GABRG2,PPFIA2,GABBR2,NCALD,ADCY2,CACNA2D1,GABRA2,RPS6KA3
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.000966784731877726	-6.94153470169063	48	8	0.0177383592017738	451	10391	2045,1946,2534,2047,2043,83464,2042,161	EPHA7,EFNA5,FYN,EPHB1,EPHA4,APH1B,EPHA3,AP2A2
R-HSA-416700	Other semaphorin interactions	0.0010562665215628	-6.85301473769896	19	5	0.0110864745011086	451	10391	10507,91584,5788,80031,9723	SEMA4D,PLXNA4,PTPRC,SEMA6D,SEMA3E
R-HSA-112316	Neuronal System	0.00125897291732316	-6.67745903541169	349	28	0.0620842572062084	451	10391	8499,5789,3747,781,108,83988,590,2911,8825,3755,161,90134,114,2890,3739,5594,9568,6197,2555,22999,2898,2566,2897,2770,406974,6857,6507,2035	PPFIA2,PTPRD,KCNC2,CACNA2D1,ADCY2,NCALD,BCHE,GRM1,LIN7A,KCNG1,AP2A2,KCNH7,ADCY8,GRIA1,KCNA4,MAPK1,GABBR2,RPS6KA3,GABRA2,RIMS1,GRIK2,GABRG2,GRIK1,GNAI1,MIR197,SYT1,SLC1A3,EPB41
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.00145612683912451	-6.5319752182186	51	8	0.0177383592017738	451	10391	411,3074,10090,2239,1462,2262,83539,337876	ARSB,HEXB,UST,GPC4,VCAN,GPC5,CHST9,CHSY3
R-HSA-382551	Transmembrane transport of small molecules	0.00154480412184552	-6.47285815864695	677	46	0.1019955654102	451	10391	51000,85320,285335,5244,9688,9194,6588,8001,115111,7223,861,353189,64116,30061,6561,2555,55117,196527,85413,2566,6546,127124,5205,81031,50617,114,11046,64078,53373,1317,129401,56606,26266,108,9429,53919,1968,6507,80036,2743,10350,154091,55129,340273,6262,23327	SLC35B3,ABCC11,SLC9C1,ABCB4,NUP93,SLC16A7,SLN,GLRA3,SLC26A7,TRPC4,RUNX1,SLCO4C1,SLC39A8,SLC40A1,SLC13A1,GABRA2,SLC6A15,ANO6,SLC22A16,GABRG2,SLC8A1,ATP6V1G3,ATP8B1,SLC2A10,ATP6V0A4,ADCY8,SLC35D2,SLC28A3,TPCN1,SLC31A1,NUP35,SLC2A9,SLC13A4,ADCY2,ABCG2,SLCO1C1,EIF2S3,SLC1A3,TRPM3,GLRB,ABCA9,SLC2A12,ANO10,ABCB5,RYR2,NEDD4L
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.00187981955585486	-6.27657948767501	2	2	0.00443458980044346	451	10391	2897,2898	GRIK1,GRIK2
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.00209412820430059	-6.16861794381358	106	12	0.0266075388026608	451	10391	861,81031,64116,1317,154091,9194,55117,30061,26266,56606,6561,85413	RUNX1,SLC2A10,SLC39A8,SLC31A1,SLC2A12,SLC16A7,SLC6A15,SLC40A1,SLC13A4,SLC2A9,SLC13A1,SLC22A16
R-HSA-3928663	EPHA-mediated growth cone collapse	0.00308796304072073	-5.78024361556975	34	6	0.0133037694013304	451	10391	2534,3791,2043,2042,2045,1946	FYN,KDR,EPHA4,EPHA3,EPHA7,EFNA5
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.00326233287967215	-5.72531273226691	15	4	0.00886917960088692	451	10391	406974,2770,114,108	MIR197,GNAI1,ADCY8,ADCY2
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.00326233287967215	-5.72531273226691	15	4	0.00886917960088692	451	10391	406974,108,114,2770	MIR197,ADCY2,ADCY8,GNAI1
R-HSA-375276	Peptide ligand-binding receptors	0.0033314605127634	-5.70434447872189	188	17	0.0376940133037694	451	10391	5179,2861,886,5368,552,2925,57007,7852,7201,1909,128674,56923,351,4887,4158,7504,10886	PENK,GPR37,CCKAR,PNOC,AVPR1A,GRPR,ACKR3,CXCR4,TRHR,EDNRA,PROKR2,NMUR2,APP,NPY2R,MC2R,XK,NPFFR2
R-HSA-399956	CRMPs in Sema3A signaling	0.0042024394130234	-5.47209010967457	16	4	0.00886917960088692	451	10391	91584,10371,2932,2534	PLXNA4,SEMA3A,GSK3B,FYN
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.00430556659133789	-5.44784653737284	87	10	0.0221729490022173	451	10391	5594,4254,5291,50852,8817,5519,3084,2534,1956,2263	MAPK1,KITLG,PIK3CB,TRAT1,FGF18,PPP2R1B,NRG1,FYN,EGFR,FGFR2
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.00441076609995874	-5.42370688579924	146	14	0.0310421286031042	451	10391	9568,108,83988,6197,2555,2898,2566,2897,2770,406974,114,161,2890,5594	GABBR2,ADCY2,NCALD,RPS6KA3,GABRA2,GRIK2,GABRG2,GRIK1,GNAI1,MIR197,ADCY8,AP2A2,GRIA1,MAPK1
R-HSA-5173105	O-linked glycosylation	0.00443570807406155	-5.41806802003154	116	12	0.0266075388026608	451	10391	64409,29071,6480,118430,146712,11174,92949,9508,80070,9215,256435,79875	GALNT17,C1GALT1C1,ST6GAL1,MUCL1,B3GNTL1,ADAMTS6,ADAMTSL1,ADAMTS3,ADAMTS20,LARGE1,ST6GALNAC3,THSD4
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.00560873386569352	-5.18343027730964	9	3	0.00665188470066519	451	10391	10486,6091,9353	CAP2,ROBO1,SLIT2
R-HSA-210993	Tie2 Signaling	0.00659617302196583	-5.02126564328167	18	4	0.00886917960088692	451	10391	7010,284,2888,5291	TEK,ANGPT1,GRB14,PIK3CB
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.00680932973930017	-4.98946158667483	65	8	0.0177383592017738	451	10391	5291,4254,8817,50852,1956,2534,2263,3084	PIK3CB,KITLG,FGF18,TRAT1,EGFR,FYN,FGFR2,NRG1
R-HSA-425407	SLC-mediated transmembrane transport	0.00689390432128515	-4.97711768953249	287	22	0.0487804878048781	451	10391	51000,11046,6507,81031,861,353189,154091,64078,64116,1317,30061,129401,6561,56606,26266,9688,55117,9194,115111,6546,53919,85413	SLC35B3,SLC35D2,SLC1A3,SLC2A10,RUNX1,SLCO4C1,SLC2A12,SLC28A3,SLC39A8,SLC31A1,SLC40A1,NUP35,SLC13A1,SLC2A9,SLC13A4,NUP93,SLC6A15,SLC16A7,SLC26A7,SLC8A1,SLCO1C1,SLC22A16
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.00744266406562838	-4.90052642089295	94	10	0.0221729490022173	451	10391	8817,5519,50852,1956,2534,2263,3084,5291,5594,4254	FGF18,PPP2R1B,TRAT1,EGFR,FYN,FGFR2,NRG1,PIK3CB,MAPK1,KITLG
R-HSA-437239	Recycling pathway of L1	0.00754749406542686	-4.88653968268013	29	5	0.0110864745011086	451	10391	6456,285643,161,5594,6197	SH3GL2,KIF4B,AP2A2,MAPK1,RPS6KA3
R-HSA-418886	Netrin mediated repulsion signals	0.00775672644287645	-4.8591948839356	10	3	0.00665188470066519	451	10391	137970,1630,2534	UNC5D,DCC,FYN
R-HSA-373755	Semaphorin interactions	0.00891164745906518	-4.720396154584	68	8	0.0177383592017738	451	10391	80031,9723,2534,10371,5788,2932,10507,91584	SEMA6D,SEMA3E,FYN,SEMA3A,PTPRC,GSK3B,SEMA4D,PLXNA4
R-HSA-2022928	HS-GAG biosynthesis	0.0100594059753528	-4.59924716422962	31	5	0.0110864745011086	451	10391	2262,9957,11046,2239,64579	GPC5,HS3ST1,SLC35D2,GPC4,NDST4
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.0100594059753528	-4.59924716422962	31	5	0.0110864745011086	451	10391	1272,83464,8788,1840,54492	CNTN1,APH1B,DLK1,DTX1,NEURL1B
R-HSA-1236394	Signaling by ERBB4	0.01008450044363	-4.5967556433958	43	6	0.0133037694013304	451	10391	2099,1956,3084,83464,4734,10413	ESR1,EGFR,NRG1,APH1B,NEDD4,YAP1
R-HSA-977443	GABA receptor activation	0.0102118335813877	-4.58420807611371	56	7	0.0155210643015521	451	10391	406974,9568,108,114,2555,2566,2770	MIR197,GABBR2,ADCY2,ADCY8,GABRA2,GABRG2,GNAI1
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.0105603147816069	-4.55065219228401	70	8	0.0177383592017738	451	10391	9508,26577,5352,1308,1297,340267,1301,84570	ADAMTS3,PCOLCE2,PLOD2,COL17A1,COL9A1,COL28A1,COL11A1,COL25A1
R-HSA-3781865	Diseases of glycosylation	0.0120237888691804	-4.42086818580236	86	9	0.0199556541019956	451	10391	11174,118430,79875,1462,2239,92949,2262,80070,9508	ADAMTS6,MUCL1,THSD4,VCAN,GPC4,ADAMTSL1,GPC5,ADAMTS20,ADAMTS3
R-HSA-373760	L1CAM interactions	0.0129232923933264	-4.3487239838863	102	10	0.0221729490022173	451	10391	6197,161,1956,1272,285643,6456,4897,214,287,5594	RPS6KA3,AP2A2,EGFR,CNTN1,KIF4B,SH3GL2,NRCAM,ALCAM,ANK2,MAPK1
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.0133303537328109	-4.31771160854864	12	3	0.00665188470066519	451	10391	2898,83988,2897	GRIK2,NCALD,GRIK1
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.0133303537328109	-4.31771160854864	12	3	0.00665188470066519	451	10391	2898,83988,2897	GRIK2,NCALD,GRIK1
R-HSA-428157	Sphingolipid metabolism	0.0158805459970937	-4.1426604410657	90	9	0.0199556541019956	451	10391	55331,57733,7368,171546,9218,3074,411,5587,8613	ACER3,GBA3,UGT8,SPTSSA,VAPA,HEXB,ARSB,PRKD1,PLPP3
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.0158805459970937	-4.1426604410657	90	9	0.0199556541019956	451	10391	50852,8817,3084,2263,2534,1956,4254,5291,2932	TRAT1,FGF18,NRG1,FGFR2,FYN,EGFR,KITLG,PIK3CB,GSK3B
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.0160893066354106	-4.12960041179571	23	4	0.00886917960088692	451	10391	8825,6857,8499,22999	LIN7A,SYT1,PPFIA2,RIMS1
R-HSA-4791275	Signaling by WNT in cancer	0.0166868807315365	-4.09313245323091	35	5	0.0110864745011086	451	10391	5519,83999,1488,2932,8658	PPP2R1B,KREMEN1,CTBP2,GSK3B,TNKS
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	0.0167801407441248	-4.08755919036653	13	3	0.00665188470066519	451	10391	200734,161742,8817	SPRED2,SPRED1,FGF18
R-HSA-418597	G alpha (z) signalling events	0.0169397292904245	-4.07809357038034	48	6	0.0133037694013304	451	10391	108,114,151,406974,353299,2770	ADCY2,ADCY8,ADRA2B,MIR197,RGSL1,GNAI1
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.0172252783861919	-4.06137730046022	5	2	0.00443458980044346	451	10391	26266,6561	SLC13A4,SLC13A1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0172252783861919	-4.06137730046022	5	2	0.00443458980044346	451	10391	57214,3037	CEMIP,HAS2
R-HSA-1266738	Developmental Biology	0.017711522970083	-4.03353983596193	1078	61	0.135254988913525	451	10391	10371,3642,9723,9314,285643,6092,4254,1829,2932,6256,161742,2534,2034,3791,285704,10507,6928,161,83464,7010,1272,2263,4897,5519,200734,6091,214,8202,5291,2043,92,7223,2047,287,4651,91584,5788,6197,137970,80031,1946,1630,1297,284,3084,2042,1956,6456,5594,9353,7903,5915,2045,8817,9462,10486,91653,1000,6657,6938,10891	SEMA3A,INSM1,SEMA3E,KLF4,KIF4B,ROBO2,KITLG,DSG2,GSK3B,RXRA,SPRED1,FYN,EPAS1,KDR,RGMB,SEMA4D,HNF1B,AP2A2,APH1B,TEK,CNTN1,FGFR2,NRCAM,PPP2R1B,SPRED2,ROBO1,ALCAM,NCOA3,PIK3CB,EPHA4,ACVR2A,TRPC4,EPHB1,ANK2,MYO10,PLXNA4,PTPRC,RPS6KA3,UNC5D,SEMA6D,EFNA5,DCC,COL9A1,ANGPT1,NRG1,EPHA3,EGFR,SH3GL2,MAPK1,SLIT2,ST8SIA4,RARB,EPHA7,FGF18,RASAL2,CAP2,BOC,CDH2,SOX2,TCF12,PPARGC1A
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.0186616014525649	-3.98128726449283	24	4	0.00886917960088692	451	10391	6507,22999,8499,6857	SLC1A3,RIMS1,PPFIA2,SYT1
R-HSA-201451	Signaling by BMP	0.0186616014525649	-3.98128726449283	24	4	0.00886917960088692	451	10391	9241,4093,658,92	NOG,SMAD9,BMPR1B,ACVR2A
R-HSA-1474290	Collagen formation	0.0193186674023283	-3.94668342761142	93	9	0.0199556541019956	451	10391	1297,340267,1301,84570,1308,26577,5352,9508,3655	COL9A1,COL28A1,COL11A1,COL25A1,COL17A1,PCOLCE2,PLOD2,ADAMTS3,ITGA6
R-HSA-983712	Ion channel transport	0.0197252592551286	-3.9258552688573	209	16	0.0354767184035477	451	10391	2566,23327,196527,8001,6588,6262,2555,55129,53373,285335,2743,80036,50617,5205,127124,7223	GABRG2,NEDD4L,ANO6,GLRA3,SLN,RYR2,GABRA2,ANO10,TPCN1,SLC9C1,GLRB,TRPM3,ATP6V0A4,ATP8B1,ATP6V1G3,TRPC4
R-HSA-1257604	PIP3 activates AKT signaling	0.0198543179497099	-3.91933376655229	125	11	0.024390243902439	451	10391	8817,5519,2534,5291,50852,1956,2263,3084,5594,4254,2932	FGF18,PPP2R1B,FYN,PIK3CB,TRAT1,EGFR,FGFR2,NRG1,MAPK1,KITLG,GSK3B
R-HSA-2024101	CS/DS degradation	0.0206811639340904	-3.87853194784594	14	3	0.00665188470066519	451	10391	3074,411,1462	HEXB,ARSB,VCAN
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.0206811639340904	-3.87853194784594	14	3	0.00665188470066519	451	10391	5289,8898,8821	PIK3C3,MTMR2,INPP4B
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.0206811639340904	-3.87853194784594	14	3	0.00665188470066519	451	10391	56606,154091,81031	SLC2A9,SLC2A12,SLC2A10
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.0206811639340904	-3.87853194784594	14	3	0.00665188470066519	451	10391	8050,5160,6256	PDHX,PDHA1,RXRA
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.0208834954021741	-3.86879612565955	37	5	0.0110864745011086	451	10391	80070,79875,9508,92949,11174	ADAMTS20,THSD4,ADAMTS3,ADAMTSL1,ADAMTS6
R-HSA-1251985	Nuclear signaling by ERBB4	0.0214746113702443	-3.840883908121	25	4	0.00886917960088692	451	10391	2099,3084,83464,10413	ESR1,NRG1,APH1B,YAP1
R-HSA-2682334	EPH-Ephrin signaling	0.0218915610342906	-3.82165405732254	95	9	0.0199556541019956	451	10391	2043,83464,2042,2534,3791,2047,161,2045,1946	EPHA4,APH1B,EPHA3,FYN,KDR,EPHB1,AP2A2,EPHA7,EFNA5
R-HSA-198203	PI3K/AKT activation	0.0232360171402921	-3.76205174119107	128	11	0.024390243902439	451	10391	2932,4254,5594,5291,3084,2263,2534,1956,50852,8817,5519	GSK3B,KITLG,MAPK1,PIK3CB,NRG1,FGFR2,FYN,EGFR,TRAT1,FGF18,PPP2R1B
R-HSA-180292	GAB1 signalosome	0.0232360171402921	-3.76205174119107	128	11	0.024390243902439	451	10391	5291,8817,5519,2534,5594,4254,2932,50852,3084,1956,2263	PIK3CB,FGF18,PPP2R1B,FYN,MAPK1,KITLG,GSK3B,TRAT1,NRG1,EGFR,FGFR2
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.0236072848008532	-3.74619993657957	322	22	0.0487804878048781	451	10391	5368,2861,3350,9890,1902,2925,552,4887,4158,1909,151,886,5179,7201,7852,57007,351,56923,128674,10886,7504,9287	PNOC,GPR37,HTR1A,PLPPR4,LPAR1,GRPR,AVPR1A,NPY2R,MC2R,EDNRA,ADRA2B,CCKAR,PENK,TRHR,CXCR4,ACKR3,APP,NMUR2,PROKR2,NPFFR2,XK,TAAR2
R-HSA-975298	Ligand-gated ion channel transport	0.0245333704877914	-3.70772102746854	26	4	0.00886917960088692	451	10391	8001,2555,2566,2743	GLRA3,GABRA2,GABRG2,GLRB
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.025035871697889	-3.68744561463768	15	3	0.00665188470066519	451	10391	2534,91584,10371	FYN,PLXNA4,SEMA3A
R-HSA-444257	RSK activation	0.025101635299604	-3.68482228358801	6	2	0.00443458980044346	451	10391	5594,6197	MAPK1,RPS6KA3
R-HSA-8848021	Signaling by PTK6	0.0255621557074221	-3.66664231392813	67	7	0.0155210643015521	451	10391	9462,9844,2034,1956,3084,200734,161742	RASAL2,ELMO1,EPAS1,EGFR,NRG1,SPRED2,SPRED1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.0257143162701256	-3.66070738886528	39	5	0.0110864745011086	451	10391	92949,11174,80070,79875,9508	ADAMTSL1,ADAMTS6,ADAMTS20,THSD4,ADAMTS3
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	0.0278419805513489	-3.58121030555243	27	4	0.00886917960088692	451	10391	9462,9844,200734,161742	RASAL2,ELMO1,SPRED2,SPRED1
R-HSA-1643685	Disease	0.0283134727349199	-3.56441751924581	859	49	0.108647450110865	451	10391	54492,5519,11116,129401,79875,5291,161,83464,2263,552,2239,253970,7518,92949,140801,2534,23327,50852,7852,200916,2262,4254,2932,8817,9462,80070,9688,4158,1488,3084,6456,1956,1462,5594,6235,4552,5950,9734,9508,8658,9844,351,9061,83999,29080,8029,6857,11174,118430	NEURL1B,PPP2R1B,CEP43,NUP35,THSD4,PIK3CB,AP2A2,APH1B,FGFR2,AVPR1A,GPC4,SFTA3,XRCC4,ADAMTSL1,RPL10L,FYN,NEDD4L,TRAT1,CXCR4,RPL22L1,GPC5,KITLG,GSK3B,FGF18,RASAL2,ADAMTS20,NUP93,MC2R,CTBP2,NRG1,SH3GL2,EGFR,VCAN,MAPK1,RPS29,MTRR,RBP4,HDAC9,ADAMTS3,TNKS,ELMO1,APP,PAPSS1,KREMEN1,CCDC59,CUBN,SYT1,ADAMTS6,MUCL1
R-HSA-977444	GABA B receptor activation	0.0283763088301395	-3.56220067807203	40	5	0.0110864745011086	451	10391	9568,406974,2770,114,108	GABBR2,MIR197,GNAI1,ADCY8,ADCY2
R-HSA-991365	Activation of GABAB receptors	0.0283763088301395	-3.56220067807203	40	5	0.0110864745011086	451	10391	2770,108,114,9568,406974	GNAI1,ADCY2,ADCY8,GABBR2,MIR197
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.0283763088301395	-3.56220067807203	40	5	0.0110864745011086	451	10391	353189,51000,64078,11046,53919	SLCO4C1,SLC35B3,SLC28A3,SLC35D2,SLCO1C1
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.0287304954662283	-3.54979616053476	54	6	0.0133037694013304	451	10391	2262,9957,11046,1462,2239,64579	GPC5,HS3ST1,SLC35D2,VCAN,GPC4,NDST4
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.0298435868407214	-3.51178530843327	16	3	0.00665188470066519	451	10391	2534,91584,10371	FYN,PLXNA4,SEMA3A
R-HSA-174362	Transport and synthesis of PAPS	0.0341446183282702	-3.37715029459992	7	2	0.00443458980044346	451	10391	51000,9061	SLC35B3,PAPSS1
R-HSA-447043	Neurofascin interactions	0.0341446183282702	-3.37715029459992	7	2	0.00443458980044346	451	10391	4897,1272	NRCAM,CNTN1
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.035100860585823	-3.34952963069627	17	3	0.00665188470066519	451	10391	6857,22999,8499	SYT1,RIMS1,PPFIA2
R-HSA-2142845	Hyaluronan metabolism	0.035100860585823	-3.34952963069627	17	3	0.00665188470066519	451	10391	57214,3037,3074	CEMIP,HAS2,HEXB
R-HSA-418594	G alpha (i) signalling events	0.0356727861064554	-3.33336717482713	243	17	0.0376940133037694	451	10391	108,151,353299,9568,4887,2770,351,56923,8787,1902,7852,114,57007,406974,5368,3350,5179	ADCY2,ADRA2B,RGSL1,GABBR2,NPY2R,GNAI1,APP,NMUR2,RGS9,LPAR1,CXCR4,ADCY8,ACKR3,MIR197,PNOC,HTR1A,PENK
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.0358900489292998	-3.32729521051066	137	11	0.024390243902439	451	10391	3084,1956,2534,2263,8817,50852,5519,2932,5594,4254,5291	NRG1,EGFR,FYN,FGFR2,FGF18,TRAT1,PPP2R1B,GSK3B,MAPK1,KITLG,PIK3CB
R-HSA-5362517	Signaling by Retinoic Acid	0.0373819109518171	-3.28656835595492	43	5	0.0110864745011086	451	10391	6256,5915,340665,5160,8050	RXRA,RARB,CYP26C1,PDHA1,PDHX
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.0407307428686662	-3.20077211863064	44	5	0.0110864745011086	451	10391	8613,171546,9218,55331,5587	PLPP3,SPTSSA,VAPA,ACER3,PRKD1
R-HSA-5668914	Diseases of metabolism	0.0407307428686662	-3.20077211863064	44	5	0.0110864745011086	451	10391	4552,29080,253970,4158,8029	MTRR,CCDC59,SFTA3,MC2R,CUBN
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.0408017980984444	-3.19902912750282	18	3	0.00665188470066519	451	10391	6857,22999,8499	SYT1,RIMS1,PPFIA2
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.0408017980984444	-3.19902912750282	18	3	0.00665188470066519	451	10391	22999,8499,6857	RIMS1,PPFIA2,SYT1
R-HSA-197264	Nicotinamide salvaging	0.0408017980984444	-3.19902912750282	18	3	0.00665188470066519	451	10391	83594,79668,4837	NUDT12,PARP8,NNMT
R-HSA-196854	Metabolism of vitamins and cofactors	0.0411447722517213	-3.19065840119993	175	13	0.0288248337028825	451	10391	55788,83594,5950,4552,79668,2239,2262,8029,5948,10243,55312,4837,79646	LMBRD1,NUDT12,RBP4,MTRR,PARP8,GPC4,GPC5,CUBN,RBP2,GPHN,RFK,NNMT,PANK3
R-HSA-6809583	Retinoid metabolism disease events	0.0434029448562864	-3.13722798634626	1	1	0.00221729490022173	451	10391	5950	RBP4
R-HSA-8853333	Signaling by FGFR2 fusions	0.0434029448562864	-3.13722798634626	1	1	0.00221729490022173	451	10391	2263	FGFR2
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.0434029448562864	-3.13722798634626	1	1	0.00221729490022173	451	10391	2263	FGFR2
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.0434029448562864	-3.13722798634626	1	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.0436254588835842	-3.13211437969345	31	4	0.00886917960088692	451	10391	6197,5594,5602,5519	RPS6KA3,MAPK1,MAPK10,PPP2R1B
R-HSA-164944	Nef and signal transduction	0.0442385810705761	-3.11815799573233	8	2	0.00443458980044346	451	10391	9844,2534	ELMO1,FYN
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.0442385810705761	-3.11815799573233	8	2	0.00443458980044346	451	10391	9459,6251	ARHGEF6,RSU1
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.0449432188550496	-3.10235538917691	60	6	0.0133037694013304	451	10391	11174,118430,92949,79875,9508,80070	ADAMTS6,MUCL1,ADAMTSL1,THSD4,ADAMTS3,ADAMTS20
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.046680504377943	-3.06442866661052	443	27	0.0598669623059867	451	10391	6197,10886,161742,2534,1608,351,56923,128674,7201,886,4254,5519,8817,9462,200734,353299,1909,2911,1902,284,2925,3084,7010,1956,552,2263,5594	RPS6KA3,NPFFR2,SPRED1,FYN,DGKG,APP,NMUR2,PROKR2,TRHR,CCKAR,KITLG,PPP2R1B,FGF18,RASAL2,SPRED2,RGSL1,EDNRA,GRM1,LPAR1,ANGPT1,GRPR,NRG1,TEK,EGFR,AVPR1A,FGFR2,MAPK1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.0469383574756581	-3.05892008116855	19	3	0.00665188470066519	451	10391	1462,2239,2262	VCAN,GPC4,GPC5
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.0469383574756581	-3.05892008116855	19	3	0.00665188470066519	451	10391	2239,1462,2262	GPC4,VCAN,GPC5
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.0469383574756581	-3.05892008116855	19	3	0.00665188470066519	451	10391	2262,2239,1462	GPC5,GPC4,VCAN
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.0496413463285247	-3.00293119716572	387	24	0.0532150776053215	451	10391	6197,2534,161742,4254,2932,6014,50852,5291,108,9462,5519,8817,4915,200734,5607,5594,114,161,1956,6456,2263,284,3084,7010	RPS6KA3,FYN,SPRED1,KITLG,GSK3B,RIT2,TRAT1,PIK3CB,ADCY2,RASAL2,PPP2R1B,FGF18,NTRK2,SPRED2,MAP2K5,MAPK1,ADCY8,AP2A2,EGFR,SH3GL2,FGFR2,ANGPT1,NRG1,TEK
R-HSA-8948216	Collagen chain trimerization	0.0518375402732818	-2.95964067649589	47	5	0.0110864745011086	451	10391	84570,1301,1297,340267,1308	COL25A1,COL11A1,COL9A1,COL28A1,COL17A1
R-HSA-112043	PLC beta mediated events	0.0518375402732818	-2.95964067649589	47	5	0.0110864745011086	451	10391	406974,2770,5594,114,108	MIR197,GNAI1,MAPK1,ADCY8,ADCY2
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.0520452891582246	-2.95564099410306	78	7	0.0155210643015521	451	10391	144245,199857,6480,6675,6489,7903,256435	ALG10B,ALG14,ST6GAL1,UAP1,ST8SIA1,ST8SIA4,ST6GALNAC3
R-HSA-376176	Signaling by Robo receptor	0.0530581481039568	-2.9363668328048	33	4	0.00886917960088692	451	10391	6092,6091,10486,9353	ROBO2,ROBO1,CAP2,SLIT2
R-HSA-4085001	Sialic acid metabolism	0.0530581481039568	-2.9363668328048	33	4	0.00886917960088692	451	10391	7903,6480,6489,256435	ST8SIA4,ST6GAL1,ST8SIA1,ST6GALNAC3
R-HSA-194223	HDL-mediated lipid transport	0.0535006240411209	-2.92806196082819	20	3	0.00665188470066519	451	10391	19,8029,1071	ABCA1,CUBN,CETP
R-HSA-190241	FGFR2 ligand binding and activation	0.0535006240411209	-2.92806196082819	20	3	0.00665188470066519	451	10391	8817,9982,2263	FGF18,FGFBP1,FGFR2
R-HSA-1483255	PI Metabolism	0.0550766645979773	-2.89902916254753	79	7	0.0155210643015521	451	10391	8821,5289,54477,8898,5783,5291,5288	INPP4B,PIK3C3,PLEKHA5,MTMR2,PTPN13,PIK3CB,PIK3C2G
R-HSA-428543	Inactivation of Cdc42 and Rac	0.0552756802698095	-2.8954222453074	9	2	0.00443458980044346	451	10391	6091,9353	ROBO1,SLIT2
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.0552756802698095	-2.8954222453074	9	2	0.00443458980044346	451	10391	7247,23405	TSN,DICER1
R-HSA-112040	G-protein mediated events	0.0558954252705398	-2.88427273990629	48	5	0.0110864745011086	451	10391	406974,108,114,5594,2770	MIR197,ADCY2,ADCY8,MAPK1,GNAI1
R-HSA-71387	Metabolism of carbohydrates	0.0570146341505516	-2.86444730461617	296	19	0.0421286031042129	451	10391	411,3074,10090,64579,2239,1462,2262,51000,11046,9061,57214,129401,9688,337876,83539,9957,2632,5519,3037	ARSB,HEXB,UST,NDST4,GPC4,VCAN,GPC5,SLC35B3,SLC35D2,PAPSS1,CEMIP,NUP35,NUP93,CHSY3,CHST9,HS3ST1,GBE1,PPP2R1B,HAS2
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.0581570573356531	-2.84460804305386	34	4	0.00886917960088692	451	10391	83990,23514,7486,5890	BRIP1,SPIDR,WRN,RAD51B
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0594913103563266	-2.82192502152757	97	8	0.0177383592017738	451	10391	6197,5519,5289,6885,351,57161,5594,5602	RPS6KA3,PPP2R1B,PIK3C3,MAP3K7,APP,PELI2,MAPK1,MAPK10
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.0604770616639853	-2.80549113188921	21	3	0.00665188470066519	451	10391	1462,83539,337876	VCAN,CHST9,CHSY3
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.0604770616639853	-2.80549113188921	21	3	0.00665188470066519	451	10391	1272,83464,54492	CNTN1,APH1B,NEURL1B
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.0604770616639853	-2.80549113188921	21	3	0.00665188470066519	451	10391	55788,8029,4552	LMBRD1,CUBN,MTRR
R-HSA-5693537	Resolution of D-Loop Structures	0.0635080478643577	-2.75658864309269	35	4	0.00886917960088692	451	10391	7486,5890,23514,83990	WRN,RAD51B,SPIDR,BRIP1
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.0645448312313583	-2.74039523877073	50	5	0.0110864745011086	451	10391	8821,5783,5291,54477,5288	INPP4B,PTPN13,PIK3CB,PLEKHA5,PIK3C2G
R-HSA-5654736	Signaling by FGFR1	0.0645448312313583	-2.74039523877073	50	5	0.0110864745011086	451	10391	200734,161742,23767,8817,5594	SPRED2,SPRED1,FLRT3,FGF18,MAPK1
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	5289,8898	PIK3C3,MTMR2
R-HSA-170660	Adenylate cyclase activating pathway	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	108,114	ADCY2,ADCY8
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	5594,5602	MAPK1,MAPK10
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	1630,7223	DCC,TRPC4
R-HSA-190377	FGFR2b ligand binding and activation	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	2263,9982	FGFR2,FGFBP1
R-HSA-5687613	Diseases associated with surfactant metabolism	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	253970,29080	SFTA3,CCDC59
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	5519,2029	PPP2R1B,ENSA
R-HSA-727802	Transport of nucleotide sugars	0.0671554187286025	-2.70074566338475	10	2	0.00443458980044346	451	10391	11046,51000	SLC35D2,SLC35B3
R-HSA-389513	CTLA4 inhibitory signaling	0.0678547427060053	-2.69038599527671	22	3	0.00665188470066519	451	10391	1493,5519,2534	CTLA4,PPP2R1B,FYN
R-HSA-373753	Nephrin interactions	0.0678547427060053	-2.69038599527671	22	3	0.00665188470066519	451	10391	2534,5291,23607	FYN,PIK3CB,CD2AP
R-HSA-198753	ERK/MAPK targets	0.0678547427060053	-2.69038599527671	22	3	0.00665188470066519	451	10391	5519,6197,5594	PPP2R1B,RPS6KA3,MAPK1
R-HSA-1483257	Phospholipid metabolism	0.0687772980971621	-2.67688155801275	208	14	0.0310421286031042	451	10391	5288,590,347516,84803,5291,8898,54477,5289,30814,56894,8821,64850,58488,5783	PIK3C2G,BCHE,DGAT2L6,GPAT3,PIK3CB,MTMR2,PLEKHA5,PIK3C3,PLA2G2E,AGPAT3,INPP4B,ETNPPL,PCTP,PTPN13
R-HSA-432720	Lysosome Vesicle Biogenesis	0.0691080737561687	-2.67208371341068	36	4	0.00886917960088692	451	10391	134829,6456,351,81567	CLVS2,SH3GL2,APP,TXNDC5
R-HSA-383280	Nuclear Receptor transcription pathway	0.069135220270252	-2.67169097805779	51	5	0.0110864745011086	451	10391	2099,2104,8013,6256,5915	ESR1,ESRRG,NR4A3,RXRA,RARB
R-HSA-112310	Neurotransmitter Release Cycle	0.069135220270252	-2.67169097805779	51	5	0.0110864745011086	451	10391	8825,6507,8499,22999,6857	LIN7A,SLC1A3,PPFIA2,RIMS1,SYT1
R-HSA-913709	O-linked glycosylation of mucins	0.0698907219291283	-2.66082237204111	67	6	0.0133037694013304	451	10391	29071,6480,64409,256435,146712,118430	C1GALT1C1,ST6GAL1,GALNT17,ST6GALNAC3,B3GNTL1,MUCL1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.0718601014574782	-2.6330340854208	84	7	0.0155210643015521	451	10391	5602,5594,57161,351,6197,5519,6885	MAPK10,MAPK1,PELI2,APP,RPS6KA3,PPP2R1B,MAP3K7
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.0718601014574782	-2.6330340854208	84	7	0.0155210643015521	451	10391	57161,5594,5602,351,6885,6197,5519	PELI2,MAPK1,MAPK10,APP,MAP3K7,RPS6KA3,PPP2R1B
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.0718601014574782	-2.6330340854208	84	7	0.0155210643015521	451	10391	6885,5519,6197,57161,5602,5594,351	MAP3K7,PPP2R1B,RPS6KA3,PELI2,MAPK10,MAPK1,APP
R-HSA-416476	G alpha (q) signalling events	0.0747310493206698	-2.59385961964689	192	13	0.0288248337028825	451	10391	2925,552,7201,1902,886,353299,10886,128674,2911,1909,1608,56923,351	GRPR,AVPR1A,TRHR,LPAR1,CCKAR,RGSL1,NPFFR2,PROKR2,GRM1,EDNRA,DGKG,NMUR2,APP
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.0788420879557903	-2.54030831359079	53	5	0.0110864745011086	451	10391	2262,8029,5950,2239,5948	GPC5,CUBN,RBP4,GPC4,RBP2
R-HSA-2022923	Dermatan sulfate biosynthesis	0.079784213039201	-2.52842962568658	11	2	0.00443458980044346	451	10391	1462,10090	VCAN,UST
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.079784213039201	-2.52842962568658	11	2	0.00443458980044346	451	10391	1829,9414	DSG2,TJP2
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.079784213039201	-2.52842962568658	11	2	0.00443458980044346	451	10391	8029,4552	CUBN,MTRR
R-HSA-549127	Organic cation transport	0.079784213039201	-2.52842962568658	11	2	0.00443458980044346	451	10391	85413,861	SLC22A16,RUNX1
R-HSA-446107	Type I hemidesmosome assembly	0.079784213039201	-2.52842962568658	11	2	0.00443458980044346	451	10391	1308,3655	COL17A1,ITGA6
R-HSA-2672351	Stimuli-sensing channels	0.0821147203058784	-2.49963798132545	104	8	0.0177383592017738	451	10391	6262,80036,7223,55129,285335,53373,23327,196527	RYR2,TRPM3,TRPC4,ANO10,SLC9C1,TPCN1,NEDD4L,ANO6
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.0826093316058818	-2.4936326313994	70	6	0.0133037694013304	451	10391	129401,9688,3308,2932,6119,5594	NUP35,NUP93,HSPA4,GSK3B,RPA3,MAPK1
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	4158	MC2R
R-HSA-198765	Signalling to ERK5	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	5607	MAP2K5
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	8658	TNKS
R-HSA-190872	Transport of connexons to the plasma membrane	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-111995	phospho-PLA2 pathway	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-141424	Amplification of signal from the kinetochores	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	4085	MAD2L1
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	4552	MTRR
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	4552	MTRR
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	4085	MAD2L1
R-HSA-6804754	Regulation of TP53 Expression	0.0849260701559193	-2.46597416382655	2	1	0.00221729490022173	451	10391	639	PRDM1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.0865561669553412	-2.44696174680366	123	9	0.0199556541019956	451	10391	4552,10243,55312,79668,4837,83594,55788,79646,8029	MTRR,GPHN,RFK,PARP8,NNMT,NUDT12,LMBRD1,PANK3,CUBN
R-HSA-190236	Signaling by FGFR	0.0913660023909294	-2.39288183480651	89	7	0.0155210643015521	451	10391	2263,161742,200734,8817,9982,23767,5594	FGFR2,SPRED1,SPRED2,FGF18,FGFBP1,FLRT3,MAPK1
R-HSA-500792	GPCR ligand binding	0.0915966541716044	-2.39036053448003	455	26	0.057649667405765	451	10391	9568,9287,10886,7504,128674,10203,56923,351,57007,7201,7852,5179,886,151,1909,2911,4887,4158,8321,2925,552,1902,9890,3350,5368,2861	GABBR2,TAAR2,NPFFR2,XK,PROKR2,CALCRL,NMUR2,APP,ACKR3,TRHR,CXCR4,PENK,CCKAR,ADRA2B,EDNRA,GRM1,NPY2R,MC2R,FZD1,GRPR,AVPR1A,LPAR1,PLPPR4,HTR1A,PNOC,GPR37
R-HSA-6794362	Protein-protein interactions at synapses	0.0917562623292614	-2.3886195401068	72	6	0.0133037694013304	451	10391	6857,5789,8825,2035,2890,2911	SYT1,PTPRD,LIN7A,EPB41,GRIA1,GRM1
R-HSA-182971	EGFR downregulation	0.0922493814866098	-2.38325970083618	25	3	0.00665188470066519	451	10391	10252,6456,1956	SPRY1,SH3GL2,EGFR
R-HSA-425410	Metal ion SLC transporters	0.0922493814866098	-2.38325970083618	25	3	0.00665188470066519	451	10391	30061,64116,1317	SLC40A1,SLC39A8,SLC31A1
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.0922493814866098	-2.38325970083618	25	3	0.00665188470066519	451	10391	8050,5160,594	PDHX,PDHA1,BCKDHB
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.0922493814866098	-2.38325970083618	25	3	0.00665188470066519	451	10391	6197,5594,5519	RPS6KA3,MAPK1,PPP2R1B
R-HSA-879518	Transport of organic anions	0.0930749848987133	-2.37434982147195	12	2	0.00443458980044346	451	10391	53919,353189	SLCO1C1,SLCO4C1
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.0930749848987133	-2.37434982147195	12	2	0.00443458980044346	451	10391	2262,2239	GPC5,GPC4
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.0930749848987133	-2.37434982147195	12	2	0.00443458980044346	451	10391	2262,2239	GPC5,GPC4
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.0939170403954858	-2.36534343537197	40	4	0.00886917960088692	451	10391	6119,83990,5890,7486	RPA3,BRIP1,RAD51B,WRN
R-HSA-162582	Signal Transduction	0.0951907326565887	-2.35187268796749	2596	125	0.277161862527716	451	10391	8050,8887,1488,8607,23767,6657,64411,4158,3084,2925,284,6456,1956,5948,84643,5915,5607,5596,9287,9734,7504,220134,1297,1608,8788,406974,92,8549,2099,55553,58504,353299,6885,5160,8321,5291,127124,83464,2263,1272,552,161,27152,9568,10252,161742,9414,3791,2534,10886,6256,4983,50852,4093,6014,395,2932,9982,4254,886,79971,23322,8817,5151,9462,11245,1909,91653,2737,102464826,4734,9890,5950,3350,5594,5368,2861,8658,56288,6197,51339,2770,10203,10602,9844,351,57007,5289,5139,83999,340665,50508,200734,4915,5519,54492,151,108,658,2911,51701,10413,8202,4887,4085,7010,9241,50617,114,1902,2239,2034,128674,8038,8787,23327,10788,56923,9459,2262,7201,83478,1840,7852,5179	PDHX,TAX1BP1,CTBP2,RUVBL1,FLRT3,SOX2,ARAP3,MC2R,NRG1,GRPR,ANGPT1,SH3GL2,EGFR,RBP2,KIF2B,RARB,MAP2K5,MAPK4,TAAR2,HDAC9,XK,SKA1,COL9A1,DGKG,DLK1,MIR197,ACVR2A,LGR5,ESR1,SOX6,ARHGAP22,RGSL1,MAP3K7,PDHA1,FZD1,PIK3CB,ATP6V1G3,APH1B,FGFR2,CNTN1,AVPR1A,AP2A2,INTU,GABBR2,SPRY1,SPRED1,TJP2,KDR,FYN,NPFFR2,RXRA,OPHN1,TRAT1,SMAD9,RIT2,ARHGAP6,GSK3B,FGFBP1,KITLG,CCKAR,WLS,RPGRIP1L,FGF18,PDE8A,RASAL2,GPR176,EDNRA,BOC,GLI3,MIR6073,NEDD4,PLPPR4,RBP4,HTR1A,MAPK1,PNOC,GPR37,TNKS,PARD3,RPS6KA3,DACT1,GNAI1,CALCRL,CDC42EP3,ELMO1,APP,ACKR3,PIK3C3,PDE3A,KREMEN1,CYP26C1,NOX3,SPRED2,NTRK2,PPP2R1B,NEURL1B,ADRA2B,ADCY2,BMPR1B,GRM1,NLK,YAP1,NCOA3,NPY2R,MAD2L1,TEK,NOG,ATP6V0A4,ADCY8,LPAR1,GPC4,EPAS1,PROKR2,ADAM12,RGS9,NEDD4L,IQGAP2,NMUR2,ARHGEF6,GPC5,TRHR,ARHGAP24,DTX1,CXCR4,PENK
R-HSA-1474244	Extracellular matrix organization	0.0956357970839748	-2.34720808252728	297	18	0.0399113082039911	451	10391	4593,5352,388743,26577,22795,1462,1301,9508,3655,2201,7043,7042,3791,1308,84570,10516,340267,1297	MUSK,PLOD2,CAPN8,PCOLCE2,NID2,VCAN,COL11A1,ADAMTS3,ITGA6,FBN2,TGFB3,TGFB2,KDR,COL17A1,COL25A1,FBLN5,COL28A1,COL9A1
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0970002992908843	-2.33304121501048	126	9	0.0199556541019956	451	10391	351,5602,5594,57161,4064,6885,10010,6197,5519	APP,MAPK10,MAPK1,PELI2,CD180,MAP3K7,TANK,RPS6KA3,PPP2R1B
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0999232856214372	-2.30335253118504	91	7	0.0155210643015521	451	10391	6197,5519,6885,351,57161,5594,5602	RPS6KA3,PPP2R1B,MAP3K7,APP,PELI2,MAPK1,MAPK10
R-HSA-3000178	ECM proteoglycans	0.100311334126202	-2.29947658814326	57	5	0.0110864745011086	451	10391	4593,1462,7043,1297,7042	MUSK,VCAN,TGFB3,COL9A1,TGFB2
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.100696543671581	-2.2956438028697	41	4	0.00886917960088692	451	10391	114,5594,6197,2890	ADCY8,MAPK1,RPS6KA3,GRIA1
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.10108190465806	-2.29182415356429	26	3	0.00665188470066519	451	10391	2262,2239,1462	GPC5,GPC4,VCAN
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.10108190465806	-2.29182415356429	26	3	0.00665188470066519	451	10391	6480,25834,2530	ST6GAL1,MGAT4C,FUT8
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.10108190465806	-2.29182415356429	26	3	0.00665188470066519	451	10391	2262,2239,1462	GPC5,GPC4,VCAN
R-HSA-977068	Termination of O-glycan biosynthesis	0.10108190465806	-2.29182415356429	26	3	0.00665188470066519	451	10391	6480,118430,256435	ST6GAL1,MUCL1,ST6GALNAC3
R-HSA-1980143	Signaling by NOTCH1	0.101427943608477	-2.28840664779683	74	6	0.0133037694013304	451	10391	83464,1272,9734,1840,54492,8788	APH1B,CNTN1,HDAC9,DTX1,NEURL1B,DLK1
R-HSA-418555	G alpha (s) signalling events	0.102770308039896	-2.27525879997788	146	10	0.0221729490022173	451	10391	11245,4158,2770,10203,9287,406974,5139,108,114,5151	GPR176,MC2R,GNAI1,CALCRL,TAAR2,MIR197,PDE3A,ADCY2,ADCY8,PDE8A
R-HSA-202670	ERKs are inactivated	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	5594,5519	MAPK1,PPP2R1B
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	351,5594	APP,MAPK1
R-HSA-977441	GABA A receptor activation	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	2555,2566	GABRA2,GABRG2
R-HSA-190375	FGFR2c ligand binding and activation	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	8817,2263	FGF18,FGFR2
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	5289,50508	PIK3C3,NOX3
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	4682,83990	NUBP1,BRIP1
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	3084,1956	NRG1,EGFR
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.106946774746909	-2.23542400055259	13	2	0.00443458980044346	451	10391	5519,28227	PPP2R1B,PPP2R3B
R-HSA-1566948	Elastic fibre formation	0.107695359485297	-2.22844878316408	42	4	0.00886917960088692	451	10391	7042,10516,7043,2201	TGFB2,FBLN5,TGFB3,FBN2
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.108903930452272	-2.21728915738717	93	7	0.0155210643015521	451	10391	6885,5519,6197,5594,5602,57161,351	MAP3K7,PPP2R1B,RPS6KA3,MAPK1,MAPK10,PELI2,APP
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.108903930452272	-2.21728915738717	93	7	0.0155210643015521	451	10391	6885,5519,6197,57161,5594,5602,351	MAP3K7,PPP2R1B,RPS6KA3,PELI2,MAPK1,MAPK10,APP
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.110236895171854	-2.20512363637453	27	3	0.00665188470066519	451	10391	7486,5890,83990	WRN,RAD51B,BRIP1
R-HSA-177929	Signaling by EGFR	0.111918823351371	-2.189981461981	364	21	0.0465631929046563	451	10391	108,9462,5519,8817,2534,10252,161742,200734,5291,8038,114,50852,1956,6456,2263,284,3084,7010,5594,4254,2932	ADCY2,RASAL2,PPP2R1B,FGF18,FYN,SPRY1,SPRED1,SPRED2,PIK3CB,ADAM12,ADCY8,TRAT1,EGFR,SH3GL2,FGFR2,ANGPT1,NRG1,TEK,MAPK1,KITLG,GSK3B
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.114906995233096	-2.16363221492668	43	4	0.00886917960088692	451	10391	6119,83990,7486,5890	RPA3,BRIP1,WRN,RAD51B
R-HSA-983189	Kinesins	0.114906995233096	-2.16363221492668	43	4	0.00886917960088692	451	10391	9371,23303,84643,285643	KIF3B,KIF13B,KIF2B,KIF4B
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.118300171968524	-2.13453005433423	95	7	0.0155210643015521	451	10391	5519,6197,6885,5594,5602,57161,351	PPP2R1B,RPS6KA3,MAP3K7,MAPK1,MAPK10,PELI2,APP
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.118300171968524	-2.13453005433423	95	7	0.0155210643015521	451	10391	57161,5602,5594,351,6885,5519,6197	PELI2,MAPK10,MAPK1,APP,MAP3K7,PPP2R1B,RPS6KA3
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.118300171968524	-2.13453005433423	95	7	0.0155210643015521	451	10391	57161,5519,5594,6197,5602,351,6885	PELI2,PPP2R1B,MAPK1,RPS6KA3,MAPK10,APP,MAP3K7
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.118300171968524	-2.13453005433423	95	7	0.0155210643015521	451	10391	57161,5594,5602,351,6885,6197,5519	PELI2,MAPK1,MAPK10,APP,MAP3K7,RPS6KA3,PPP2R1B
R-HSA-70268	Pyruvate metabolism	0.119696887144802	-2.12279267223003	28	3	0.00665188470066519	451	10391	5160,8050,6256	PDHA1,PDHX,RXRA
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	5519,2932	PPP2R1B,GSK3B
R-HSA-162594	Early Phase of HIV Life Cycle	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	7852,7518	CXCR4,XRCC4
R-HSA-419408	Lysosphingolipid and LPA receptors	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	9890,1902	PLPPR4,LPAR1
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-177504	Retrograde neurotrophin signalling	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	6456,161	SH3GL2,AP2A2
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-418885	DCC mediated attractive signaling	0.121324376545502	-2.10928752241824	14	2	0.00443458980044346	451	10391	2534,1630	FYN,DCC
R-HSA-917937	Iron uptake and transport	0.122324620470024	-2.10107694444799	44	4	0.00886917960088692	451	10391	127124,30061,9429,50617	ATP6V1G3,SLC40A1,ABCG2,ATP6V0A4
R-HSA-1296072	Voltage gated Potassium channels	0.122324620470024	-2.10107694444799	44	4	0.00886917960088692	451	10391	3739,90134,3747,3755	KCNA4,KCNH7,KCNC2,KCNG1
R-HSA-975634	Retinoid metabolism and transport	0.122324620470024	-2.10107694444799	44	4	0.00886917960088692	451	10391	2262,5950,2239,5948	GPC5,RBP4,GPC4,RBP2
R-HSA-5663202	Diseases of signal transduction	0.123662747403074	-2.09019719770345	369	21	0.0465631929046563	451	10391	50852,9061,83999,3084,83464,2263,1956,4254,5594,5950,2932,5519,8817,9734,54492,9462,11116,8658,2534,5291,1488	TRAT1,PAPSS1,KREMEN1,NRG1,APH1B,FGFR2,EGFR,KITLG,MAPK1,RBP4,GSK3B,PPP2R1B,FGF18,HDAC9,NEURL1B,RASAL2,CEP43,TNKS,FYN,PIK3CB,CTBP2
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	2737	GLI3
R-HSA-352238	Breakdown of the nuclear lamina	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	839	CASP6
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	6857	SYT1
R-HSA-190827	Transport of connexins along the secretory pathway	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	6857	SYT1
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	2034	EPAS1
R-HSA-190704	Oligomerization of connexins into connexons	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-191650	Regulation of gap junction activity	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	29080	CCDC59
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	6657	SOX2
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	151	ADRA2B
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	8029	CUBN
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	8029	CUBN
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	1488	CTBP2
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.124650619426272	-2.08224049970063	3	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-166054	Activated TLR4 signalling	0.1266060852617	-2.06667470358916	115	8	0.0177383592017738	451	10391	10010,5519,6197,6885,351,57161,5602,5594	TANK,PPP2R1B,RPS6KA3,MAP3K7,APP,PELI2,MAPK10,MAPK1
R-HSA-168898	Toll-Like Receptors Cascades	0.128637420271913	-2.05075752760896	153	10	0.0221729490022173	451	10391	5602,5594,57161,351,6197,5519,10010,5289,6885,4064	MAPK10,MAPK1,PELI2,APP,RPS6KA3,PPP2R1B,TANK,PIK3C3,MAP3K7,CD180
R-HSA-375170	CDO in myogenesis	0.129444149859716	-2.044505766083	29	3	0.00665188470066519	451	10391	91653,1000,6938	BOC,CDH2,TCF12
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.129444149859716	-2.044505766083	29	3	0.00665188470066519	451	10391	161,9844,2534	AP2A2,ELMO1,FYN
R-HSA-196807	Nicotinate metabolism	0.129444149859716	-2.044505766083	29	3	0.00665188470066519	451	10391	4837,79668,83594	NNMT,PARP8,NUDT12
R-HSA-525793	Myogenesis	0.129444149859716	-2.044505766083	29	3	0.00665188470066519	451	10391	6938,91653,1000	TCF12,BOC,CDH2
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-975577	N-Glycan antennae elongation	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	25834,6480	MGAT4C,ST6GAL1
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	5519,2932	PPP2R1B,GSK3B
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	2932,5519	GSK3B,PPP2R1B
R-HSA-428540	Activation of Rac	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	6091,9353	ROBO1,SLIT2
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	1956,3084	EGFR,NRG1
R-HSA-156581	Methylation	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	4552,4837	MTRR,NNMT
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	5519,2932	PPP2R1B,GSK3B
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.13613799267949	-1.99408625560247	15	2	0.00443458980044346	451	10391	5519,2932	PPP2R1B,GSK3B
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.137339428627346	-1.9852998360768	63	5	0.0110864745011086	451	10391	6675,256435,7903,6480,6489	UAP1,ST6GALNAC3,ST8SIA4,ST6GAL1,ST8SIA1
R-HSA-1660662	Glycosphingolipid metabolism	0.137749044104833	-1.98232177032105	46	4	0.00886917960088692	451	10391	7368,411,3074,57733	UGT8,ARSB,HEXB,GBA3
R-HSA-166520	Signalling by NGF	0.138209878979421	-1.97898188699482	478	26	0.057649667405765	451	10391	5291,200734,4915,5519,8817,9462,108,5594,5607,7010,3084,83464,284,6456,2263,1956,161,114,161742,2534,6197,2932,4254,9459,50852,6014	PIK3CB,SPRED2,NTRK2,PPP2R1B,FGF18,RASAL2,ADCY2,MAPK1,MAP2K5,TEK,NRG1,APH1B,ANGPT1,SH3GL2,FGFR2,EGFR,AP2A2,ADCY8,SPRED1,FYN,RPS6KA3,GSK3B,KITLG,ARHGEF6,TRAT1,RIT2
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.138300194465565	-1.97832863419842	99	7	0.0155210643015521	451	10391	6197,10010,5519,6885,5602,5594,351	RPS6KA3,TANK,PPP2R1B,MAP3K7,MAPK10,MAPK1,APP
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.138300194465565	-1.97832863419842	99	7	0.0155210643015521	451	10391	5519,10010,6197,6885,351,5594,5602	PPP2R1B,TANK,RPS6KA3,MAP3K7,APP,MAPK1,MAPK10
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.138300194465565	-1.97832863419842	99	7	0.0155210643015521	451	10391	351,5602,5594,6885,6197,10010,5519	APP,MAPK10,MAPK1,MAP3K7,RPS6KA3,TANK,PPP2R1B
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	0.139460793700296	-1.96997176596571	30	3	0.00665188470066519	451	10391	7328,7324,29089	UBE2H,UBE2E1,UBE2T
R-HSA-5683826	Surfactant metabolism	0.139460793700296	-1.96997176596571	30	3	0.00665188470066519	451	10391	29080,253970,51201	CCDC59,SFTA3,ZDHHC2
R-HSA-111996	Ca-dependent events	0.139460793700296	-1.96997176596571	30	3	0.00665188470066519	451	10391	5594,108,114	MAPK1,ADCY2,ADCY8
R-HSA-450294	MAP kinase activation in TLR cascade	0.144030221894297	-1.9377321271607	64	5	0.0110864745011086	451	10391	6885,5602,5594,5519,6197	MAP3K7,MAPK10,MAPK1,PPP2R1B,RPS6KA3
R-HSA-75109	Triglyceride Biosynthesis	0.14510172329112	-1.93032024258692	82	6	0.0133037694013304	451	10391	392636,84803,56894,58488,79966,2710	AGMO,GPAT3,AGPAT3,PCTP,SCD5,GK
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.14885398291319	-1.90478943397985	197	12	0.0266075388026608	451	10391	4254,5594,5291,2932,5519,8817,50852,3084,6885,2263,2534,1956	KITLG,MAPK1,PIK3CB,GSK3B,PPP2R1B,FGF18,TRAT1,NRG1,MAP3K7,FGFR2,FYN,EGFR
R-HSA-420029	Tight junction interactions	0.149728865286569	-1.89892918525855	31	3	0.00665188470066519	451	10391	101928583,64398,56288	SLC7A14-AS1,PALS1,PARD3
R-HSA-2129379	Molecules associated with elastic fibres	0.149728865286569	-1.89892918525855	31	3	0.00665188470066519	451	10391	7042,7043,10516	TGFB2,TGFB3,FBLN5
R-HSA-1963642	PI3K events in ERBB2 signaling	0.151322907796159	-1.88833926319682	16	2	0.00443458980044346	451	10391	3084,1956	NRG1,EGFR
R-HSA-163615	PKA activation	0.151322907796159	-1.88833926319682	16	2	0.00443458980044346	451	10391	108,114	ADCY2,ADCY8
R-HSA-446353	Cell-extracellular matrix interactions	0.151322907796159	-1.88833926319682	16	2	0.00443458980044346	451	10391	9459,6251	ARHGEF6,RSU1
R-HSA-549132	Organic cation/anion/zwitterion transport	0.151322907796159	-1.88833926319682	16	2	0.00443458980044346	451	10391	85413,861	SLC22A16,RUNX1
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	0.151322907796159	-1.88833926319682	16	2	0.00443458980044346	451	10391	1956,2099	EGFR,ESR1
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.151322907796159	-1.88833926319682	16	2	0.00443458980044346	451	10391	3084,1956	NRG1,EGFR
R-HSA-1433559	Regulation of KIT signaling	0.151322907796159	-1.88833926319682	16	2	0.00443458980044346	451	10391	4254,2534	KITLG,FYN
R-HSA-2132295	MHC class II antigen presentation	0.159829783869362	-1.83364588085575	103	7	0.0155210643015521	451	10391	161,6456,285643,1519,1075,84643,9371	AP2A2,SH3GL2,KIF4B,CTSO,CTSC,KIF2B,KIF3B
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.160230432632064	-1.83114229589694	32	3	0.00665188470066519	451	10391	2932,8321,5519	GSK3B,FZD1,PPP2R1B
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.160230432632064	-1.83114229589694	32	3	0.00665188470066519	451	10391	2898,2897,83988	GRIK2,GRIK1,NCALD
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.162244330101629	-1.81865186945305	49	4	0.00886917960088692	451	10391	5160,50,8050,6256	PDHA1,ACO2,PDHX,RXRA
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	3791	KDR
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	51008	ASCC1
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	9061	PAPSS1
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	54790	TET2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	6507	SLC1A3
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	552	AVPR1A
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	6507	SLC1A3
R-HSA-399710	Activation of AMPA receptors	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	2890	GRIA1
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-173107	Binding and entry of HIV virion	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	7852	CXCR4
R-HSA-428776	Class II GLUTs	0.162654332424634	-1.81612798993038	4	1	0.00221729490022173	451	10391	56606	SLC2A9
R-HSA-111885	Opioid Signalling	0.163382162703223	-1.81166326589796	85	6	0.0133037694013304	451	10391	406974,114,108,5519,2770,5594	MIR197,ADCY8,ADCY2,PPP2R1B,GNAI1,MAPK1
R-HSA-196299	Beta-catenin phosphorylation cascade	0.166819180757794	-1.79084480311591	17	2	0.00443458980044346	451	10391	5519,2932	PPP2R1B,GSK3B
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.166819180757794	-1.79084480311591	17	2	0.00443458980044346	451	10391	4552,8029	MTRR,CUBN
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.166819180757794	-1.79084480311591	17	2	0.00443458980044346	451	10391	108,114	ADCY2,ADCY8
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.166819180757794	-1.79084480311591	17	2	0.00443458980044346	451	10391	2890,161	GRIA1,AP2A2
R-HSA-164378	PKA activation in glucagon signalling	0.166819180757794	-1.79084480311591	17	2	0.00443458980044346	451	10391	114,108	ADCY8,ADCY2
R-HSA-2033519	Activated point mutants of FGFR2	0.166819180757794	-1.79084480311591	17	2	0.00443458980044346	451	10391	2263,8817	FGFR2,FGF18
R-HSA-1980145	Signaling by NOTCH2	0.170947661085073	-1.76639784485604	33	3	0.00665188470066519	451	10391	1272,83464,54492	CNTN1,APH1B,NEURL1B
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.172127700488938	-1.75951863294128	68	5	0.0110864745011086	451	10391	6119,83990,23514,5890,7486	RPA3,BRIP1,SPIDR,RAD51B,WRN
R-HSA-556833	Metabolism of lipids and lipoproteins	0.180301876534329	-1.71312274098272	816	41	0.0909090909090909	451	10391	10413,8202,5291,26031,590,5288,10891,57733,55331,7368,79966,58488,5244,3074,411,161,441282,1071,27235,56894,19,54477,8898,84803,347516,2710,6256,9218,392636,2534,8613,5783,23417,5587,8821,64850,171546,30814,8029,5289,65985	YAP1,NCOA3,PIK3CB,OSBPL3,BCHE,PIK3C2G,PPARGC1A,GBA3,ACER3,UGT8,SCD5,PCTP,ABCB4,HEXB,ARSB,AP2A2,AKR1B15,CETP,COQ2,AGPAT3,ABCA1,PLEKHA5,MTMR2,GPAT3,DGAT2L6,GK,RXRA,VAPA,AGMO,FYN,PLPP3,PTPN13,MLYCD,PRKD1,INPP4B,ETNPPL,SPTSSA,PLA2G2E,CUBN,PIK3C3,AACS
R-HSA-1483166	Synthesis of PA	0.181862880805644	-1.70450227802217	34	3	0.00665188470066519	451	10391	30814,56894,84803	PLA2G2E,AGPAT3,GPAT3
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.181862880805644	-1.70450227802217	34	3	0.00665188470066519	451	10391	2263,8817,5594	FGFR2,FGF18,MAPK1
R-HSA-113510	E2F mediated regulation of DNA replication	0.181862880805644	-1.70450227802217	34	3	0.00665188470066519	451	10391	4999,5519,28227	ORC2,PPP2R1B,PPP2R3B
R-HSA-912631	Regulation of signaling by CBL	0.182571353591718	-1.70061420378705	18	2	0.00443458980044346	451	10391	5291,2534	PIK3CB,FYN
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.182571353591718	-1.70061420378705	18	2	0.00443458980044346	451	10391	8817,2263	FGF18,FGFR2
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.182571353591718	-1.70061420378705	18	2	0.00443458980044346	451	10391	59272,10159	ACE2,ATP6AP2
R-HSA-3371556	Cellular response to heat stress	0.189184142311912	-1.66503444029606	89	6	0.0133037694013304	451	10391	9688,6119,129401,2932,5594,3308	NUP93,RPA3,NUP35,GSK3B,MAPK1,HSPA4
R-HSA-5683057	MAPK family signaling cascades	0.19370776468395	-1.64140462323968	290	16	0.0354767184035477	451	10391	8202,10602,161742,5596,200734,2534,5519,8817,9462,5594,4254,284,3084,7010,1956,2263	NCOA3,CDC42EP3,SPRED1,MAPK4,SPRED2,FYN,PPP2R1B,FGF18,RASAL2,MAPK1,KITLG,ANGPT1,NRG1,TEK,EGFR,FGFR2
R-HSA-187706	Signalling to p38 via RIT and RIN	0.194350424511518	-1.63809243742327	249	14	0.0310421286031042	451	10391	200734,161742,2534,5519,8817,9462,4254,5594,7010,3084,284,2263,1956,6014	SPRED2,SPRED1,FYN,PPP2R1B,FGF18,RASAL2,KITLG,MAPK1,TEK,NRG1,ANGPT1,FGFR2,EGFR,RIT2
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.198528176664269	-1.61682424099772	19	2	0.00443458980044346	451	10391	5288,5289	PIK3C2G,PIK3C3
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.198528176664269	-1.61682424099772	19	2	0.00443458980044346	451	10391	6885,5602	MAP3K7,MAPK10
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.198528176664269	-1.61682424099772	19	2	0.00443458980044346	451	10391	9314,590	KLF4,BCHE
R-HSA-156584	Cytosolic sulfonation of small molecules	0.198528176664269	-1.61682424099772	19	2	0.00443458980044346	451	10391	51000,9061	SLC35B3,PAPSS1
R-HSA-3928664	Ephrin signaling	0.198528176664269	-1.61682424099772	19	2	0.00443458980044346	451	10391	2047,2534	EPHB1,FYN
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.198528176664269	-1.61682424099772	19	2	0.00443458980044346	451	10391	6857,22999	SYT1,RIMS1
R-HSA-2161517	Abacavir transmembrane transport	0.199011595932509	-1.6143921849377	5	1	0.00221729490022173	451	10391	9429	ABCG2
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.199011595932509	-1.6143921849377	5	1	0.00221729490022173	451	10391	3642	INSM1
R-HSA-8849473	PTK6 Expression	0.199011595932509	-1.6143921849377	5	1	0.00221729490022173	451	10391	2034	EPAS1
R-HSA-187024	NGF-independant TRKA activation	0.199011595932509	-1.6143921849377	5	1	0.00221729490022173	451	10391	4915	NTRK2
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.199011595932509	-1.6143921849377	5	1	0.00221729490022173	451	10391	3084	NRG1
R-HSA-8866376	Reelin signalling pathway	0.199011595932509	-1.6143921849377	5	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.20421778935718	-1.58856825972393	36	3	0.00665188470066519	451	10391	1956,108,114	EGFR,ADCY2,ADCY8
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.20421778935718	-1.58856825972393	36	3	0.00665188470066519	451	10391	6657,9314,2034	SOX2,KLF4,EPAS1
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.20421778935718	-1.58856825972393	36	3	0.00665188470066519	451	10391	639,900,5519	PRDM1,CCNG1,PPP2R1B
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.214642349174629	-1.538782128205	20	2	0.00443458980044346	451	10391	4085,7324	MAD2L1,UBE2E1
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.214642349174629	-1.538782128205	20	2	0.00443458980044346	451	10391	7324,4085	UBE2E1,MAD2L1
R-HSA-438064	Post NMDA receptor activation events	0.215623463959195	-1.53422161488939	37	3	0.00665188470066519	451	10391	6197,5594,114	RPS6KA3,MAPK1,ADCY8
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.217304441877484	-1.52645595070693	234	13	0.0288248337028825	451	10391	2932,5594,4254,3084,1956,2263,868,50852,5291,6885,2534,8817,5519	GSK3B,MAPK1,KITLG,NRG1,EGFR,FGFR2,CBLB,TRAT1,PIK3CB,MAP3K7,FYN,FGF18,PPP2R1B
R-HSA-174824	Lipoprotein metabolism	0.217765382101049	-1.52433702463749	74	5	0.0110864745011086	451	10391	19,8029,2534,161,1071	ABCA1,CUBN,FYN,AP2A2,CETP
R-HSA-912526	Interleukin receptor SHC signaling	0.218612983846356	-1.52045230954903	255	14	0.0310421286031042	451	10391	5291,9462,8817,5519,2534,161742,200734,5594,4254,1956,2263,284,3084,7010	PIK3CB,RASAL2,FGF18,PPP2R1B,FYN,SPRED1,SPRED2,MAPK1,KITLG,EGFR,FGFR2,ANGPT1,NRG1,TEK
R-HSA-375165	NCAM signaling for neurite out-growth	0.219456063163634	-1.5166032343226	276	15	0.0332594235033259	451	10391	1297,200734,161742,2534,8817,5519,9462,4254,5594,7903,7010,3084,284,2263,1956	COL9A1,SPRED2,SPRED1,FYN,FGF18,PPP2R1B,RASAL2,KITLG,MAPK1,ST8SIA4,TEK,NRG1,ANGPT1,FGFR2,EGFR
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.227159186983065	-1.48210424302903	38	3	0.00665188470066519	451	10391	6119,83990,7486	RPA3,BRIP1,WRN
R-HSA-69618	Mitotic Spindle Checkpoint	0.23087027417893	-1.46589930984849	21	2	0.00443458980044346	451	10391	4085,7324	MAD2L1,UBE2E1
R-HSA-2024096	HS-GAG degradation	0.23087027417893	-1.46589930984849	21	2	0.00443458980044346	451	10391	2262,2239	GPC5,GPC4
R-HSA-2028269	Signaling by Hippo	0.23087027417893	-1.46589930984849	21	2	0.00443458980044346	451	10391	9414,10413	TJP2,YAP1
R-HSA-8849932	SALM protein interactions at the synapses	0.23087027417893	-1.46589930984849	21	2	0.00443458980044346	451	10391	2890,5789	GRIA1,PTPRD
R-HSA-445144	Signal transduction by L1	0.23087027417893	-1.46589930984849	21	2	0.00443458980044346	451	10391	5594,1956	MAPK1,EGFR
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.231214603949781	-1.46440897830604	258	14	0.0310421286031042	451	10391	200734,161742,3791,2534,8817,5519,9462,7010,3084,284,2263,1956,4254,5594	SPRED2,SPRED1,KDR,FYN,FGF18,PPP2R1B,RASAL2,TEK,NRG1,ANGPT1,FGFR2,EGFR,KITLG,MAPK1
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-193144	Estrogen biosynthesis	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	441282	AKR1B15
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	4158	MC2R
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	83999	KREMEN1
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-8857538	PTK6 promotes HIF1A stabilization	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-947581	Molybdenum cofactor biosynthesis	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	10243	GPHN
R-HSA-388479	Vasopressin-like receptors	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	552	AVPR1A
R-HSA-211916	Vitamins	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	340665	CYP26C1
R-HSA-187015	Activation of TRKA receptors	0.233793588069388	-1.45331665517315	6	1	0.00221729490022173	451	10391	4915	NTRK2
R-HSA-74752	Signaling by Insulin receptor	0.235199003690179	-1.44732329897778	322	17	0.0376940133037694	451	10391	5594,4254,1956,2263,5289,284,3084,127124,7010,50617,5291,2534,161742,200734,9462,5519,8817	MAPK1,KITLG,EGFR,FGFR2,PIK3C3,ANGPT1,NRG1,ATP6V1G3,TEK,ATP6V0A4,PIK3CB,FYN,SPRED1,SPRED2,RASAL2,PPP2R1B,FGF18
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.238808871963128	-1.43209174587941	39	3	0.00665188470066519	451	10391	9414,1829,839	TJP2,DSG2,CASP6
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.243457960761377	-1.41281099710832	58	4	0.00886917960088692	451	10391	8825,2035,2911,6857	LIN7A,EPB41,GRM1,SYT1
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.247171827323605	-1.39767152703087	22	2	0.00443458980044346	451	10391	1956,3084	EGFR,NRG1
R-HSA-451927	Interleukin-2 signaling	0.248466814404262	-1.39244598600802	262	14	0.0310421286031042	451	10391	2534,161742,200734,9462,8817,5519,5291,1956,2263,284,3084,7010,5594,4254	FYN,SPRED1,SPRED2,RASAL2,FGF18,PPP2R1B,PIK3CB,EGFR,FGFR2,ANGPT1,NRG1,TEK,MAPK1,KITLG
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.250056061131271	-1.38607014173385	78	5	0.0110864745011086	451	10391	9688,84733,7518,129401,7486	NUP93,CBX2,XRCC4,NUP35,WRN
R-HSA-187687	Signalling to ERKs	0.252855813831574	-1.37493585851671	263	14	0.0310421286031042	451	10391	284,3084,7010,1956,2263,6014,5594,4254,161742,200734,2534,5519,8817,9462	ANGPT1,NRG1,TEK,EGFR,FGFR2,RIT2,MAPK1,KITLG,SPRED1,SPRED2,FYN,PPP2R1B,FGF18,RASAL2
R-HSA-5358351	Signaling by Hedgehog	0.25659035942142	-1.36027439796072	139	8	0.0177383592017738	451	10391	114,108,2262,23322,2737,27152,91653,2932	ADCY8,ADCY2,GPC5,RPGRIP1L,GLI3,INTU,BOC,GSK3B
R-HSA-1442490	Collagen degradation	0.262387935771814	-1.33793119944852	41	3	0.00665188470066519	451	10391	1308,84570,1297	COL17A1,COL25A1,COL9A1
R-HSA-74158	RNA Polymerase III Transcription	0.262387935771814	-1.33793119944852	41	3	0.00665188470066519	451	10391	2971,55703,4781	GTF3A,POLR3B,NFIB
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.262387935771814	-1.33793119944852	41	3	0.00665188470066519	451	10391	2971,55703,4781	GTF3A,POLR3B,NFIB
R-HSA-73980	RNA Polymerase III Transcription Termination	0.263510138676849	-1.33366343478895	23	2	0.00443458980044346	451	10391	4781,55703	NFIB,POLR3B
R-HSA-8855121	VLDL interactions	0.263510138676849	-1.33366343478895	23	2	0.00443458980044346	451	10391	2534,161	FYN,AP2A2
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.263510138676849	-1.33366343478895	23	2	0.00443458980044346	451	10391	8817,2263	FGF18,FGFR2
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.263510138676849	-1.33366343478895	23	2	0.00443458980044346	451	10391	2770,406974	GNAI1,MIR197
R-HSA-5654695	PI-3K cascade:FGFR2	0.263510138676849	-1.33366343478895	23	2	0.00443458980044346	451	10391	2263,8817	FGFR2,FGF18
R-HSA-180336	SHC1 events in EGFR signaling	0.266923047571196	-1.3207948734666	245	13	0.0288248337028825	451	10391	2534,200734,161742,9462,5519,8817,2263,1956,3084,7010,284,4254,5594	FYN,SPRED2,SPRED1,RASAL2,PPP2R1B,FGF18,FGFR2,EGFR,NRG1,TEK,ANGPT1,KITLG,MAPK1
R-HSA-5673001	RAF/MAP kinase cascade	0.266923047571196	-1.3207948734666	245	13	0.0288248337028825	451	10391	9462,5519,8817,2534,200734,161742,2263,1956,7010,3084,284,4254,5594	RASAL2,PPP2R1B,FGF18,FYN,SPRED2,SPRED1,FGFR2,EGFR,TEK,NRG1,ANGPT1,KITLG,MAPK1
R-HSA-112412	SOS-mediated signalling	0.266923047571196	-1.3207948734666	245	13	0.0288248337028825	451	10391	4254,5594,7010,3084,284,2263,1956,200734,161742,2534,5519,8817,9462	KITLG,MAPK1,TEK,NRG1,ANGPT1,FGFR2,EGFR,SPRED2,SPRED1,FYN,PPP2R1B,FGF18,RASAL2
R-HSA-179812	GRB2 events in EGFR signaling	0.266923047571196	-1.3207948734666	245	13	0.0288248337028825	451	10391	5594,4254,1956,2263,284,3084,7010,2534,161742,200734,9462,8817,5519	MAPK1,KITLG,EGFR,FGFR2,ANGPT1,NRG1,TEK,FYN,SPRED1,SPRED2,RASAL2,FGF18,PPP2R1B
R-HSA-171319	Telomere Extension By Telomerase	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	8607	RUVBL1
R-HSA-164843	2-LTR circle formation	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	7518	XRCC4
R-HSA-433692	Proton-coupled monocarboxylate transport	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	9194	SLC16A7
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	80333	KCNIP4
R-HSA-190371	FGFR3b ligand binding and activation	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	55312	RFK
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	5519	PPP2R1B
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	114	ADCY8
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	161	AP2A2
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	1462	VCAN
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	1462	VCAN
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	7444	VRK2
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	51008	ASCC1
R-HSA-447038	NrCAM interactions	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	4897	NRCAM
R-HSA-5619102	SLC transporter disorders	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	552	AVPR1A
R-HSA-199920	CREB phosphorylation	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	6197	RPS6KA3
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	6928	HNF1B
R-HSA-3595177	Defective CHSY1 causes TPBS	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	1462	VCAN
R-HSA-196791	Vitamin D (calciferol) metabolism	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	8029	CUBN
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	0.267068416358672	-1.3202504123623	7	1	0.00221729490022173	451	10391	64078	SLC28A3
R-HSA-186763	Downstream signal transduction	0.268968030434808	-1.3131627524103	352	18	0.0399113082039911	451	10391	5291,2534,161742,200734,108,9462,8817,5519,2932,5594,4254,1956,2263,284,3084,7010,114,50852	PIK3CB,FYN,SPRED1,SPRED2,ADCY2,RASAL2,FGF18,PPP2R1B,GSK3B,MAPK1,KITLG,EGFR,FGFR2,ANGPT1,NRG1,TEK,ADCY8,TRAT1
R-HSA-186797	Signaling by PDGF	0.278610237217679	-1.27794147309372	376	19	0.0421286031042129	451	10391	114,50852,1956,2263,284,3084,7010,5594,4254,2932,108,9462,5519,8817,2534,161742,200734,5291,1297	ADCY8,TRAT1,EGFR,FGFR2,ANGPT1,NRG1,TEK,MAPK1,KITLG,GSK3B,ADCY2,RASAL2,PPP2R1B,FGF18,FYN,SPRED1,SPRED2,PIK3CB,COL9A1
R-HSA-171052	LDL-mediated lipid transport	0.279851386825037	-1.2734965780557	24	2	0.00443458980044346	451	10391	1071,161	CETP,AP2A2
R-HSA-5610787	Hedgehog 'off' state	0.281935773116586	-1.26607598888983	102	6	0.0133037694013304	451	10391	2932,27152,23322,2737,108,114	GSK3B,INTU,RPGRIP1L,GLI3,ADCY2,ADCY8
R-HSA-8852135	Protein ubiquitination	0.282115830725657	-1.26543754512348	62	4	0.00886917960088692	451	10391	220441,7328,7324,29089	RNF152,UBE2H,UBE2E1,UBE2T
R-HSA-8853659	RET signaling	0.284350920950663	-1.25754616644202	270	14	0.0310421286031042	451	10391	5594,4254,1956,2263,284,7010,3084,5291,2534,161742,200734,9462,8817,5519	MAPK1,KITLG,EGFR,FGFR2,ANGPT1,TEK,NRG1,PIK3CB,FYN,SPRED1,SPRED2,RASAL2,FGF18,PPP2R1B
R-HSA-2424491	DAP12 signaling	0.284806597757474	-1.25594493342939	356	18	0.0399113082039911	451	10391	161742,200734,2534,8817,5519,108,9462,5291,284,7010,3084,1956,2263,50852,114,2932,5594,4254	SPRED1,SPRED2,FYN,FGF18,PPP2R1B,ADCY2,RASAL2,PIK3CB,ANGPT1,TEK,NRG1,EGFR,FGFR2,TRAT1,ADCY8,GSK3B,MAPK1,KITLG
R-HSA-170984	ARMS-mediated activation	0.285877848593737	-1.25219066221577	249	13	0.0288248337028825	451	10391	1956,2263,284,3084,7010,5594,4254,9462,5519,8817,2534,161742,200734	EGFR,FGFR2,ANGPT1,NRG1,TEK,MAPK1,KITLG,RASAL2,PPP2R1B,FGF18,FYN,SPRED1,SPRED2
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.286240892436577	-1.2509215414353	43	3	0.00665188470066519	451	10391	102464826,6657,55553	MIR6073,SOX2,SOX6
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.286240892436577	-1.2509215414353	43	3	0.00665188470066519	451	10391	2770,8787,406974	GNAI1,RGS9,MIR197
R-HSA-375280	Amine ligand-binding receptors	0.286240892436577	-1.2509215414353	43	3	0.00665188470066519	451	10391	3350,9287,151	HTR1A,TAAR2,ADRA2B
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.286356566969393	-1.2505175070391	378	19	0.0421286031042129	451	10391	9462,8817,5519,2534,161742,6885,200734,5291,3702,50852,1956,2263,284,7010,3084,5602,5594,4254,2932	RASAL2,FGF18,PPP2R1B,FYN,SPRED1,MAP3K7,SPRED2,PIK3CB,ITK,TRAT1,EGFR,FGFR2,ANGPT1,TEK,NRG1,MAPK10,MAPK1,KITLG,GSK3B
R-HSA-2871796	FCERI mediated MAPK activation	0.288951770906916	-1.2414954874712	271	14	0.0310421286031042	451	10391	5519,8817,9462,161742,200734,2534,5602,5594,4254,284,7010,3084,1956,2263	PPP2R1B,FGF18,RASAL2,SPRED1,SPRED2,FYN,MAPK10,MAPK1,KITLG,ANGPT1,TEK,NRG1,EGFR,FGFR2
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.288951770906916	-1.2414954874712	271	14	0.0310421286031042	451	10391	5291,2534,161742,200734,9462,8817,5519,5594,4254,1956,2263,284,3084,7010	PIK3CB,FYN,SPRED1,SPRED2,RASAL2,FGF18,PPP2R1B,MAPK1,KITLG,EGFR,FGFR2,ANGPT1,NRG1,TEK
R-HSA-170968	Frs2-mediated activation	0.290681521504584	-1.23552703895339	250	13	0.0288248337028825	451	10391	4254,5594,3084,7010,284,2263,1956,200734,161742,2534,8817,5519,9462	KITLG,MAPK1,NRG1,TEK,ANGPT1,FGFR2,EGFR,SPRED2,SPRED1,FYN,FGF18,PPP2R1B,RASAL2
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	0.2919420091103	-1.23120009537456	83	5	0.0110864745011086	451	10391	285643,9371,84643,53407,23303	KIF4B,KIF3B,KIF2B,STX18,KIF13B
R-HSA-5684996	MAPK1/MAPK3 signaling	0.295509459996456	-1.21905442912402	251	13	0.0288248337028825	451	10391	1956,2263,284,3084,7010,5594,4254,2534,161742,200734,9462,5519,8817	EGFR,FGFR2,ANGPT1,NRG1,TEK,MAPK1,KITLG,FYN,SPRED1,SPRED2,RASAL2,PPP2R1B,FGF18
R-HSA-112399	IRS-mediated signalling	0.295970946804085	-1.21749398216427	294	15	0.0332594235033259	451	10391	161742,200734,2534,5519,8817,9462,5291,284,5289,3084,7010,1956,2263,5594,4254	SPRED1,SPRED2,FYN,PPP2R1B,FGF18,RASAL2,PIK3CB,ANGPT1,PIK3C3,NRG1,TEK,EGFR,FGFR2,MAPK1,KITLG
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.296164604688174	-1.21683988230316	25	2	0.00443458980044346	451	10391	2263,8817	FGFR2,FGF18
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.296164604688174	-1.21683988230316	25	2	0.00443458980044346	451	10391	26289,6240	AK5,RRM1
R-HSA-3295583	TRP channels	0.296164604688174	-1.21683988230316	25	2	0.00443458980044346	451	10391	80036,7223	TRPM3,TRPC4
R-HSA-3000157	Laminin interactions	0.296164604688174	-1.21683988230316	25	2	0.00443458980044346	451	10391	22795,3655	NID2,ITGA6
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.296164604688174	-1.21683988230316	25	2	0.00443458980044346	451	10391	4085,7324	MAD2L1,UBE2E1
R-HSA-5632681	Ligand-receptor interactions	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	91653	BOC
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	351	APP
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	2262	GPC5
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	6928	HNF1B
R-HSA-77111	Synthesis of Ketone Bodies	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	65985	AACS
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	3791	KDR
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	253970	SFTA3
R-HSA-196783	Coenzyme A biosynthesis	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	79646	PANK3
R-HSA-5576890	Phase 3 - rapid repolarisation	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	9992	KCNE2
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	10886	NPFFR2
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	10507	SEMA4D
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	253970	SFTA3
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	6675	UAP1
R-HSA-72731	Recycling of eIF2:GDP	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	1968	EIF2S3
R-HSA-1253288	Downregulation of ERBB4 signaling	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	4734	NEDD4
R-HSA-194313	VEGF ligand-receptor interactions	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	3791	KDR
R-HSA-2142789	Ubiquinol biosynthesis	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	27235	COQ2
R-HSA-73942	DNA Damage Reversal	0.298901249967241	-1.20764202780992	8	1	0.00221729490022173	451	10391	51008	ASCC1
R-HSA-169893	Prolonged ERK activation events	0.300360790512147	-1.20277089187169	252	13	0.0288248337028825	451	10391	4254,5594,3084,7010,284,2263,1956,8817,5519,9462,200734,161742,2534	KITLG,MAPK1,NRG1,TEK,ANGPT1,FGFR2,EGFR,FGF18,PPP2R1B,RASAL2,SPRED2,SPRED1,FYN
R-HSA-391251	Protein folding	0.304717038431446	-1.1883716758422	105	6	0.0133037694013304	451	10391	8787,6902,2770,406974,11328,6468	RGS9,TBCA,GNAI1,MIR197,FKBP9,FBXW4
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.305234633618962	-1.18667450757306	253	13	0.0288248337028825	451	10391	5244,58488,79966,65985,19,56894,10891,84803,8202,10413,392636,6256,2710	ABCB4,PCTP,SCD5,AACS,ABCA1,AGPAT3,PPARGC1A,GPAT3,NCOA3,YAP1,AGMO,RXRA,GK
R-HSA-2586552	Signaling by Leptin	0.305234633618962	-1.18667450757306	253	13	0.0288248337028825	451	10391	5594,4254,284,3084,7010,1956,2263,5519,8817,9462,161742,200734,2534	MAPK1,KITLG,ANGPT1,NRG1,TEK,EGFR,FGFR2,PPP2R1B,FGF18,RASAL2,SPRED1,SPRED2,FYN
R-HSA-74751	Insulin receptor signalling cascade	0.309481581122901	-1.1728567003476	297	15	0.0332594235033259	451	10391	5291,2534,161742,200734,9462,8817,5519,5594,4254,1956,2263,284,5289,7010,3084	PIK3CB,FYN,SPRED1,SPRED2,RASAL2,FGF18,PPP2R1B,MAPK1,KITLG,EGFR,FGFR2,ANGPT1,PIK3C3,TEK,NRG1
R-HSA-2428924	IGF1R signaling cascade	0.314023496812182	-1.15828746526151	298	15	0.0332594235033259	451	10391	1956,2263,5289,284,3084,7010,5594,4254,9462,8817,5519,2534,161742,200734,5291	EGFR,FGFR2,PIK3C3,ANGPT1,NRG1,TEK,MAPK1,KITLG,RASAL2,FGF18,PPP2R1B,FYN,SPRED1,SPRED2,PIK3CB
R-HSA-2428928	IRS-related events triggered by IGF1R	0.314023496812182	-1.15828746526151	298	15	0.0332594235033259	451	10391	7010,3084,5289,284,2263,1956,4254,5594,8817,5519,9462,200734,161742,2534,5291	TEK,NRG1,PIK3C3,ANGPT1,FGFR2,EGFR,KITLG,MAPK1,FGF18,PPP2R1B,RASAL2,SPRED2,SPRED1,FYN,PIK3CB
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.318583434946916	-1.14387087611929	299	15	0.0332594235033259	451	10391	9462,8817,5519,2534,200734,161742,5291,2263,1956,3084,7010,284,5289,4254,5594	RASAL2,FGF18,PPP2R1B,FYN,SPRED2,SPRED1,PIK3CB,FGFR2,EGFR,NRG1,TEK,ANGPT1,PIK3C3,KITLG,MAPK1
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.318733036560271	-1.14340140256011	170	9	0.0199556541019956	451	10391	6256,4710,518,4724,1345,29078,8050,5160,50	RXRA,NDUFB4,ATP5MC3,NDUFS4,COX6C,NDUFAF4,PDHX,PDHA1,ACO2
R-HSA-167044	Signalling to RAS	0.319982366503851	-1.13948938938215	256	13	0.0288248337028825	451	10391	2534,161742,200734,9462,5519,8817,5594,4254,1956,2263,284,7010,3084	FYN,SPRED1,SPRED2,RASAL2,PPP2R1B,FGF18,MAPK1,KITLG,EGFR,FGFR2,ANGPT1,TEK,NRG1
R-HSA-77387	Insulin receptor recycling	0.328596264444936	-1.11292544153569	27	2	0.00443458980044346	451	10391	50617,127124	ATP6V0A4,ATP6V1G3
R-HSA-74182	Ketone body metabolism	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	65985	AACS
R-HSA-2179392	EGFR Transactivation by Gastrin	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	4837	NNMT
R-HSA-390696	Adrenoceptors	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	151	ADRA2B
R-HSA-112411	MAPK1 (ERK2) activation	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-162592	Integration of provirus	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	7518	XRCC4
R-HSA-2453864	Retinoid cycle disease events	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	5950	RBP4
R-HSA-2474795	Diseases associated with visual transduction	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	5950	RBP4
R-HSA-196025	Formation of annular gap junctions	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.329354446174579	-1.11062076413965	9	1	0.00221729490022173	451	10391	347516	DGAT2L6
R-HSA-1483206	Glycerophospholipid biosynthesis	0.334750603745385	-1.0943694908415	130	7	0.0155210643015521	451	10391	58488,84803,347516,590,64850,56894,30814	PCTP,GPAT3,DGAT2L6,BCHE,ETNPPL,AGPAT3,PLA2G2E
R-HSA-111997	CaM pathway	0.344665447319714	-1.06518105034525	28	2	0.00443458980044346	451	10391	108,114	ADCY2,ADCY8
R-HSA-5576893	Phase 2 - plateau phase	0.344665447319714	-1.06518105034525	28	2	0.00443458980044346	451	10391	781,9992	CACNA2D1,KCNE2
R-HSA-1368082	RORA activates gene expression	0.344665447319714	-1.06518105034525	28	2	0.00443458980044346	451	10391	6256,10891	RXRA,PPARGC1A
R-HSA-111933	Calmodulin induced events	0.344665447319714	-1.06518105034525	28	2	0.00443458980044346	451	10391	114,108	ADCY8,ADCY2
R-HSA-1483191	Synthesis of PC	0.344665447319714	-1.06518105034525	28	2	0.00443458980044346	451	10391	58488,590	PCTP,BCHE
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.344665447319714	-1.06518105034525	28	2	0.00443458980044346	451	10391	55703,2971	POLR3B,GTF3A
R-HSA-4570464	SUMOylation of RNA binding proteins	0.346356614603478	-1.06028635666361	48	3	0.00665188470066519	451	10391	84733,9688,129401	CBX2,NUP93,NUP35
R-HSA-2172127	DAP12 interactions	0.346686050602985	-1.05933566187711	371	18	0.0399113082039911	451	10391	50852,114,7010,3084,284,2263,1956,4254,5594,2932,8817,5519,9462,108,200734,161742,2534,5291	TRAT1,ADCY8,TEK,NRG1,ANGPT1,FGFR2,EGFR,KITLG,MAPK1,GSK3B,FGF18,PPP2R1B,RASAL2,ADCY2,SPRED2,SPRED1,FYN,PIK3CB
R-HSA-446203	Asparagine N-linked glycosylation	0.350585391156527	-1.04815097548486	284	14	0.0310421286031042	451	10391	6675,6480,25834,2890,7369,7903,287,6489,2530,91949,199857,144245,256435,1075	UAP1,ST6GAL1,MGAT4C,GRIA1,UMOD,ST8SIA4,ANK2,ST8SIA1,FUT8,COG7,ALG14,ALG10B,ST6GALNAC3,CTSC
R-HSA-8856688	Golgi-to-ER retrograde transport	0.351128824869936	-1.04660210043106	111	6	0.0133037694013304	451	10391	285643,56894,53407,84643,23303,9371	KIF4B,AGPAT3,STX18,KIF2B,KIF13B,KIF3B
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	0.35836393750223	-1.02620622375248	49	3	0.00665188470066519	451	10391	339122,60592,91949	RAB43,SCOC,COG7
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	10891	PPARGC1A
R-HSA-2161522	Abacavir transport and metabolism	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	9429	ABCG2
R-HSA-74749	Signal attenuation	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-427601	Multifunctional anion exchangers	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	115111	SLC26A7
R-HSA-1250342	PI3K events in ERBB4 signaling	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	3084	NRG1
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	2530	FUT8
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-190873	Gap junction degradation	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	64116	SLC39A8
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	134353	LSM11
R-HSA-419812	Calcitonin-like ligand receptors	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	10203	CALCRL
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	161	AP2A2
R-HSA-193692	Regulated proteolysis of p75NTR	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	83464	APH1B
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	590	BCHE
R-HSA-168799	Neurotoxicity of clostridium toxins	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	6857	SYT1
R-HSA-1300644	Interaction With The Zona Pellucida	0.358487671459329	-1.02586100876857	10	1	0.00221729490022173	451	10391	57829	ZP4
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.360155188180557	-1.02122026214021	330	16	0.0354767184035477	451	10391	5594,4254,1956,2263,284,3084,7010,9844,5291,9462,5519,8817,2534,3791,161742,200734	MAPK1,KITLG,EGFR,FGFR2,ANGPT1,NRG1,TEK,ELMO1,PIK3CB,RASAL2,PPP2R1B,FGF18,FYN,KDR,SPRED1,SPRED2
R-HSA-5621480	Dectin-2 family	0.3606077656448	-1.01996443310149	29	2	0.00443458980044346	451	10391	2534,118430	FYN,MUCL1
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.3606077656448	-1.01996443310149	29	2	0.00443458980044346	451	10391	8817,5594	FGF18,MAPK1
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.3606077656448	-1.01996443310149	29	2	0.00443458980044346	451	10391	10413,6256	YAP1,RXRA
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.3606077656448	-1.01996443310149	29	2	0.00443458980044346	451	10391	6885,351	MAP3K7,APP
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.3606077656448	-1.01996443310149	29	2	0.00443458980044346	451	10391	6197,5594	RPS6KA3,MAPK1
R-HSA-202040	G-protein activation	0.3606077656448	-1.01996443310149	29	2	0.00443458980044346	451	10391	406974,2770	MIR197,GNAI1
R-HSA-2980736	Peptide hormone metabolism	0.36099423582925	-1.01889328800873	91	5	0.0110864745011086	451	10391	59272,9314,1803,590,10159	ACE2,KLF4,DPP4,BCHE,ATP6AP2
R-HSA-157118	Signaling by NOTCH	0.366750236604527	-1.0030742168208	113	6	0.0133037694013304	451	10391	83464,1272,9734,1840,54492,8788	APH1B,CNTN1,HDAC9,DTX1,NEURL1B,DLK1
R-HSA-1280218	Adaptive Immune System	0.367814983792576	-1.00017522867333	823	38	0.0842572062084257	451	10391	2932,5788,4254,285643,1519,3702,50852,868,6468,7337,23327,10225,1075,2534,7324,154214,57520,57531,5594,84861,9371,1493,84643,10075,1956,6456,201456,7328,2263,3084,4734,161,5291,9520,6885,4012,8817,5519	GSK3B,PTPRC,KITLG,KIF4B,CTSO,ITK,TRAT1,CBLB,FBXW4,UBE3A,NEDD4L,CD96,CTSC,FYN,UBE2E1,RNF217,HECW2,HACE1,MAPK1,KLHL22,KIF3B,CTLA4,KIF2B,HUWE1,EGFR,SH3GL2,FBXO15,UBE2H,FGFR2,NRG1,NEDD4,AP2A2,PIK3CB,NPEPPS,MAP3K7,LNPEP,FGF18,PPP2R1B
R-HSA-5654696	Downstream signaling of activated FGFR2	0.376403977926194	-0.97709230297874	30	2	0.00443458980044346	451	10391	2263,8817	FGFR2,FGF18
R-HSA-8863795	Downregulation of ERBB2 signaling	0.376403977926194	-0.97709230297874	30	2	0.00443458980044346	451	10391	3084,1956	NRG1,EGFR
R-HSA-5669034	TNFs bind their physiological receptors	0.376403977926194	-0.97709230297874	30	2	0.00443458980044346	451	10391	7292,9966	TNFSF4,TNFSF15
R-HSA-445095	Interaction between L1 and Ankyrins	0.376403977926194	-0.97709230297874	30	2	0.00443458980044346	451	10391	287,4897	ANK2,NRCAM
R-HSA-917977	Transferrin endocytosis and recycling	0.376403977926194	-0.97709230297874	30	2	0.00443458980044346	451	10391	50617,127124	ATP6V0A4,ATP6V1G3
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.379178954667081	-0.969747009437086	312	15	0.0332594235033259	451	10391	23327,7324,9520,4012,154214,57520,57531,10075,84861,7328,201456,4734,7337,868,6468	NEDD4L,UBE2E1,NPEPPS,LNPEP,RNF217,HECW2,HACE1,HUWE1,KLHL22,UBE2H,FBXO15,NEDD4,UBE3A,CBLB,FBXW4
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	0.380402866219375	-0.96652441358804	180	9	0.0199556541019956	451	10391	9371,84643,339122,60592,285643,91949,23303,53407,56894	KIF3B,KIF2B,RAB43,SCOC,KIF4B,COG7,KIF13B,STX18,AGPAT3
R-HSA-1227986	Signaling by ERBB2	0.382274486725321	-0.961616376773224	51	3	0.00665188470066519	451	10391	3084,1956,2534	NRG1,EGFR,FYN
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	57161	PELI2
R-HSA-418889	Ligand-independent caspase activation via DCC	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	1630	DCC
R-HSA-376172	DSCAM interactions	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	1630	DCC
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	134353	LSM11
R-HSA-1980150	Signaling by NOTCH4	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	83464	APH1B
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	8821	INPP4B
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	6256	RXRA
R-HSA-1980148	Signaling by NOTCH3	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	83464	APH1B
R-HSA-937039	IRAK1 recruits IKK complex	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	57161	PELI2
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-68689	CDC6 association with the ORC:origin complex	0.386358017291857	-0.950990833447701	11	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-421837	Clathrin derived vesicle budding	0.391350069109131	-0.938152802139683	73	4	0.00886917960088692	451	10391	351,81567,6456,134829	APP,TXNDC5,SH3GL2,CLVS2
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.391350069109131	-0.938152802139683	73	4	0.00886917960088692	451	10391	134829,6456,81567,351	CLVS2,SH3GL2,TXNDC5,APP
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.392036744314283	-0.936399708088952	31	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.392036744314283	-0.936399708088952	31	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.392036744314283	-0.936399708088952	31	2	0.00443458980044346	451	10391	5594,8817	MAPK1,FGF18
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.392036744314283	-0.936399708088952	31	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-180786	Extension of Telomeres	0.392036744314283	-0.936399708088952	31	2	0.00443458980044346	451	10391	6119,8607	RPA3,RUVBL1
R-HSA-1433557	Signaling by SCF-KIT	0.392139594110388	-0.936137395158415	337	16	0.0354767184035477	451	10391	9462,5519,8817,2534,200734,161742,5291,50852,2263,1956,3084,7010,284,4254,5594,2932	RASAL2,PPP2R1B,FGF18,FYN,SPRED2,SPRED1,PIK3CB,TRAT1,FGFR2,EGFR,NRG1,TEK,ANGPT1,KITLG,MAPK1,GSK3B
R-HSA-2980766	Nuclear Envelope Breakdown	0.394157968034231	-0.93100351593977	52	3	0.00665188470066519	451	10391	9688,129401,7444	NUP93,NUP35,VRK2
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.395813147646631	-0.926813028460799	95	5	0.0110864745011086	451	10391	2534,9844,5291,5594,4651	FYN,ELMO1,PIK3CB,MAPK1,MYO10
R-HSA-194138	Signaling by VEGF	0.39673790940236	-0.924479394136094	338	16	0.0354767184035477	451	10391	5594,4254,284,3084,7010,1956,2263,9844,5291,161742,200734,2534,3791,5519,8817,9462	MAPK1,KITLG,ANGPT1,NRG1,TEK,EGFR,FGFR2,ELMO1,PIK3CB,SPRED1,SPRED2,FYN,KDR,PPP2R1B,FGF18,RASAL2
R-HSA-195721	Signaling by Wnt	0.39673790940236	-0.924479394136094	338	16	0.0354767184035477	451	10391	8321,6657,8607,1488,51339,51701,5519,6885,79971,8658,55553,2932,161,8549,83999,102464826	FZD1,SOX2,RUVBL1,CTBP2,DACT1,NLK,PPP2R1B,MAP3K7,WLS,TNKS,SOX6,GSK3B,AP2A2,LGR5,KREMEN1,MIR6073
R-HSA-75153	Apoptotic execution  phase	0.40598126760278	-0.901448259354245	53	3	0.00665188470066519	451	10391	1829,9414,839	DSG2,TJP2,CASP6
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.407490498428114	-0.897737663313883	32	2	0.00443458980044346	451	10391	2890,161	GRIA1,AP2A2
R-HSA-68962	Activation of the pre-replicative complex	0.407490498428114	-0.897737663313883	32	2	0.00443458980044346	451	10391	6119,4999	RPA3,ORC2
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.407490498428114	-0.897737663313883	32	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-399719	Trafficking of AMPA receptors	0.407490498428114	-0.897737663313883	32	2	0.00443458980044346	451	10391	161,2890	AP2A2,GRIA1
R-HSA-5654738	Signaling by FGFR2	0.411159516631868	-0.888774021458623	75	4	0.00886917960088692	451	10391	2263,9982,8817,5594	FGFR2,FGFBP1,FGF18,MAPK1
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	2034	EPAS1
R-HSA-8866427	VLDLR internalisation and degradation	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	161	AP2A2
R-HSA-844456	The NLRP3 inflammasome	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	351	APP
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-389359	CD28 dependent Vav1 pathway	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-1236977	Endosomal/Vacuolar pathway	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	4012	LNPEP
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	839	CASP6
R-HSA-4641265	Repression of WNT target genes	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	1488	CTBP2
R-HSA-203615	eNOS activation	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	340481	ZDHHC21
R-HSA-3371511	HSF1 activation	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-1433617	Regulation of signaling by NODAL	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	92	ACVR2A
R-HSA-2033514	FGFR3 mutant receptor activation	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-390666	Serotonin receptors	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	3350	HTR1A
R-HSA-2022857	Keratan sulfate degradation	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	3074	HEXB
R-HSA-210990	PECAM1 interactions	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-2160916	Hyaluronan uptake and degradation	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	3074	HEXB
R-HSA-71384	Ethanol oxidation	0.413020111153738	-0.88425899191918	12	1	0.00221729490022173	451	10391	131	ADH7
R-HSA-114604	GPVI-mediated activation cascade	0.41773576733257	-0.872906181907322	54	3	0.00665188470066519	451	10391	10630,2534,5291	PDPN,FYN,PIK3CB
R-HSA-5576891	Cardiac conduction	0.420589209315588	-0.866098671497738	142	7	0.0155210643015521	451	10391	781,6262,6588,9992,80333,56660,6546	CACNA2D1,RYR2,SLN,KCNE2,KCNIP4,KCNK12,SLC8A1
R-HSA-202733	Cell surface interactions at the vascular wall	0.420589209315588	-0.866098671497738	142	7	0.0155210643015521	451	10391	2888,2534,7010,284,5291,5669,3655	GRB14,FYN,TEK,ANGPT1,PIK3CB,PSG1,ITGA6
R-HSA-392518	Signal amplification	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	2770,406974	GNAI1,MIR197
R-HSA-163359	Glucagon signaling in metabolic regulation	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	114,108	ADCY8,ADCY2
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	3074,11046	HEXB,SLC35D2
R-HSA-1839126	FGFR2 mutant receptor activation	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	2263,8817	FGFR2,FGF18
R-HSA-180746	Nuclear import of Rev protein	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-186712	Regulation of beta-cell development	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	6928,3642	HNF1B,INSM1
R-HSA-1222556	ROS, RNS production in phagocytes	0.422751326646086	-0.860971153074519	33	2	0.00443458980044346	451	10391	50617,127124	ATP6V0A4,ATP6V1G3
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.43045792081815	-0.84290570479727	99	5	0.0110864745011086	451	10391	85439,161,1956,6456,6857	STON2,AP2A2,EGFR,SH3GL2,SYT1
R-HSA-390466	Chaperonin-mediated protein folding	0.43045792081815	-0.84290570479727	99	5	0.0110864745011086	451	10391	11328,6468,2770,8787,406974	FKBP9,FBXW4,GNAI1,RGS9,MIR197
R-HSA-1169408	ISG15 antiviral mechanism	0.430831911553376	-0.842037261342642	77	4	0.00886917960088692	451	10391	9688,129401,7324,4734	NUP93,NUP35,UBE2E1,NEDD4
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.430831911553376	-0.842037261342642	77	4	0.00886917960088692	451	10391	4734,129401,7324,9688	NEDD4,NUP35,UBE2E1,NUP93
R-HSA-1489509	DAG and IP3 signaling	0.437806854511201	-0.825977437297802	34	2	0.00443458980044346	451	10391	114,108	ADCY8,ADCY2
R-HSA-192105	Synthesis of bile acids and bile salts	0.437806854511201	-0.825977437297802	34	2	0.00443458980044346	451	10391	6256,26031	RXRA,OSBPL3
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.437806854511201	-0.825977437297802	34	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-5694530	Cargo concentration in the ER	0.437806854511201	-0.825977437297802	34	2	0.00443458980044346	451	10391	2890,1075	GRIA1,CTSC
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.437806854511201	-0.825977437297802	34	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	781	CACNA2D1
R-HSA-190239	FGFR3 ligand binding and activation	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-1502540	Signaling by Activin	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	92	ACVR2A
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	6657	SOX2
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-5626467	RHO GTPases activate IQGAPs	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	10788	IQGAP2
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	2932	GSK3B
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	7444	VRK2
R-HSA-71240	Tryptophan catabolism	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	8942	KYNU
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	1803	DPP4
R-HSA-190372	FGFR3c ligand binding and activation	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-425561	Sodium/Calcium exchangers	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	6546	SLC8A1
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	161	AP2A2
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	3084	NRG1
R-HSA-75205	Dissolution of Fibrin Clot	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	5270	SERPINE2
R-HSA-75892	Platelet Adhesion to exposed collagen	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-1663150	The activation of arylsulfatases	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	411	ARSB
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	351	APP
R-HSA-2995410	Nuclear Envelope Reassembly	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	7444	VRK2
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.438526222520197	-0.824335668455719	13	1	0.00221729490022173	451	10391	839	CASP6
R-HSA-1296071	Potassium Channels	0.43906254376742	-0.823113407336172	100	5	0.0110864745011086	451	10391	3755,9568,3739,90134,3747	KCNG1,GABBR2,KCNA4,KCNH7,KCNC2
R-HSA-5578775	Ion homeostasis	0.441006319077245	-0.818696074664606	56	3	0.00665188470066519	451	10391	6588,6262,6546	SLN,RYR2,SLC8A1
R-HSA-2187338	Visual phototransduction	0.447637240201359	-0.803772106270332	101	5	0.0110864745011086	451	10391	5948,2239,5950,8787,2262	RBP2,GPC4,RBP4,RGS9,GPC5
R-HSA-109704	PI3K Cascade	0.450325635129712	-0.797784324292758	79	4	0.00886917960088692	451	10391	8817,5291,5289,2263	FGF18,PIK3CB,PIK3C3,FGFR2
R-HSA-6799198	Complex I biogenesis	0.452507528850455	-0.792950877637026	57	3	0.00665188470066519	451	10391	4710,4724,29078	NDUFB4,NDUFS4,NDUFAF4
R-HSA-1989781	PPARA activates gene expression	0.45256386770586	-0.7928263817007	124	6	0.0133037694013304	451	10391	19,6256,10891,8202,10413,5244	ABCA1,RXRA,PPARGC1A,NCOA3,YAP1,ABCB4
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.452646139845099	-0.792644606999183	35	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.452646139845099	-0.792644606999183	35	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-6804757	Regulation of TP53 Degradation	0.452646139845099	-0.792644606999183	35	2	0.00443458980044346	451	10391	900,5519	CCNG1,PPP2R1B
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	3084	NRG1
R-HSA-877312	Regulation of IFNG signaling	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	3459	IFNGR1
R-HSA-69166	Removal of the Flap Intermediate	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-1483213	Synthesis of PE	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	64850	ETNPPL
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	79370	BCL2L14
R-HSA-190322	FGFR4 ligand binding and activation	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.462926364512536	-0.770187277473821	14	1	0.00221729490022173	451	10391	6546	SLC8A1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.463910232576479	-0.768064209747338	58	3	0.00665188470066519	451	10391	54492,9734,83464	NEURL1B,HDAC9,APH1B
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.463910232576479	-0.768064209747338	58	3	0.00665188470066519	451	10391	9734,54492,83464	HDAC9,NEURL1B,APH1B
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.463910232576479	-0.768064209747338	58	3	0.00665188470066519	451	10391	54492,9734,83464	NEURL1B,HDAC9,APH1B
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.463910232576479	-0.768064209747338	58	3	0.00665188470066519	451	10391	54492,9734,83464	NEURL1B,HDAC9,APH1B
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.463910232576479	-0.768064209747338	58	3	0.00665188470066519	451	10391	83464,9734,54492	APH1B,HDAC9,NEURL1B
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.467259572225653	-0.760870346552074	36	2	0.00443458980044346	451	10391	2971,55703	GTF3A,POLR3B
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.467259572225653	-0.760870346552074	36	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-177243	Interactions of Rev with host cellular proteins	0.467259572225653	-0.760870346552074	36	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-167021	PLC-gamma1 signalling	0.467259572225653	-0.760870346552074	36	2	0.00443458980044346	451	10391	108,114	ADCY2,ADCY8
R-HSA-201681	TCF dependent signaling in response to WNT	0.470638460515431	-0.753665079476182	240	11	0.024390243902439	451	10391	8658,102464826,5519,8549,83999,6657,8607,51339,2932,8321,55553	TNKS,MIR6073,PPP2R1B,LGR5,KREMEN1,SOX2,RUVBL1,DACT1,GSK3B,FZD1,SOX6
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.473147756345597	-0.748347557990746	104	5	0.0110864745011086	451	10391	129401,84733,9688,7518,7486	NUP35,CBX2,NUP93,XRCC4,WRN
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.475611535417192	-0.743153860008022	127	6	0.0133037694013304	451	10391	6256,19,5244,8202,10413,10891	RXRA,ABCA1,ABCB4,NCOA3,YAP1,PPARGC1A
R-HSA-419037	NCAM1 interactions	0.481638778414523	-0.730560868265373	37	2	0.00443458980044346	451	10391	7903,1297	ST8SIA4,COL9A1
R-HSA-176187	Activation of ATR in response to replication stress	0.481638778414523	-0.730560868265373	37	2	0.00443458980044346	451	10391	4999,6119	ORC2,RPA3
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	6256	RXRA
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	54492	NEURL1B
R-HSA-69183	Processive synthesis on the lagging strand	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-5358508	Mismatch Repair	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-205043	NRIF signals cell death from the nucleus	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	83464	APH1B
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	83999	KREMEN1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	161	AP2A2
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	54492	NEURL1B
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	6456	SH3GL2
R-HSA-3322077	Glycogen synthesis	0.486268391073675	-0.720994562505239	15	1	0.00221729490022173	451	10391	2632	GBE1
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.486395396224316	-0.720733413374323	60	3	0.00665188470066519	451	10391	3655,1297,1301	ITGA6,COL9A1,COL11A1
R-HSA-1430728	Metabolism	0.495263950203856	-0.702664425796439	2177	95	0.210643015521064	451	10391	2239,594,56894,114,4710,4837,8202,10413,340481,26031,108,5519,129401,5783,64579,171546,65985,2262,2632,4552,5244,83594,55788,5950,1345,57214,10891,5288,590,26289,7368,9688,83539,9957,23417,8613,5587,340665,9061,5289,84803,2770,3037,79966,3074,131,11046,441282,161,4682,8898,54477,19,5291,83990,55312,9429,5160,518,6611,29078,57733,79668,8821,4724,64850,200916,10243,6256,9218,2710,8942,2534,140801,337876,392636,58488,6235,1462,411,10090,27235,1071,5948,51000,3747,79646,55331,55347,8050,30814,8029,347516,50,6240	GPC4,BCKDHB,AGPAT3,ADCY8,NDUFB4,NNMT,NCOA3,YAP1,ZDHHC21,OSBPL3,ADCY2,PPP2R1B,NUP35,PTPN13,NDST4,SPTSSA,AACS,GPC5,GBE1,MTRR,ABCB4,NUDT12,LMBRD1,RBP4,COX6C,CEMIP,PPARGC1A,PIK3C2G,BCHE,AK5,UGT8,NUP93,CHST9,HS3ST1,MLYCD,PLPP3,PRKD1,CYP26C1,PAPSS1,PIK3C3,GPAT3,GNAI1,HAS2,SCD5,HEXB,ADH7,SLC35D2,AKR1B15,AP2A2,NUBP1,MTMR2,PLEKHA5,ABCA1,PIK3CB,BRIP1,RFK,ABCG2,PDHA1,ATP5MC3,SMS,NDUFAF4,GBA3,PARP8,INPP4B,NDUFS4,ETNPPL,RPL22L1,GPHN,RXRA,VAPA,GK,KYNU,FYN,RPL10L,CHSY3,AGMO,PCTP,RPS29,VCAN,ARSB,UST,COQ2,CETP,RBP2,SLC35B3,KCNC2,PANK3,ACER3,ABHD10,PDHX,PLA2G2E,CUBN,DGAT2L6,ACO2,RRM1
R-HSA-382556	ABC-family proteins mediated transport	0.498271191143462	-0.696610789647722	107	5	0.0110864745011086	451	10391	85320,340273,10350,5244,1968	ABCC11,ABCB5,ABCA9,ABCB4,EIF2S3
R-HSA-156580	Phase II conjugation	0.506545876123105	-0.680140384620899	108	5	0.0110864745011086	451	10391	55347,51000,4837,4552,9061	ABHD10,SLC35B3,NNMT,MTRR,PAPSS1
R-HSA-1268020	Mitochondrial protein import	0.50841659605036	-0.676454096512849	62	3	0.00665188470066519	451	10391	56942,50,27235	CMC2,ACO2,COQ2
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.508598089954607	-0.676097181497421	16	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.508598089954607	-0.676097181497421	16	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-159418	Recycling of bile acids and salts	0.508598089954607	-0.676097181497421	16	1	0.00221729490022173	451	10391	6256	RXRA
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.508598089954607	-0.676097181497421	16	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-110312	Translesion synthesis by REV1	0.508598089954607	-0.676097181497421	16	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-1295596	Spry regulation of FGF signaling	0.508598089954607	-0.676097181497421	16	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-69236	G1 Phase	0.509666677363058	-0.673998340734152	39	2	0.00443458980044346	451	10391	28227,5519	PPP2R3B,PPP2R1B
R-HSA-69231	Cyclin D associated events in G1	0.509666677363058	-0.673998340734152	39	2	0.00443458980044346	451	10391	5519,28227	PPP2R1B,PPP2R3B
R-HSA-6783310	Fanconi Anemia Pathway	0.509666677363058	-0.673998340734152	39	2	0.00443458980044346	451	10391	29089,6119	UBE2T,RPA3
R-HSA-1226099	Signaling by FGFR in disease	0.519240866849011	-0.655387405501432	63	3	0.00665188470066519	451	10391	2263,11116,8817	FGFR2,CEP43,FGF18
R-HSA-2990846	SUMOylation	0.522929365530466	-0.648308880385244	110	5	0.0110864745011086	451	10391	9688,84733,7518,129401,7486	NUP93,CBX2,XRCC4,NUP35,WRN
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.52330403625608	-0.647592652551207	40	2	0.00443458980044346	451	10391	2911,9568	GRM1,GABBR2
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.52330403625608	-0.647592652551207	40	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-5675221	Negative regulation of MAPK pathway	0.52330403625608	-0.647592652551207	40	2	0.00443458980044346	451	10391	5594,5519	MAPK1,PPP2R1B
R-HSA-5654741	Signaling by FGFR3	0.52330403625608	-0.647592652551207	40	2	0.00443458980044346	451	10391	8817,5594	FGF18,MAPK1
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.52330403625608	-0.647592652551207	40	2	0.00443458980044346	451	10391	11328,6468	FKBP9,FBXW4
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	0.52330403625608	-0.647592652551207	40	2	0.00443458980044346	451	10391	1956,2099	EGFR,ESR1
R-HSA-597592	Post-translational protein modification	0.524794320274631	-0.644748864058248	1037	45	0.0997782705099778	451	10391	2099,118430,146712,11174,7369,287,6489,6675,6480,64409,256435,1075,7486,2530,8658,9508,199857,411,57403,152330,2890,7903,7328,84733,8607,9215,9688,80070,221937,53942,339122,161357,7324,92949,91949,220441,7518,4978,29071,25834,29089,79875,129401,6885,144245	ESR1,MUCL1,B3GNTL1,ADAMTS6,UMOD,ANK2,ST8SIA1,UAP1,ST6GAL1,GALNT17,ST6GALNAC3,CTSC,WRN,FUT8,TNKS,ADAMTS3,ALG14,ARSB,RAB22A,CNTN4,GRIA1,ST8SIA4,UBE2H,CBX2,RUVBL1,LARGE1,NUP93,ADAMTS20,FOXK1,CNTN5,RAB43,MDGA2,UBE2E1,ADAMTSL1,COG7,RNF152,XRCC4,OPCML,C1GALT1C1,MGAT4C,UBE2T,THSD4,NUP35,MAP3K7,ALG10B
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.525943087207602	-0.642562271323477	157	7	0.0155210643015521	451	10391	285643,221037,5890,23303,91768,84643,9371	KIF4B,JMJD1C,RAD51B,KIF13B,CABLES1,KIF2B,KIF3B
R-HSA-5656121	Translesion synthesis by POLI	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	56288	PARD3
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	79646	PANK3
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	2890	GRIA1
R-HSA-432142	Platelet sensitization by LDL	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	5519	PPP2R1B
R-HSA-1482922	Acyl chain remodelling of PI	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	30814	PLA2G2E
R-HSA-622312	Inflammasomes	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	351	APP
R-HSA-5655862	Translesion synthesis by POLK	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-435354	Zinc transporters	0.52995927178627	-0.634955121075033	17	1	0.00221729490022173	451	10391	64116	SLC39A8
R-HSA-163685	Integration of energy metabolism	0.531033164612982	-0.632930802792278	111	5	0.0110864745011086	451	10391	2770,5519,114,3747,108	GNAI1,PPP2R1B,ADCY8,KCNC2,ADCY2
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.534885473898296	-0.625702622481665	88	4	0.00886917960088692	451	10391	6256,8202,9314,10891	RXRA,NCOA3,KLF4,PPARGC1A
R-HSA-5654743	Signaling by FGFR4	0.536684349099244	-0.6223451615824	41	2	0.00443458980044346	451	10391	5594,8817	MAPK1,FGF18
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	0.549804198330373	-0.59819306717543	42	2	0.00443458980044346	451	10391	220441,7324	RNF152,UBE2E1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.549804198330373	-0.59819306717543	42	2	0.00443458980044346	451	10391	3747,114	KCNC2,ADCY8
R-HSA-168253	Host Interactions with Influenza Factors	0.549804198330373	-0.59819306717543	42	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-3928662	EPHB-mediated forward signaling	0.549804198330373	-0.59819306717543	42	2	0.00443458980044346	451	10391	2047,2534	EPHB1,FYN
R-HSA-8856828	Clathrin-mediated endocytosis	0.550044130353786	-0.597756766967553	137	6	0.0133037694013304	451	10391	85439,161,112574,1956,6857,6456	STON2,AP2A2,SNX18,EGFR,SYT1,SH3GL2
R-HSA-5654710	PI-3K cascade:FGFR3	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-1482925	Acyl chain remodelling of PG	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	30814	PLA2G2E
R-HSA-73780	RNA Polymerase III Chain Elongation	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	55703	POLR3B
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	118430	MUCL1
R-HSA-5635838	Activation of SMO	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	91653	BOC
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	10010	TANK
R-HSA-418457	cGMP effects	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	5139	PDE3A
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	118430	MUCL1
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-1369062	ABC transporters in lipid homeostasis	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	10350	ABCA9
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	518	ATP5MC3
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.55039385521073	-0.597121156650015	18	1	0.00221729490022173	451	10391	118430	MUCL1
R-HSA-5633007	Regulation of TP53 Activity	0.559520398509227	-0.580675293433218	162	7	0.0155210643015521	451	10391	639,900,6119,9891,7486,83990,5519	PRDM1,CCNG1,RPA3,NUAK1,WRN,BRIP1,PPP2R1B
R-HSA-194068	Bile acid and bile salt metabolism	0.56266094496368	-0.575078061449461	43	2	0.00443458980044346	451	10391	6256,26031	RXRA,OSBPL3
R-HSA-5655253	Signaling by FGFR2 in disease	0.56266094496368	-0.575078061449461	43	2	0.00443458980044346	451	10391	2263,8817	FGFR2,FGF18
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.56266094496368	-0.575078061449461	43	2	0.00443458980044346	451	10391	114,108	ADCY8,ADCY2
R-HSA-168325	Viral Messenger RNA Synthesis	0.56266094496368	-0.575078061449461	43	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-75893	TNF signaling	0.56266094496368	-0.575078061449461	43	2	0.00443458980044346	451	10391	8887,6885	TAX1BP1,MAP3K7
R-HSA-73923	Lipid digestion, mobilization, and transport	0.562808804473998	-0.574815309809547	115	5	0.0110864745011086	451	10391	19,8029,2534,161,1071	ABCA1,CUBN,FYN,AP2A2,CETP
R-HSA-110320	Translesion Synthesis by POLH	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	2263	FGFR2
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	7324	UBE2E1
R-HSA-190861	Gap junction assembly	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-71403	Citric acid cycle (TCA cycle)	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	50	ACO2
R-HSA-176412	Phosphorylation of the APC/C	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	7324	UBE2E1
R-HSA-5576886	Phase 4 - resting membrane potential	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	56660	KCNK12
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.56994194845472	-0.562220768156357	19	1	0.00221729490022173	451	10391	55117	SLC6A15
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.570340341949721	-0.561522005201668	92	4	0.00886917960088692	451	10391	53942,152330,161357,4978	CNTN5,CNTN4,MDGA2,OPCML
R-HSA-216083	Integrin cell surface interactions	0.571339142736139	-0.559772300394616	68	3	0.00665188470066519	451	10391	3791,1297,3655	KDR,COL9A1,ITGA6
R-HSA-948021	Transport to the Golgi and subsequent modification	0.572653899708159	-0.557473759228554	164	7	0.0155210643015521	451	10391	1075,6480,25834,287,2530,91949,2890	CTSC,ST6GAL1,MGAT4C,ANK2,FUT8,COG7,GRIA1
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.575252667762924	-0.552945912506056	44	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.575252667762924	-0.552945912506056	44	2	0.00443458980044346	451	10391	868,2534	CBLB,FYN
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.57896646615571	-0.546510719915902	93	4	0.00886917960088692	451	10391	9891,83990,7486,6119	NUAK1,BRIP1,WRN,RPA3
R-HSA-68875	Mitotic Prophase	0.585435514744641	-0.53539923908139	142	6	0.0133037694013304	451	10391	7444,5519,5594,2029,129401,9688	VRK2,PPP2R1B,MAPK1,ENSA,NUP35,NUP93
R-HSA-194840	Rho GTPase cycle	0.585435514744641	-0.53539923908139	142	6	0.0133037694013304	451	10391	83478,9459,58504,64411,395,4983	ARHGAP24,ARHGEF6,ARHGAP22,ARAP3,ARHGAP6,OPHN1
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.587578106163706	-0.53174609513882	45	2	0.00443458980044346	451	10391	10891,6256	PPARGC1A,RXRA
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.587578106163706	-0.53174609513882	45	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.587578106163706	-0.53174609513882	45	2	0.00443458980044346	451	10391	79370,839	BCL2L14,CASP6
R-HSA-109582	Hemostasis	0.587817116743781	-0.531339405408062	639	27	0.0598669623059867	451	10391	10630,2534,7042,5669,1608,2770,351,6546,5139,406974,285643,5270,5890,221037,2888,7043,5519,3655,23303,151,5291,91768,284,7010,9371,5594,84643	PDPN,FYN,TGFB2,PSG1,DGKG,GNAI1,APP,SLC8A1,PDE3A,MIR197,KIF4B,SERPINE2,RAD51B,JMJD1C,GRB14,TGFB3,PPP2R1B,ITGA6,KIF13B,ADRA2B,PIK3CB,CABLES1,ANGPT1,TEK,KIF3B,MAPK1,KIF2B
R-HSA-3000170	Syndecan interactions	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	3655	ITGA6
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	1803	DPP4
R-HSA-5654720	PI-3K cascade:FGFR4	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-1643713	Signaling by EGFR in Cancer	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	1956	EGFR
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	6456	SH3GL2
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-69186	Lagging Strand Synthesis	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.588641927361497	-0.52993721336918	20	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.59117588915095	-0.525641693077371	70	3	0.00665188470066519	451	10391	5594,4651,9844	MAPK1,MYO10,ELMO1
R-HSA-5658442	Regulation of RAS by GAPs	0.59117588915095	-0.525641693077371	70	3	0.00665188470066519	451	10391	9462,161742,200734	RASAL2,SPRED1,SPRED2
R-HSA-5693532	DNA Double-Strand Break Repair	0.598355113329756	-0.513570866282144	168	7	0.0155210643015521	451	10391	6119,83990,7486,23514,7518,2138,5890	RPA3,BRIP1,WRN,SPIDR,XRCC4,EYA1,RAD51B
R-HSA-446652	Interleukin-1 signaling	0.599636606780592	-0.511431462614971	46	2	0.00443458980044346	451	10391	57161,6885	PELI2,MAP3K7
R-HSA-4615885	SUMOylation of DNA replication proteins	0.599636606780592	-0.511431462614971	46	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-70153	Glucose transport	0.599636606780592	-0.511431462614971	46	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-6807004	Negative regulation of MET activity	0.606530510034445	-0.500000246777644	21	1	0.00221729490022173	451	10391	6456	SH3GL2
R-HSA-1181150	Signaling by NODAL	0.606530510034445	-0.500000246777644	21	1	0.00221729490022173	451	10391	92	ACVR2A
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.606530510034445	-0.500000246777644	21	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.606530510034445	-0.500000246777644	21	1	0.00221729490022173	451	10391	351	APP
R-HSA-3000480	Scavenging by Class A Receptors	0.606530510034445	-0.500000246777644	21	1	0.00221729490022173	451	10391	4481	MSR1
R-HSA-2408522	Selenoamino acid metabolism	0.615659949325733	-0.485060498188819	122	5	0.0110864745011086	451	10391	9061,6235,4837,140801,200916	PAPSS1,RPS29,NNMT,RPL10L,RPL22L1
R-HSA-202403	TCR signaling	0.615659949325733	-0.485060498188819	122	5	0.0110864745011086	451	10391	50852,3702,5291,5788,6885	TRAT1,ITK,PIK3CB,PTPRC,MAP3K7
R-HSA-3214841	PKMTs methylate histone lysines	0.619799916114015	-0.478358568972133	73	3	0.00665188470066519	451	10391	55729,56979,2122	ATF7IP,PRDM9,MECOM
R-HSA-388841	Costimulation by the CD28 family	0.619799916114015	-0.478358568972133	73	3	0.00665188470066519	451	10391	2534,5519,1493	FYN,PPP2R1B,CTLA4
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.622952919229903	-0.473284334109866	48	2	0.00443458980044346	451	10391	351,6885	APP,MAP3K7
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.622952919229903	-0.473284334109866	48	2	0.00443458980044346	451	10391	10891,6256	PPARGC1A,RXRA
R-HSA-380108	Chemokine receptors bind chemokines	0.622952919229903	-0.473284334109866	48	2	0.00443458980044346	451	10391	7852,57007	CXCR4,ACKR3
R-HSA-1482801	Acyl chain remodelling of PS	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	30814	PLA2G2E
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-5655332	Signaling by FGFR3 in disease	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-2029481	FCGR activation	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	5270	SERPINE2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	8549	LGR5
R-HSA-202131	Metabolism of nitric oxide	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	340481	ZDHHC21
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	5519	PPP2R1B
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	5270	SERPINE2
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	161	AP2A2
R-HSA-5620916	VxPx cargo-targeting to cilium	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	50807	ASAP1
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-203765	eNOS activation and regulation	0.623642828243124	-0.472177465126787	22	1	0.00221729490022173	451	10391	340481	ZDHHC21
R-HSA-6802957	Oncogenic MAPK signaling	0.62903360859007	-0.463570591928407	74	3	0.00665188470066519	451	10391	9462,9061,5594	RASAL2,PAPSS1,MAPK1
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.637129678524112	-0.450782067168022	125	5	0.0110864745011086	451	10391	4710,4724,518,29078,1345	NDUFB4,NDUFS4,ATP5MC3,NDUFAF4,COX6C
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	1803	DPP4
R-HSA-8863678	Neurodegenerative Diseases	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	351	APP
R-HSA-112409	RAF-independent MAPK1/3 activation	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	7324	UBE2E1
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	351	APP
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	23327	NEDD4L
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	129880	BBS5
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	6902	TBCA
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	5950	RBP4
R-HSA-5365859	RA biosynthesis pathway	0.640012495965368	-0.446267577873141	23	1	0.00221729490022173	451	10391	340665	CYP26C1
R-HSA-6802949	Signaling by RAS mutants	0.645206695143304	-0.438184555935412	50	2	0.00443458980044346	451	10391	9462,5594	RASAL2,MAPK1
R-HSA-73887	Death Receptor Signalling	0.645206695143304	-0.438184555935412	50	2	0.00443458980044346	451	10391	6885,8887	MAP3K7,TAX1BP1
R-HSA-611105	Respiratory electron transport	0.651936175377469	-0.427808612372429	102	4	0.00886917960088692	451	10391	4724,4710,1345,29078	NDUFS4,NDUFB4,COX6C,NDUFAF4
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.655671674616812	-0.422095111338941	24	1	0.00221729490022173	451	10391	5139	PDE3A
R-HSA-156588	Glucuronidation	0.655671674616812	-0.422095111338941	24	1	0.00221729490022173	451	10391	55347	ABHD10
R-HSA-70895	Branched-chain amino acid catabolism	0.655671674616812	-0.422095111338941	24	1	0.00221729490022173	451	10391	594	BCKDHB
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.655671674616812	-0.422095111338941	24	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.655671674616812	-0.422095111338941	24	1	0.00221729490022173	451	10391	10507	SEMA4D
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.655671674616812	-0.422095111338941	24	1	0.00221729490022173	451	10391	6256	RXRA
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.655671674616812	-0.422095111338941	24	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.659501954760699	-0.416270342825069	103	4	0.00886917960088692	451	10391	4085,220134,84643,5519	MAD2L1,SKA1,KIF2B,PPP2R1B
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.661984568183	-0.412513034218644	374	15	0.0332594235033259	451	10391	57531,10075,84861,57520,4734,7337,6468,868,201456,7328,23327,4012,154214,7324,9520	HACE1,HUWE1,KLHL22,HECW2,NEDD4,UBE3A,FBXW4,CBLB,FBXO15,UBE2H,NEDD4L,LNPEP,RNF217,UBE2E1,NPEPPS
R-HSA-397014	Muscle contraction	0.665951859912561	-0.406537893467819	204	8	0.0177383592017738	451	10391	6546,56660,80333,9992,6262,6588,781,800	SLC8A1,KCNK12,KCNIP4,KCNE2,RYR2,SLN,CACNA2D1,CALD1
R-HSA-445717	Aquaporin-mediated transport	0.666409848182143	-0.405850410054212	52	2	0.00443458980044346	451	10391	114,108	ADCY8,ADCY2
R-HSA-1296059	G protein gated Potassium channels	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	9568	GABBR2
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	23405	DICER1
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	351	APP
R-HSA-1296041	Activation of G protein gated Potassium channels	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	9568	GABBR2
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-982772	Growth hormone receptor signaling	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	5788	PTPRC
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	9568	GABBR2
R-HSA-933542	TRAF6 mediated NF-kB activation	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	351	APP
R-HSA-5654708	Downstream signaling of activated FGFR3	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-5673000	RAF activation	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	5519	PPP2R1B
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	2932	GSK3B
R-HSA-162588	Budding and maturation of HIV virion	0.670651135881857	-0.399506193932561	25	1	0.00221729490022173	451	10391	23327	NEDD4L
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.676622733704723	-0.390641423281691	53	2	0.00443458980044346	451	10391	50807,129880	ASAP1,BBS5
R-HSA-191859	snRNP Assembly	0.676622733704723	-0.390641423281691	53	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-194441	Metabolism of non-coding RNA	0.676622733704723	-0.390641423281691	53	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.676622733704723	-0.390641423281691	53	2	0.00443458980044346	451	10391	1968,6235	EIF2S3,RPS29
R-HSA-422356	Regulation of insulin secretion	0.681150100031196	-0.383972585913737	80	3	0.00665188470066519	451	10391	2770,3747,114	GNAI1,KCNC2,ADCY8
R-HSA-1474165	Reproduction	0.684980321446524	-0.378365168947856	26	1	0.00221729490022173	451	10391	57829	ZP4
R-HSA-1614635	Sulfur amino acid metabolism	0.684980321446524	-0.378365168947856	26	1	0.00221729490022173	451	10391	4552	MTRR
R-HSA-1187000	Fertilization	0.684980321446524	-0.378365168947856	26	1	0.00221729490022173	451	10391	57829	ZP4
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.684980321446524	-0.378365168947856	26	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-210991	Basigin interactions	0.684980321446524	-0.378365168947856	26	1	0.00221729490022173	451	10391	3655	ITGA6
R-HSA-379716	Cytosolic tRNA aminoacylation	0.684980321446524	-0.378365168947856	26	1	0.00221729490022173	451	10391	6897	TARS1
R-HSA-76002	Platelet activation, signaling and aggregation	0.68548898774431	-0.377622844668527	282	11	0.024390243902439	451	10391	2770,5594,1608,5291,351,406974,10630,7042,2534,7043,151	GNAI1,MAPK1,DGKG,PIK3CB,APP,MIR197,PDPN,TGFB2,FYN,TGFB3,ADRA2B
R-HSA-1592230	Mitochondrial biogenesis	0.686579924709459	-0.376032637084724	54	2	0.00443458980044346	451	10391	10891,6256	PPARGC1A,RXRA
R-HSA-189200	Hexose transport	0.686579924709459	-0.376032637084724	54	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.688644480517949	-0.373030134581651	107	4	0.00886917960088692	451	10391	115111,6507,6546,55117	SLC26A7,SLC1A3,SLC8A1,SLC6A15
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.690651113259723	-0.370120483936037	133	5	0.0110864745011086	451	10391	6119,83990,7486,5890,23514	RPA3,BRIP1,WRN,RAD51B,SPIDR
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.696284324277517	-0.361997190173	55	2	0.00443458980044346	451	10391	79966,58488	SCD5,PCTP
R-HSA-162909	Host Interactions of HIV factors	0.696948636085856	-0.361043563783755	134	5	0.0110864745011086	451	10391	9688,129401,2534,161,9844	NUP93,NUP35,FYN,AP2A2,ELMO1
R-HSA-392499	Metabolism of proteins	0.697906905804698	-0.359669557887342	1624	67	0.148558758314856	451	10391	25834,29071,1803,6902,144245,6885,129401,79875,29089,1968,6468,200916,9314,221937,253970,4978,7518,220441,51201,91949,7324,92949,140801,161357,339122,53942,8787,56942,27235,84733,7328,6235,7903,2890,152330,57403,411,80070,10159,9688,9215,8607,590,64409,6480,11328,29080,406974,59272,6675,6489,287,11174,7369,118430,146712,2099,9508,199857,8658,2530,2770,7486,1075,351,50,256435	MGAT4C,C1GALT1C1,DPP4,TBCA,ALG10B,MAP3K7,NUP35,THSD4,UBE2T,EIF2S3,FBXW4,RPL22L1,KLF4,FOXK1,SFTA3,OPCML,XRCC4,RNF152,ZDHHC2,COG7,UBE2E1,ADAMTSL1,RPL10L,MDGA2,RAB43,CNTN5,RGS9,CMC2,COQ2,CBX2,UBE2H,RPS29,ST8SIA4,GRIA1,CNTN4,RAB22A,ARSB,ADAMTS20,ATP6AP2,NUP93,LARGE1,RUVBL1,BCHE,GALNT17,ST6GAL1,FKBP9,CCDC59,MIR197,ACE2,UAP1,ST8SIA1,ANK2,ADAMTS6,UMOD,MUCL1,B3GNTL1,ESR1,ADAMTS3,ALG14,TNKS,FUT8,GNAI1,WRN,CTSC,APP,ACO2,ST6GALNAC3
R-HSA-1482788	Acyl chain remodelling of PC	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	30814	PLA2G2E
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	79971	WLS
R-HSA-400685	Sema4D in semaphorin signaling	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	10507	SEMA4D
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	23327	NEDD4L
R-HSA-180024	DARPP-32 events	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	5519	PPP2R1B
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	55703	POLR3B
R-HSA-114508	Effects of PIP2 hydrolysis	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	1608	DGKG
R-HSA-5654716	Downstream signaling of activated FGFR4	0.698687400568977	-0.358551846262755	27	1	0.00221729490022173	451	10391	8817	FGF18
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.705090461335658	-0.349429170450112	83	3	0.00665188470066519	451	10391	2932,1488,5519	GSK3B,CTBP2,PPP2R1B
R-HSA-190828	Gap junction trafficking	0.711799324768763	-0.339959254531442	28	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.711799324768763	-0.339959254531442	28	1	0.00221729490022173	451	10391	55703	POLR3B
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	0.711799324768763	-0.339959254531442	28	1	0.00221729490022173	451	10391	1630	DCC
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.711799324768763	-0.339959254531442	28	1	0.00221729490022173	451	10391	2770	GNAI1
R-HSA-2022854	Keratan sulfate biosynthesis	0.711799324768763	-0.339959254531442	28	1	0.00221729490022173	451	10391	11046	SLC35D2
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	0.711799324768763	-0.339959254531442	28	1	0.00221729490022173	451	10391	56894	AGPAT3
R-HSA-211976	Endogenous sterols	0.711799324768763	-0.339959254531442	28	1	0.00221729490022173	451	10391	6256	RXRA
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.712759185839913	-0.338611663387574	84	3	0.00665188470066519	451	10391	10010,8887,351	TANK,TAX1BP1,APP
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.714947484714469	-0.335546186937354	57	2	0.00443458980044346	451	10391	81567,6456	TXNDC5,SH3GL2
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.715309627389621	-0.335039784725015	137	5	0.0110864745011086	451	10391	6235,140801,129401,200916,9688	RPS29,RPL10L,NUP35,RPL22L1,NUP93
R-HSA-68877	Mitotic Prometaphase	0.71598155126434	-0.334100878744037	111	4	0.00886917960088692	451	10391	84643,5519,4085,220134	KIF2B,PPP2R1B,MAD2L1,SKA1
R-HSA-1474228	Degradation of the extracellular matrix	0.722533639035148	-0.324991300861198	112	4	0.00886917960088692	451	10391	1297,388743,84570,1308	COL9A1,CAPN8,COL25A1,COL17A1
R-HSA-936837	Ion transport by P-type ATPases	0.723913100881712	-0.323083920206642	58	2	0.00443458980044346	451	10391	6588,5205	SLN,ATP8B1
R-HSA-390918	Peroxisomal lipid metabolism	0.724341880445688	-0.322491787492399	29	1	0.00221729490022173	451	10391	23417	MLYCD
R-HSA-1482839	Acyl chain remodelling of PE	0.724341880445688	-0.322491787492399	29	1	0.00221729490022173	451	10391	30814	PLA2G2E
R-HSA-5693538	Homology Directed Repair	0.727106306400845	-0.318682586002654	139	5	0.0110864745011086	451	10391	6119,23514,5890,7486,83990	RPA3,SPIDR,RAD51B,WRN,BRIP1
R-HSA-199991	Membrane Trafficking	0.731725205541624	-0.312350237767437	613	24	0.0532150776053215	451	10391	60592,23303,81567,4012,2890,9371,84643,57533,1956,6456,161,2697,56894,112574,85439,339122,351,1075,91949,134829,287,285643,6857,53407	SCOC,KIF13B,TXNDC5,LNPEP,GRIA1,KIF3B,KIF2B,TBC1D14,EGFR,SH3GL2,AP2A2,GJA1,AGPAT3,SNX18,STON2,RAB43,APP,CTSC,COG7,CLVS2,ANK2,KIF4B,SYT1,STX18
R-HSA-5419276	Mitochondrial translation termination	0.734842853460634	-0.308098607444272	87	3	0.00665188470066519	451	10391	64983,10884,28957	MRPL32,MRPS30,MRPS28
R-HSA-5368286	Mitochondrial translation initiation	0.734842853460634	-0.308098607444272	87	3	0.00665188470066519	451	10391	64983,28957,10884	MRPL32,MRPS28,MRPS30
R-HSA-157858	Gap junction trafficking and regulation	0.736339739156571	-0.306063664643837	30	1	0.00221729490022173	451	10391	2697	GJA1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.736339739156571	-0.306063664643837	30	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-6784531	tRNA processing in the nucleus	0.74113076980737	-0.299578191783533	60	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-6802952	Signaling by BRAF and RAF fusions	0.74113076980737	-0.299578191783533	60	2	0.00443458980044346	451	10391	9061,5594	PAPSS1,MAPK1
R-HSA-5389840	Mitochondrial translation elongation	0.741900172749669	-0.298540582939037	88	3	0.00665188470066519	451	10391	28957,10884,64983	MRPS28,MRPS30,MRPL32
R-HSA-1296065	Inwardly rectifying K+ channels	0.747816505646781	-0.290597644408333	31	1	0.00221729490022173	451	10391	9568	GABBR2
R-HSA-5654687	Downstream signaling of activated FGFR1	0.747816505646781	-0.290597644408333	31	1	0.00221729490022173	451	10391	23767	FLRT3
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.747816505646781	-0.290597644408333	31	1	0.00221729490022173	451	10391	134353	LSM11
R-HSA-5339562	Uptake and actions of bacterial toxins	0.747816505646781	-0.290597644408333	31	1	0.00221729490022173	451	10391	6857	SYT1
R-HSA-418360	Platelet calcium homeostasis	0.747816505646781	-0.290597644408333	31	1	0.00221729490022173	451	10391	6546	SLC8A1
R-HSA-352230	Amino acid transport across the plasma membrane	0.747816505646781	-0.290597644408333	31	1	0.00221729490022173	451	10391	55117	SLC6A15
R-HSA-1839124	FGFR1 mutant receptor activation	0.747816505646781	-0.290597644408333	31	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-72702	Ribosomal scanning and start codon recognition	0.749390573575512	-0.288494971330549	61	2	0.00443458980044346	451	10391	6235,1968	RPS29,EIF2S3
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.749390573575512	-0.288494971330549	61	2	0.00443458980044346	451	10391	2932,2737	GSK3B,GLI3
R-HSA-4086398	Ca2+ pathway	0.749390573575512	-0.288494971330549	61	2	0.00443458980044346	451	10391	6885,51701	MAP3K7,NLK
R-HSA-5663220	RHO GTPases Activate Formins	0.753615825148324	-0.282872556539826	117	4	0.00886917960088692	451	10391	84643,5519,4085,220134	KIF2B,PPP2R1B,MAD2L1,SKA1
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.753615825148324	-0.282872556539826	117	4	0.00886917960088692	451	10391	1968,6235,140801,200916	EIF2S3,RPS29,RPL10L,RPL22L1
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.753615825148324	-0.282872556539826	117	4	0.00886917960088692	451	10391	140801,200916,6235,1968	RPL10L,RPL22L1,RPS29,EIF2S3
R-HSA-5687128	MAPK6/MAPK4 signaling	0.75556655089431	-0.280287412605813	90	3	0.00665188470066519	451	10391	5596,8202,10602	MAPK4,NCOA3,CDC42EP3
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.757423039497941	-0.277833344782562	62	2	0.00443458980044346	451	10391	9371,4012	KIF3B,LNPEP
R-HSA-72649	Translation initiation complex formation	0.757423039497941	-0.277833344782562	62	2	0.00443458980044346	451	10391	1968,6235	EIF2S3,RPS29
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.758794763949787	-0.276023941380264	32	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-70171	Glycolysis	0.758794763949787	-0.276023941380264	32	1	0.00221729490022173	451	10391	5519	PPP2R1B
R-HSA-168638	NOD1/2 Signaling Pathway	0.758794763949787	-0.276023941380264	32	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-2559585	Oncogene Induced Senescence	0.758794763949787	-0.276023941380264	32	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-69190	DNA strand elongation	0.758794763949787	-0.276023941380264	32	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-196071	Metabolism of steroid hormones	0.758794763949787	-0.276023941380264	32	1	0.00221729490022173	451	10391	441282	AKR1B15
R-HSA-418346	Platelet homeostasis	0.762178471276643	-0.271574536445563	91	3	0.00665188470066519	451	10391	5519,6546,5139	PPP2R1B,SLC8A1,PDE3A
R-HSA-168249	Innate Immune System	0.764498395845159	-0.268535351921095	1302	52	0.11529933481153	451	10391	81567,9462,8817,8887,10159,84766,5912,1956,284,3084,5594,10075,411,6197,4064,351,9844,1075,10875,196527,245929,5289,4651,5602,353189,118430,5788,108,5519,6885,200734,5291,57161,114,50617,161,2263,127124,7010,3074,9218,2534,161742,10788,3702,29099,10010,50852,55703,5787,4254,2932	TXNDC5,RASAL2,FGF18,TAX1BP1,ATP6AP2,CRACR2A,RAP2B,EGFR,ANGPT1,NRG1,MAPK1,HUWE1,ARSB,RPS6KA3,CD180,APP,ELMO1,CTSC,FGL2,ANO6,DEFB115,PIK3C3,MYO10,MAPK10,SLCO4C1,MUCL1,PTPRC,ADCY2,PPP2R1B,MAP3K7,SPRED2,PIK3CB,PELI2,ADCY8,ATP6V0A4,AP2A2,FGFR2,ATP6V1G3,TEK,HEXB,VAPA,FYN,SPRED1,IQGAP2,ITK,COMMD9,TANK,TRAT1,POLR3B,PTPRB,KITLG,GSK3B
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.765232291057408	-0.267575842806402	63	2	0.00443458980044346	451	10391	1968,6235	EIF2S3,RPS29
R-HSA-69206	G1/S Transition	0.765275254784032	-0.267519699696554	119	4	0.00886917960088692	451	10391	6119,28227,5519,4999	RPA3,PPP2R3B,PPP2R1B,ORC2
R-HSA-168255	Influenza Life Cycle	0.765608698255284	-0.267084077550455	146	5	0.0110864745011086	451	10391	129401,140801,9688,200916,6235	NUP35,RPL10L,NUP93,RPL22L1,RPS29
R-HSA-156902	Peptide chain elongation	0.768644925062529	-0.263126152048852	92	3	0.00665188470066519	451	10391	200916,140801,6235	RPL22L1,RPL10L,RPS29
R-HSA-192823	Viral mRNA Translation	0.768644925062529	-0.263126152048852	92	3	0.00665188470066519	451	10391	200916,140801,6235	RPL22L1,RPL10L,RPS29
R-HSA-5357905	Regulation of TNFR1 signaling	0.769296121360797	-0.262279310307161	33	1	0.00221729490022173	451	10391	8887	TAX1BP1
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.769296121360797	-0.262279310307161	33	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-389356	CD28 co-stimulation	0.769296121360797	-0.262279310307161	33	1	0.00221729490022173	451	10391	2534	FYN
R-HSA-211859	Biological oxidations	0.770944078830485	-0.260139438749046	226	8	0.0177383592017738	451	10391	340665,4552,4837,55347,51000,131,6256,9061	CYP26C1,MTRR,NNMT,ABHD10,SLC35B3,ADH7,RXRA,PAPSS1
R-HSA-5656169	Termination of translesion DNA synthesis	0.779341250668533	-0.249306266557091	34	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.779341250668533	-0.249306266557091	34	1	0.00221729490022173	451	10391	23327	NEDD4L
R-HSA-913531	Interferon Signaling	0.779874322206772	-0.248622497656521	202	7	0.0155210643015521	451	10391	4734,79097,3459,7324,129401,3429,9688	NEDD4,TRIM48,IFNGR1,UBE2E1,NUP35,IFI27,NUP93
R-HSA-8873719	RAB geranylgeranylation	0.780197985838455	-0.248207563509357	65	2	0.00443458980044346	451	10391	57403,339122	RAB22A,RAB43
R-HSA-5368287	Mitochondrial translation	0.781148012560205	-0.246990630376063	94	3	0.00665188470066519	451	10391	10884,28957,64983	MRPS30,MRPS28,MRPL32
R-HSA-1500620	Meiosis	0.781953155646338	-0.245960443496651	122	4	0.00886917960088692	451	10391	23224,56979,23345,6119	SYNE2,PRDM9,SYNE1,RPA3
R-HSA-2408557	Selenocysteine synthesis	0.787188098358225	-0.239288052313893	95	3	0.00665188470066519	451	10391	6235,200916,140801	RPS29,RPL22L1,RPL10L
R-HSA-5653656	Vesicle-mediated transport	0.788606779591748	-0.237487460578674	659	25	0.0554323725055432	451	10391	134829,287,285643,6857,4481,53407,112574,351,339122,1075,85439,91949,2890,9371,84643,1956,6456,57533,56894,2697,161,60592,81567,4012,23303	CLVS2,ANK2,KIF4B,SYT1,MSR1,STX18,SNX18,APP,RAB43,CTSC,STON2,COG7,GRIA1,KIF3B,KIF2B,EGFR,SH3GL2,TBC1D14,AGPAT3,GJA1,AP2A2,SCOC,TXNDC5,LNPEP,KIF13B
R-HSA-2029485	Role of phospholipids in phagocytosis	0.78894993037779	-0.237052419747133	35	1	0.00221729490022173	451	10391	5291	PIK3CB
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	0.78894993037779	-0.237052419747133	35	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-933541	TRAF6 mediated IRF7 activation	0.78894993037779	-0.237052419747133	35	1	0.00221729490022173	451	10391	10010	TANK
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.78894993037779	-0.237052419747133	35	1	0.00221729490022173	451	10391	8787	RGS9
R-HSA-72764	Eukaryotic Translation Termination	0.793089610025738	-0.231819062437964	96	3	0.00665188470066519	451	10391	140801,200916,6235	RPL10L,RPL22L1,RPS29
R-HSA-69473	G2/M DNA damage checkpoint	0.793089610025738	-0.231819062437964	96	3	0.00665188470066519	451	10391	83990,7486,6119	BRIP1,WRN,RPA3
R-HSA-1632852	Macroautophagy	0.794321822086562	-0.230266582364574	67	2	0.00443458980044346	451	10391	5289,7405	PIK3C3,UVRAG
R-HSA-68882	Mitotic Anaphase	0.795170527030504	-0.229198687920075	179	6	0.0133037694013304	451	10391	84643,4085,5519,7444,220134,7324	KIF2B,MAD2L1,PPP2R1B,VRK2,SKA1,UBE2E1
R-HSA-162587	HIV Life Cycle	0.79522243579121	-0.229133410014629	152	5	0.0110864745011086	451	10391	7852,7518,9688,129401,23327	CXCR4,XRCC4,NUP93,NUP35,NEDD4L
R-HSA-72737	Cap-dependent Translation Initiation	0.797678562754871	-0.2260495662448	125	4	0.00886917960088692	451	10391	6235,1968,200916,140801	RPS29,EIF2S3,RPL22L1,RPL10L
R-HSA-72613	Eukaryotic Translation Initiation	0.797678562754871	-0.2260495662448	125	4	0.00886917960088692	451	10391	200916,140801,6235,1968	RPL22L1,RPL10L,RPS29,EIF2S3
R-HSA-202433	Generation of second messenger molecules	0.798141083469923	-0.225469900830732	36	1	0.00221729490022173	451	10391	3702	ITK
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.798141083469923	-0.225469900830732	36	1	0.00221729490022173	451	10391	8887	TAX1BP1
R-HSA-445355	Smooth Muscle Contraction	0.798141083469923	-0.225469900830732	36	1	0.00221729490022173	451	10391	800	CALD1
R-HSA-2514856	The phototransduction cascade	0.798141083469923	-0.225469900830732	36	1	0.00221729490022173	451	10391	8787	RGS9
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.798141083469923	-0.225469900830732	36	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.798141083469923	-0.225469900830732	36	1	0.00221729490022173	451	10391	3702	ITK
R-HSA-156842	Eukaryotic Translation Elongation	0.798854409931299	-0.224576565174168	97	3	0.00665188470066519	451	10391	6235,140801,200916	RPS29,RPL10L,RPL22L1
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.79947431428385	-0.223800874448921	180	6	0.0133037694013304	451	10391	5519,84643,7444,220134,4085,7324	PPP2R1B,KIF2B,VRK2,SKA1,MAD2L1,UBE2E1
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	0.79947431428385	-0.223800874448921	180	6	0.0133037694013304	451	10391	140801,200916,10438,11103,55781,6235	RPL10L,RPL22L1,C1D,KRR1,RIOK2,RPS29
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.801078872962141	-0.221795868643916	68	2	0.00443458980044346	451	10391	55703,351	POLR3B,APP
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.806932814173901	-0.21451486798975	37	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-73884	Base Excision Repair	0.806932814173901	-0.21451486798975	37	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-5689896	Ovarian tumor domain proteases	0.806932814173901	-0.21451486798975	37	1	0.00221729490022173	451	10391	2099	ESR1
R-HSA-6798695	Neutrophil degranulation	0.807000890766345	-0.214430506913114	492	18	0.0399113082039911	451	10391	10788,1075,196527,10875,9218,81567,10159,84766,10075,5594,5787,5788,3074,353189,411,161,5912,29099	IQGAP2,CTSC,ANO6,FGL2,VAPA,TXNDC5,ATP6AP2,CRACR2A,HUWE1,MAPK1,PTPRB,PTPRC,HEXB,SLCO4C1,ARSB,AP2A2,RAP2B,COMMD9
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.807638490171659	-0.213640733734058	69	2	0.00443458980044346	451	10391	1075,2890	CTSC,GRIA1
R-HSA-162906	HIV Infection	0.809963587689819	-0.21076598579545	236	8	0.0177383592017738	451	10391	9844,23327,7852,161,129401,2534,7518,9688	ELMO1,NEDD4L,CXCR4,AP2A2,NUP35,FYN,XRCC4,NUP93
R-HSA-5693607	Processing of DNA double-strand break ends	0.809981543033669	-0.210743817953452	99	3	0.00665188470066519	451	10391	7486,83990,6119	WRN,BRIP1,RPA3
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.809981543033669	-0.210743817953452	99	3	0.00665188470066519	451	10391	6235,200916,140801	RPS29,RPL22L1,RPL10L
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.814005037255856	-0.205788724723736	70	2	0.00443458980044346	451	10391	6256,340665	RXRA,CYP26C1
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.815342443382518	-0.20414707806099	38	1	0.00221729490022173	451	10391	151	ADRA2B
R-HSA-5655302	Signaling by FGFR1 in disease	0.815342443382518	-0.20414707806099	38	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.815342443382518	-0.20414707806099	38	1	0.00221729490022173	451	10391	2882	GPX7
R-HSA-168254	Influenza Infection	0.817596650144382	-0.201386156722619	157	5	0.0110864745011086	451	10391	6235,9688,200916,129401,140801	RPS29,NUP93,RPL22L1,NUP35,RPL10L
R-HSA-400253	Circadian Clock	0.820182871800301	-0.19822794919724	71	2	0.00443458980044346	451	10391	10891,6256	PPARGC1A,RXRA
R-HSA-202424	Downstream TCR signaling	0.82058520550127	-0.197737528016332	101	3	0.00665188470066519	451	10391	6885,50852,5291	MAP3K7,TRAT1,PIK3CB
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.823386542486523	-0.194329513614577	39	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.823386542486523	-0.194329513614577	39	1	0.00221729490022173	451	10391	5270	SERPINE2
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.823386542486523	-0.194329513614577	39	1	0.00221729490022173	451	10391	8607	RUVBL1
R-HSA-5674135	MAP2K and MAPK activation	0.823386542486523	-0.194329513614577	39	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.823386542486523	-0.194329513614577	39	1	0.00221729490022173	451	10391	411	ARSB
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.823386542486523	-0.194329513614577	39	1	0.00221729490022173	451	10391	5594	MAPK1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.831989758011206	-0.183935148319383	73	2	0.00443458980044346	451	10391	7324,4085	UBE2E1,MAD2L1
R-HSA-449147	Signaling by Interleukins	0.833348127090644	-0.182303804442755	528	19	0.0421286031042129	451	10391	6657,57161,5291,6885,161742,200734,3603,2534,5519,8817,9462,5594,4254,284,3084,7010,7291,1956,2263	SOX2,PELI2,PIK3CB,MAP3K7,SPRED1,SPRED2,IL16,FYN,PPP2R1B,FGF18,RASAL2,MAPK1,KITLG,ANGPT1,NRG1,TEK,TWIST1,EGFR,FGFR2
R-HSA-199977	ER to Golgi Anterograde Transport	0.835170104529542	-0.180119856879524	133	4	0.00886917960088692	451	10391	1075,287,91949,2890	CTSC,ANK2,COG7,GRIA1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.83762742882508	-0.177181873036143	74	2	0.00443458980044346	451	10391	7324,4085	UBE2E1,MAD2L1
R-HSA-372790	Signaling by GPCR	0.837987243340524	-0.176752401359926	1345	52	0.11529933481153	451	10391	353299,200734,151,108,5519,2911,5291,8321,4887,2263,552,7010,1902,114,2534,9568,161742,10886,8787,128674,56923,9459,7852,7201,5179,4254,886,9462,5151,8817,1909,11245,4158,1956,3084,2925,284,9890,3350,2861,5594,5368,9287,7504,6197,351,2770,1608,10203,57007,406974,5139	RGSL1,SPRED2,ADRA2B,ADCY2,PPP2R1B,GRM1,PIK3CB,FZD1,NPY2R,FGFR2,AVPR1A,TEK,LPAR1,ADCY8,FYN,GABBR2,SPRED1,NPFFR2,RGS9,PROKR2,NMUR2,ARHGEF6,CXCR4,TRHR,PENK,KITLG,CCKAR,RASAL2,PDE8A,FGF18,EDNRA,GPR176,MC2R,EGFR,NRG1,GRPR,ANGPT1,PLPPR4,HTR1A,GPR37,MAPK1,PNOC,TAAR2,XK,RPS6KA3,APP,GNAI1,DGKG,CALCRL,ACKR3,MIR197,PDE3A
R-HSA-5696400	Dual Incision in GG-NER	0.838440881135093	-0.176211205708268	41	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-5620924	Intraflagellar transport	0.838440881135093	-0.176211205708268	41	1	0.00221729490022173	451	10391	9371	KIF3B
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.838440881135093	-0.176211205708268	41	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-72689	Formation of a pool of free 40S subunits	0.840287275638021	-0.174011450804505	105	3	0.00665188470066519	451	10391	140801,200916,6235	RPL10L,RPL22L1,RPS29
R-HSA-1280215	Cytokine Signaling in Immune system	0.845206864218977	-0.168173871859374	760	28	0.0620842572062084	451	10391	3459,3603,129401,200734,6885,9688,9462,5519,8817,6657,5291,57161,2263,1956,7291,7010,3084,284,4734,5594,7324,2534,9966,7292,161742,79097,3429,4254	IFNGR1,IL16,NUP35,SPRED2,MAP3K7,NUP93,RASAL2,PPP2R1B,FGF18,SOX2,PIK3CB,PELI2,FGFR2,EGFR,TWIST1,TEK,NRG1,ANGPT1,NEDD4,MAPK1,UBE2E1,FYN,TNFSF15,TNFSF4,SPRED1,TRIM48,IFI27,KITLG
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.845480800247806	-0.167849819064783	42	1	0.00221729490022173	451	10391	6256	RXRA
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.845480800247806	-0.167849819064783	42	1	0.00221729490022173	451	10391	54901	CDKAL1
R-HSA-8868773	rRNA processing in the nucleus and cytosol	0.845809571244066	-0.167461037805286	192	6	0.0133037694013304	451	10391	6235,55781,10438,200916,11103,140801	RPS29,RIOK2,C1D,RPL22L1,KRR1,RPL10L
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.848392536455305	-0.164411853530559	76	2	0.00443458980044346	451	10391	9459,83464	ARHGEF6,APH1B
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.848392536455305	-0.164411853530559	76	2	0.00443458980044346	451	10391	4085,7324	MAD2L1,UBE2E1
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.848392536455305	-0.164411853530559	76	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.852214606320514	-0.159916898517895	43	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-1461957	Beta defensins	0.852214606320514	-0.159916898517895	43	1	0.00221729490022173	451	10391	245929	DEFB115
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.85352838052461	-0.158376485367716	77	2	0.00443458980044346	451	10391	23327,56288	NEDD4L,PARD3
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.85352838052461	-0.158376485367716	77	2	0.00443458980044346	451	10391	4085,7324	MAD2L1,UBE2E1
R-HSA-211000	Gene Silencing by RNA	0.855525983388158	-0.156038813944945	138	4	0.00886917960088692	451	10391	7247,129401,9688,23405	TSN,NUP35,NUP93,DICER1
R-HSA-72306	tRNA processing	0.858093813155921	-0.15304184612872	109	3	0.00665188470066519	451	10391	9688,129401,54901	NUP93,NUP35,CDKAL1
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.858655581631591	-0.15238739009987	44	1	0.00221729490022173	451	10391	8942	KYNU
R-HSA-2467813	Separation of Sister Chromatids	0.859920284585557	-0.15091558637316	168	5	0.0110864745011086	451	10391	7324,4085,220134,84643,5519	UBE2E1,MAD2L1,SKA1,KIF2B,PPP2R1B
R-HSA-6807878	COPI-mediated anterograde transport	0.863327321096478	-0.146961376961825	79	2	0.00443458980044346	451	10391	91949,287	COG7,ANK2
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.864816433329523	-0.145238010375237	45	1	0.00221729490022173	451	10391	3655	ITGA6
R-HSA-6811438	Intra-Golgi traffic	0.864816433329523	-0.145238010375237	45	1	0.00221729490022173	451	10391	91949	COG7
R-HSA-379724	tRNA Aminoacylation	0.864816433329523	-0.145238010375237	45	1	0.00221729490022173	451	10391	6897	TARS1
R-HSA-211945	Phase 1 - Functionalization of compounds	0.866328565646466	-0.143491036317705	111	3	0.00665188470066519	451	10391	131,6256,340665	ADH7,RXRA,CYP26C1
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.866328565646466	-0.143491036317705	111	3	0.00665188470066519	451	10391	6197,5594,7324	RPS6KA3,MAPK1,UBE2E1
R-HSA-5663205	Infectious disease	0.867145554565967	-0.142548433286641	388	13	0.0288248337028825	451	10391	9844,23327,9688,7518,129401,2534,140801,6235,161,7852,200916,6857,6456	ELMO1,NEDD4L,NUP93,XRCC4,NUP35,FYN,RPL10L,RPS29,AP2A2,CXCR4,RPL22L1,SYT1,SH3GL2
R-HSA-1221632	Meiotic synapsis	0.867998531881678	-0.141565255703773	80	2	0.00443458980044346	451	10391	23345,23224	SYNE1,SYNE2
R-HSA-68886	M Phase	0.869099697644304	-0.140297433433958	309	10	0.0221729490022173	451	10391	2029,5594,84643,4085,9688,129401,7324,5519,7444,220134	ENSA,MAPK1,KIF2B,MAD2L1,NUP93,NUP35,UBE2E1,PPP2R1B,VRK2,SKA1
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.870709318385537	-0.138447091027808	46	1	0.00221729490022173	451	10391	23327	NEDD4L
R-HSA-70326	Glucose metabolism	0.872522885840556	-0.136366395059811	81	2	0.00443458980044346	451	10391	5519,2632	PPP2R1B,GBE1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.872522885840556	-0.136366395059811	81	2	0.00443458980044346	451	10391	7324,4085	UBE2E1,MAD2L1
R-HSA-453279	Mitotic G1-G1/S phases	0.873708232001563	-0.135008789722289	143	4	0.00886917960088692	451	10391	4999,5519,28227,6119	ORC2,PPP2R1B,PPP2R3B,RPA3
R-HSA-1483249	Inositol phosphate metabolism	0.876345867200295	-0.131994440397739	47	1	0.00221729490022173	451	10391	8821	INPP4B
R-HSA-5576892	Phase 0 - rapid depolarisation	0.876345867200295	-0.131994440397739	47	1	0.00221729490022173	451	10391	781	CACNA2D1
R-HSA-8854214	TBC/RABGAPs	0.876345867200295	-0.131994440397739	47	1	0.00221729490022173	451	10391	57533	TBC1D14
R-HSA-168256	Immune System	0.877101164708241	-0.13113294011753	2124	83	0.184035476718404	451	10391	8817,8887,81567,9462,9688,84766,10159,3603,3459,6657,5912,4734,284,3084,1956,7328,6456,5594,84861,9371,84643,10075,57531,57520,411,6197,4064,9966,9844,351,1075,196527,10875,245929,868,7337,5289,1519,4651,5602,5788,118430,3429,353189,5519,108,4012,9520,6885,200734,129401,57161,5291,50617,161,114,7291,127124,7010,201456,2263,1493,3074,154214,9218,161742,7292,2534,7324,79097,10788,23327,10225,6468,50852,10010,3702,29099,55703,285643,5787,4254,2932	FGF18,TAX1BP1,TXNDC5,RASAL2,NUP93,CRACR2A,ATP6AP2,IL16,IFNGR1,SOX2,RAP2B,NEDD4,ANGPT1,NRG1,EGFR,UBE2H,SH3GL2,MAPK1,KLHL22,KIF3B,KIF2B,HUWE1,HACE1,HECW2,ARSB,RPS6KA3,CD180,TNFSF15,ELMO1,APP,CTSC,ANO6,FGL2,DEFB115,CBLB,UBE3A,PIK3C3,CTSO,MYO10,MAPK10,PTPRC,MUCL1,IFI27,SLCO4C1,PPP2R1B,ADCY2,LNPEP,NPEPPS,MAP3K7,SPRED2,NUP35,PELI2,PIK3CB,ATP6V0A4,AP2A2,ADCY8,TWIST1,ATP6V1G3,TEK,FBXO15,FGFR2,CTLA4,HEXB,RNF217,VAPA,SPRED1,TNFSF4,FYN,UBE2E1,TRIM48,IQGAP2,NEDD4L,CD96,FBXW4,TRAT1,TANK,ITK,COMMD9,POLR3B,KIF4B,PTPRB,KITLG,GSK3B
R-HSA-72312	rRNA processing	0.877436588434241	-0.13075059014588	202	6	0.0133037694013304	451	10391	140801,200916,10438,11103,55781,6235	RPL10L,RPL22L1,C1D,KRR1,RIOK2,RPS29
R-HSA-69620	Cell Cycle Checkpoints	0.877436588434241	-0.13075059014588	202	6	0.0133037694013304	451	10391	7324,6119,4085,4999,7486,83990	UBE2E1,RPA3,MAD2L1,ORC2,WRN,BRIP1
R-HSA-157579	Telomere Maintenance	0.88114661276233	-0.12653125058931	83	2	0.00443458980044346	451	10391	6119,8607	RPA3,RUVBL1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.881545552509706	-0.126078602348117	115	3	0.00665188470066519	451	10391	200916,140801,6235	RPL22L1,RPL10L,RPS29
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.881737206502679	-0.125861219182827	48	1	0.00221729490022173	451	10391	5291	PIK3CB
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.881737206502679	-0.125861219182827	48	1	0.00221729490022173	451	10391	9734	HDAC9
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.886893981109537	-0.120029829059181	49	1	0.00221729490022173	451	10391	4481	MSR1
R-HSA-73894	DNA Repair	0.887777242370235	-0.119034420645562	317	10	0.0221729490022173	451	10391	51008,7518,2138,5890,8607,6119,7486,23514,83990,29089	ASCC1,XRCC4,EYA1,RAD51B,RUVBL1,RPA3,WRN,SPIDR,BRIP1,UBE2T
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.889229047914265	-0.117400429955732	85	2	0.00443458980044346	451	10391	8607,6119	RUVBL1,RPA3
R-HSA-73893	DNA Damage Bypass	0.891826374712647	-0.11448381253148	50	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-194315	Signaling by Rho GTPases	0.892842950778242	-0.113344580561701	427	14	0.0310421286031042	451	10391	5519,220134,10788,64411,4085,4983,83478,9459,5289,5594,84643,58504,395,50508	PPP2R1B,SKA1,IQGAP2,ARAP3,MAD2L1,OPHN1,ARHGAP24,ARHGEF6,PIK3C3,MAPK1,KIF2B,ARHGAP22,ARHGAP6,NOX3
R-HSA-3858494	Beta-catenin independent WNT signaling	0.892893368028052	-0.113288113938615	149	4	0.00886917960088692	451	10391	6885,51701,8321,161	MAP3K7,NLK,FZD1,AP2A2
R-HSA-68874	M/G1 Transition	0.89307654051361	-0.113082990117295	86	2	0.00443458980044346	451	10391	4999,6119	ORC2,RPA3
R-HSA-69002	DNA Replication Pre-Initiation	0.89307654051361	-0.113082990117295	86	2	0.00443458980044346	451	10391	4999,6119	ORC2,RPA3
R-HSA-397795	G-protein beta:gamma signalling	0.896544129777454	-0.109207762633707	51	1	0.00221729490022173	451	10391	5291	PIK3CB
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.896799686089068	-0.10892275725874	87	2	0.00443458980044346	451	10391	7324,4085	UBE2E1,MAD2L1
R-HSA-5632684	Hedgehog 'on' state	0.896799686089068	-0.10892275725874	87	2	0.00443458980044346	451	10391	91653,2737	BOC,GLI3
R-HSA-453276	Regulation of mitotic cell cycle	0.896799686089068	-0.10892275725874	87	2	0.00443458980044346	451	10391	7324,4085	UBE2E1,MAD2L1
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.898389700550247	-0.107151339837501	120	3	0.00665188470066519	451	10391	6235,200916,140801	RPS29,RPL22L1,RPL10L
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.898389700550247	-0.107151339837501	120	3	0.00665188470066519	451	10391	6235,140801,200916	RPS29,RPL10L,RPL22L1
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.900402000363771	-0.10491394831301	88	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-912446	Meiotic recombination	0.903886928876797	-0.10105100508906	89	2	0.00443458980044346	451	10391	6119,56979	RPA3,PRDM9
R-HSA-1461973	Defensins	0.905372601931903	-0.0994087051716285	53	1	0.00221729490022173	451	10391	245929	DEFB115
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.913449218246819	-0.090527495024743	55	1	0.00221729490022173	451	10391	6256	RXRA
R-HSA-373080	Class B/2 (Secretin family receptors)	0.916719216665042	-0.0869540513618199	93	2	0.00443458980044346	451	10391	8321,10203	FZD1,CALCRL
R-HSA-4641257	Degradation of AXIN	0.917225766486577	-0.0864016358432849	56	1	0.00221729490022173	451	10391	8658	TNKS
R-HSA-2559580	Oxidative Stress Induced Senescence	0.918355893689166	-0.085170279734316	127	3	0.00665188470066519	451	10391	84733,5602,5594	CBX2,MAPK10,MAPK1
R-HSA-5619507	Activation of HOX genes during differentiation	0.918355893689166	-0.085170279734316	127	3	0.00665188470066519	451	10391	8202,5915,6256	NCOA3,RARB,RXRA
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.918355893689166	-0.085170279734316	127	3	0.00665188470066519	451	10391	5915,6256,8202	RARB,RXRA,NCOA3
R-HSA-877300	Interferon gamma signaling	0.919666416771674	-0.0837442651564403	94	2	0.00443458980044346	451	10391	79097,3459	TRIM48,IFNGR1
R-HSA-71291	Metabolism of amino acids and derivatives	0.920677350789787	-0.0826456289802912	362	11	0.024390243902439	451	10391	9061,8942,140801,6611,8050,200916,4552,4837,6235,594,5160	PAPSS1,KYNU,RPL10L,SMS,PDHX,RPL22L1,MTRR,NNMT,RPS29,BCKDHB,PDHA1
R-HSA-5617833	Cilium Assembly	0.924380672390179	-0.0786313090759376	192	5	0.0110864745011086	451	10391	50807,23322,129880,11116,9371	ASAP1,RPGRIP1L,BBS5,CEP43,KIF3B
R-HSA-4086400	PCP/CE pathway	0.925269153338592	-0.0776706072129254	96	2	0.00443458980044346	451	10391	161,8321	AP2A2,FZD1
R-HSA-4641258	Degradation of DVL	0.927597063254995	-0.0751578395663213	59	1	0.00221729490022173	451	10391	51339	DACT1
R-HSA-15869	Metabolism of nucleotides	0.927930516365992	-0.0747984236047914	97	2	0.00443458980044346	451	10391	6240,26289	RRM1,AK5
R-HSA-72766	Translation	0.928033270215518	-0.0746876953132449	163	4	0.00886917960088692	451	10391	140801,200916,6235,1968	RPL10L,RPL22L1,RPS29,EIF2S3
R-HSA-1852241	Organelle biogenesis and maintenance	0.929644573077344	-0.0729529453707545	340	10	0.0221729490022173	451	10391	23322,50807,129880,64983,11116,6256,10884,28957,10891,9371	RPGRIP1L,ASAP1,BBS5,MRPL32,CEP43,RXRA,MRPS30,MRPS28,PPARGC1A,KIF3B
R-HSA-114608	Platelet degranulation	0.930355108806446	-0.072188928289907	132	3	0.00665188470066519	451	10391	351,7043,7042	APP,TGFB3,TGFB2
R-HSA-193704	p75 NTR receptor-mediated signalling	0.930502310342546	-0.0720307199985121	98	2	0.00443458980044346	451	10391	83464,9459	APH1B,ARHGEF6
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.930757508921011	-0.0717564986593708	60	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-193648	NRAGE signals death through JNK	0.930757508921011	-0.0717564986593708	60	1	0.00221729490022173	451	10391	9459	ARHGEF6
R-HSA-2262752	Cellular responses to stress	0.931626262924495	-0.070823550166552	452	14	0.0310421286031042	451	10391	3308,6197,7324,2034,129401,9688,6119,84733,5289,2882,5602,5594,2932,7405	HSPA4,RPS6KA3,UBE2E1,EPAS1,NUP35,NUP93,RPA3,CBX2,PIK3C3,GPX7,MAPK10,MAPK1,GSK3B,UVRAG
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.93378029119191	-0.0685141026951182	61	1	0.00221729490022173	451	10391	2932	GSK3B
R-HSA-2559583	Cellular Senescence	0.933911372867847	-0.068373735118741	197	5	0.0110864745011086	451	10391	6197,5594,5602,7324,84733	RPS6KA3,MAPK1,MAPK10,UBE2E1,CBX2
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.935388080092323	-0.0667937768843069	100	2	0.00443458980044346	451	10391	11116,23322	CEP43,RPGRIP1L
R-HSA-69239	Synthesis of DNA	0.937707330083645	-0.064317393498868	101	2	0.00443458980044346	451	10391	4999,6119	ORC2,RPA3
R-HSA-6790901	rRNA modification in the nucleus and cytosol	0.939436540498448	-0.0624750084467298	63	1	0.00221729490022173	451	10391	11103	KRR1
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.940715356366602	-0.0611146757337293	137	3	0.00665188470066519	451	10391	7043,7042,351	TGFB3,TGFB2,APP
R-HSA-1640170	Cell Cycle	0.941104308030711	-0.0607012974733078	622	20	0.0443458980044346	451	10391	220134,4999,23224,11116,5519,129401,7324,9688,4085,83990,7486,2029,8607,6119,23345,7444,28227,56979,5594,84643	SKA1,ORC2,SYNE2,CEP43,PPP2R1B,NUP35,UBE2E1,NUP93,MAD2L1,BRIP1,WRN,ENSA,RUVBL1,RPA3,SYNE1,VRK2,PPP2R3B,PRDM9,MAPK1,KIF2B
R-HSA-69481	G2/M Checkpoints	0.941381534008961	-0.0604067656642883	170	4	0.00886917960088692	451	10391	6119,4999,83990,7486	RPA3,ORC2,BRIP1,WRN
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.942081207440465	-0.0596638006474701	64	1	0.00221729490022173	451	10391	7324	UBE2E1
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.944200783006503	-0.0574164415899481	104	2	0.00443458980044346	451	10391	7292,9966	TNFSF4,TNFSF15
R-HSA-162599	Late Phase of HIV Life Cycle	0.944445455950647	-0.0571573428339547	139	3	0.00665188470066519	451	10391	9688,129401,23327	NUP93,NUP35,NEDD4L
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.944610632762375	-0.0569824652184767	65	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-112382	Formation of RNA Pol II elongation complex	0.944610632762375	-0.0569824652184767	65	1	0.00221729490022173	451	10391	4300	MLLT3
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.944610632762375	-0.0569824652184767	65	1	0.00221729490022173	451	10391	4300	MLLT3
R-HSA-109581	Apoptosis	0.944758710890598	-0.0568257164821611	172	4	0.00886917960088692	451	10391	1829,1630,9414,839	DSG2,DCC,TJP2,CASP6
R-HSA-5689603	UCH proteinases	0.946218521010287	-0.0552817418799705	105	2	0.00443458980044346	451	10391	221937,8607	FOXK1,RUVBL1
R-HSA-195258	RHO GTPase Effectors	0.946530431218433	-0.0549521575358848	295	8	0.0177383592017738	451	10391	50508,10788,84643,5594,4085,5289,5519,220134	NOX3,IQGAP2,KIF2B,MAPK1,MAD2L1,PIK3C3,PPP2R1B,SKA1
R-HSA-6782135	Dual incision in TC-NER	0.947029827469421	-0.0544246894922614	66	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-5358346	Hedgehog ligand biogenesis	0.949343585148084	-0.0519844962145216	67	1	0.00221729490022173	451	10391	2262	GPC5
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.949343585148084	-0.0519844962145216	67	1	0.00221729490022173	451	10391	2034	EPAS1
R-HSA-4608870	Asymmetric localization of PCP proteins	0.949343585148084	-0.0519844962145216	67	1	0.00221729490022173	451	10391	8321	FZD1
R-HSA-5357801	Programmed Cell Death	0.94949258741125	-0.0518275555941297	175	4	0.00886917960088692	451	10391	839,1829,9414,1630	CASP6,DSG2,TJP2,DCC
R-HSA-5578749	Transcriptional regulation by small RNAs	0.950047644544204	-0.0512431434933343	107	2	0.00443458980044346	451	10391	9688,129401	NUP93,NUP35
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.951556491288124	-0.0496562232378139	68	1	0.00221729490022173	451	10391	7324	UBE2E1
R-HSA-1169091	Activation of NF-kappaB in B cells	0.951556491288124	-0.0496562232378139	68	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-69306	DNA Replication	0.953616104815884	-0.0474940943741838	109	2	0.00443458980044346	451	10391	4999,6119	ORC2,RPA3
R-HSA-68867	Assembly of the pre-replicative complex	0.953672932502654	-0.0474345043637823	69	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-6806834	Signaling by MET	0.953672932502654	-0.0474345043637823	69	1	0.00221729490022173	451	10391	6456	SH3GL2
R-HSA-909733	Interferon alpha/beta signaling	0.953672932502654	-0.0474345043637823	69	1	0.00221729490022173	451	10391	3429	IFI27
R-HSA-5621481	C-type lectin receptors (CLRs)	0.954369526853291	-0.0467043378224973	145	3	0.00665188470066519	451	10391	2534,6885,118430	FYN,MAP3K7,MUCL1
R-HSA-73886	Chromosome Maintenance	0.955307789477618	-0.0457216977798046	110	2	0.00443458980044346	451	10391	6119,8607	RPA3,RUVBL1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.95569710489392	-0.0453142520188503	70	1	0.00221729490022173	451	10391	7518	XRCC4
R-HSA-6809371	Formation of the cornified envelope	0.957633022495478	-0.0432906406885545	71	1	0.00221729490022173	451	10391	1829	DSG2
R-HSA-5696398	Nucleotide Excision Repair	0.958515966874564	-0.0423690584457593	112	2	0.00443458980044346	451	10391	6119,8607	RPA3,RUVBL1
R-HSA-69052	Switching of origins to a post-replicative state	0.959484525106282	-0.0413590917454401	72	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.959484525106282	-0.0413590917454401	72	1	0.00221729490022173	451	10391	134353	LSM11
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	0.959484525106282	-0.0413590917454401	72	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.959484525106282	-0.0413590917454401	72	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-68949	Orc1 removal from chromatin	0.959484525106282	-0.0413590917454401	72	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-73856	RNA Polymerase II Transcription Termination	0.959484525106282	-0.0413590917454401	72	1	0.00221729490022173	451	10391	134353	LSM11
R-HSA-774815	Nucleosome assembly	0.961255285768779	-0.0395152593282167	73	1	0.00221729490022173	451	10391	8607	RUVBL1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.961255285768779	-0.0395152593282167	73	1	0.00221729490022173	451	10391	7324	UBE2E1
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.961255285768779	-0.0395152593282167	73	1	0.00221729490022173	451	10391	8607	RUVBL1
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.961255285768779	-0.0395152593282167	73	1	0.00221729490022173	451	10391	23379	ICE1
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.961348789359166	-0.0394179916778775	150	3	0.00665188470066519	451	10391	2971,55703,4781	GTF3A,POLR3B,NFIB
R-HSA-6785807	Interleukin-4 and 13 signaling	0.961503101150046	-0.0392574886334428	114	2	0.00443458980044346	451	10391	6657,7291	SOX2,TWIST1
R-HSA-388396	GPCR downstream signaling	0.962673636954681	-0.03804082705985	1019	34	0.0753880266075388	451	10391	1902,114,552,2925,5368,3350,151,108,5151,353299,5291,4158,4887,2911,1909,11245,7852,7201,57007,406974,5139,9459,886,5179,10886,9287,9568,56923,351,2770,1608,10203,8787,128674	LPAR1,ADCY8,AVPR1A,GRPR,PNOC,HTR1A,ADRA2B,ADCY2,PDE8A,RGSL1,PIK3CB,MC2R,NPY2R,GRM1,EDNRA,GPR176,CXCR4,TRHR,ACKR3,MIR197,PDE3A,ARHGEF6,CCKAR,PENK,NPFFR2,TAAR2,GABBR2,NMUR2,APP,GNAI1,DGKG,CALCRL,RGS9,PROKR2
R-HSA-69300	Removal of licensing factors from origins	0.962948818048121	-0.0377550170407591	74	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-3700989	Transcriptional Regulation by TP53	0.963602109589552	-0.0370768189644981	370	10	0.0221729490022173	451	10391	900,639,6119,9891,7486,83990,1345,79370,839,5519	CCNG1,PRDM1,RPA3,NUAK1,WRN,BRIP1,COX6C,BCL2L14,CASP6,PPP2R1B
R-HSA-212165	Epigenetic regulation of gene expression	0.963849484757587	-0.0368201327056897	152	3	0.00665188470066519	451	10391	3720,54790,2932	JARID2,TET2,GSK3B
R-HSA-8854518	AURKA Activation by TPX2	0.964568482996075	-0.0360744455322375	75	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-212300	PRC2 methylates histones and DNA	0.964568482996075	-0.0360744455322375	75	1	0.00221729490022173	451	10391	3720	JARID2
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.966117495597885	-0.0344698211123646	76	1	0.00221729490022173	451	10391	2138	EYA1
R-HSA-5619115	Disorders of transmembrane transporters	0.966117495597885	-0.0344698211123646	76	1	0.00221729490022173	451	10391	552	AVPR1A
R-HSA-5693606	DNA Double Strand Break Response	0.967598931316195	-0.0329376047154623	77	1	0.00221729490022173	451	10391	2138	EYA1
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.967598931316195	-0.0329376047154623	77	1	0.00221729490022173	451	10391	2034	EPAS1
R-HSA-69304	Regulation of DNA replication	0.967598931316195	-0.0329376047154623	77	1	0.00221729490022173	451	10391	4999	ORC2
R-HSA-2262749	Cellular response to hypoxia	0.967598931316195	-0.0329376047154623	77	1	0.00221729490022173	451	10391	2034	EPAS1
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.970370711609111	-0.0300771035790951	79	1	0.00221729490022173	451	10391	6119	RPA3
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.974091062402933	-0.026250486482991	82	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-380287	Centrosome maturation	0.974091062402933	-0.026250486482991	82	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.97734517850112	-0.022915384831966	85	1	0.00221729490022173	451	10391	1345	COX6C
R-HSA-2871837	FCERI mediated NF-kB activation	0.97734517850112	-0.022915384831966	85	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-69242	S Phase	0.978994116317738	-0.0212296463596372	130	2	0.00443458980044346	451	10391	4999,6119	ORC2,RPA3
R-HSA-351202	Metabolism of polyamines	0.979284677588648	-0.0209328946673379	87	1	0.00221729490022173	451	10391	6611	SMS
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.980191375040301	-0.0200074457289362	88	1	0.00221729490022173	451	10391	4300	MLLT3
R-HSA-416482	G alpha (12/13) signalling events	0.980191375040301	-0.0200074457289362	88	1	0.00221729490022173	451	10391	9459	ARHGEF6
R-HSA-69278	Cell Cycle, Mitotic	0.980915348549784	-0.0192691141188681	515	14	0.0310421286031042	451	10391	5519,4999,220134,11116,9688,129401,7324,4085,6119,2029,7444,28227,5594,84643	PPP2R1B,ORC2,SKA1,CEP43,NUP93,NUP35,UBE2E1,MAD2L1,RPA3,ENSA,VRK2,PPP2R3B,MAPK1,KIF2B
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.981887691520925	-0.0182783442547191	90	1	0.00221729490022173	451	10391	11116	CEP43
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.983439037938936	-0.0166996278845974	92	1	0.00221729490022173	451	10391	8607	RUVBL1
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	0.984857778522818	-0.0152580355213747	94	1	0.00221729490022173	451	10391	2932	GSK3B
R-HSA-3214847	HATs acetylate histones	0.987276227033316	-0.0128054134216564	143	2	0.00443458980044346	451	10391	8607,51562	RUVBL1,MBIP
R-HSA-6803157	Antimicrobial peptides	0.987896363757579	-0.0121774817183398	99	1	0.00221729490022173	451	10391	245929	DEFB115
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.98893394466132	-0.0111277396189772	101	1	0.00221729490022173	451	10391	6885	MAP3K7
R-HSA-1236975	Antigen processing-Cross presentation	0.98893394466132	-0.0111277396189772	101	1	0.00221729490022173	451	10391	4012	LNPEP
R-HSA-977225	Amyloid fiber formation	0.989418958355455	-0.0106374189051025	102	1	0.00221729490022173	451	10391	351	APP
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	0.992269219790786	-0.00776081759898671	109	1	0.00221729490022173	451	10391	2932	GSK3B
R-HSA-73857	RNA Polymerase II Transcription	0.993462866049787	-0.00655859458886298	160	2	0.00443458980044346	451	10391	134353,4300	LSM11,MLLT3
R-HSA-3247509	Chromatin modifying enzymes	0.994283972903217	-0.00573242610096159	279	5	0.0110864745011086	451	10391	8607,51562,2122,56979,55729	RUVBL1,MBIP,MECOM,PRDM9,ATF7IP
R-HSA-4839726	Chromatin organization	0.994283972903217	-0.00573242610096159	279	5	0.0110864745011086	451	10391	2122,51562,8607,55729,56979	MECOM,MBIP,RUVBL1,ATF7IP,PRDM9
R-HSA-5689880	Ub-specific processing proteases	0.997084234737858	-0.00292002438676027	223	3	0.00665188470066519	451	10391	6885,8607,8658	MAP3K7,RUVBL1,TNKS
R-HSA-5688426	Deubiquitination	0.99721032268985	-0.0027935757117736	301	5	0.0110864745011086	451	10391	221937,2099,8658,6885,8607	FOXK1,ESR1,TNKS,MAP3K7,RUVBL1
R-HSA-69275	G2/M Transition	0.997279148887239	-0.00272455935606264	182	2	0.00443458980044346	451	10391	11116,5519	CEP43,PPP2R1B
R-HSA-453274	Mitotic G2-G2/M phases	0.997489372912134	-0.00251378399704163	184	2	0.00443458980044346	451	10391	11116,5519	CEP43,PPP2R1B
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.99759500034808	-0.002407896308821	135	1	0.00221729490022173	451	10391	10225	CD96
R-HSA-212436	Generic Transcription Pathway	0.999733026037929	-0.000267009605963299	874	20	0.0443458980044346	451	10391	2104,5519,839,6256,6119,23327,900,639,83990,7486,10413,8013,1956,1345,79370,79230,344787,2099,5915,9891	ESRRG,PPP2R1B,CASP6,RXRA,RPA3,NEDD4L,CCNG1,PRDM1,BRIP1,WRN,YAP1,NR4A3,EGFR,COX6C,BCL2L14,ZNF557,ZNF860,ESR1,RARB,NUAK1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.999818019715735	-0.000181996844686369	248	2	0.00443458980044346	451	10391	129401,9688	NUP35,NUP93
R-HSA-6805567	Keratinization	0.999932051547793	-6.79507608077803e-05	214	1	0.00221729490022173	451	10391	1829	DSG2
R-HSA-74160	Gene Expression	0.999999885386611	-1.14613395966915e-07	1834	42	0.0931263858093126	451	10391	6897,344787,2099,2932,11103,9891,55703,200916,23405,4781,1968,3720,7247,4300,79370,23327,900,7486,8013,23379,2104,140801,54901,839,6256,6235,5915,54790,1956,1345,79230,6119,639,10413,83990,55781,134353,9688,2971,129401,5519,10438	TARS1,ZNF860,ESR1,GSK3B,KRR1,NUAK1,POLR3B,RPL22L1,DICER1,NFIB,EIF2S3,JARID2,TSN,MLLT3,BCL2L14,NEDD4L,CCNG1,WRN,NR4A3,ICE1,ESRRG,RPL10L,CDKAL1,CASP6,RXRA,RPS29,RARB,TET2,EGFR,COX6C,ZNF557,RPA3,PRDM1,YAP1,BRIP1,RIOK2,LSM11,NUP93,GTF3A,NUP35,PPP2R1B,C1D
R-HSA-417973	Adenosine P1 receptors	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-8849474	PTK6 Activates STAT3	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-140179	Amine Oxidase reactions	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-6783984	Glycine degradation	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-8848584	Wax biosynthesis	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-173736	Alternative complement activation	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-167060	NGF processing	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-442745	Activation of CaMK IV	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-209905	Catecholamine biosynthesis	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-1296061	HCN channels	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-1296053	Classical Kir channels	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-888593	Reuptake of GABA	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-390650	Histamine receptors	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-8935690	Miscellaneous digestion events	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-447115	Interleukin-12 signaling	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-165158	Activation of AKT2	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-209563	Axonal growth stimulation	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999994601	-5.39928180679996e-12	4	0	0	451	10391
R-HSA-209543	p75NTR recruits signalling complexes	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-211958	Miscellaneous substrates	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-209952	Peptide hormone biosynthesis	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-181431	Acetylcholine Binding And Downstream Events	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-174411	Polymerase switching on the C-strand of the telomere	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-5675482	Regulation of necroptotic cell death	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-69091	Polymerase switching	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-209560	NF-kB is activated and signals survival	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-69109	Leading Strand Synthesis	1.00000000000152	1.51994848006428e-12	14	0	0	451	10391
R-HSA-113418	Formation of the Early Elongation Complex	1.00000000000188	1.88015293055421e-12	35	0	0	451	10391
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	1.00000000000188	1.88015293055421e-12	35	0	0	451	10391
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000221	2.21330170537155e-12	19	0	0	451	10391
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	1.00000000000221	2.21330170537155e-12	19	0	0	451	10391
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1.00000000000221	2.21330170537155e-12	19	0	0	451	10391
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	1.00000000000221	2.21330170537155e-12	19	0	0	451	10391
R-HSA-8876725	Protein methylation	1.00000000000221	2.21330170537155e-12	19	0	0	451	10391
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	1.00000000000221	2.21330170537155e-12	19	0	0	451	10391
R-HSA-5223345	Miscellaneous transport and binding events	1.00000000000221	2.21330170537155e-12	19	0	0	451	10391
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-168316	Assembly of Viral Components at the Budding Site	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5602566	TICAM1 deficiency - HSE	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-168277	Influenza Virus Induced Apoptosis	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-844623	The IPAF inflammasome	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-114294	Activation, translocation and oligomerization of BAX	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-141334	PAOs oxidise polyamines to amines	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-111457	Release of apoptotic factors from the mitochondria	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-71737	Pyrophosphate hydrolysis	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-75896	Plasmalogen biosynthesis	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-1483152	Hydrolysis of LPE	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-168268	Virus Assembly and Release	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5602636	IKBKB deficiency causes SCID	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-351143	Agmatine biosynthesis	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-1483101	Synthesis of PS	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-203754	NOSIP mediated eNOS trafficking	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-111452	Activation and oligomerization of BAK protein	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-916853	Degradation of GABA	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-77042	Formation of editosomes by ADAR proteins	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5357609	Glycogen storage disease type II (GAA)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-8849175	Threonine catabolism	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-380612	Metabolism of serotonin	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-8942233	Intestinal infectious diseases	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-888568	GABA synthesis	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-177162	Conjugation of phenylacetate with glutamine	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-187042	TRKA activation by NGF	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-70688	Proline catabolism	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-428559	Proton-coupled neutral amino acid transporters	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-205017	NFG and proNGF binds to p75NTR	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-192905	vRNP Assembly	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-75102	C6 deamination of adenosine	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-156582	Acetylation	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-8854521	Interaction between PHLDA1 and AURKA	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-75064	mRNA Editing: A to I Conversion	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-5652227	Fructose biosynthesis	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-165160	PDE3B signalling	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	1.00000000000314	3.141254834374e-12	2	0	0	451	10391
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	1.00000000000378	3.78259001025131e-12	20	0	0	451	10391
R-HSA-6804760	Regulation of TP53 Activity through Methylation	1.00000000000378	3.78259001025131e-12	20	0	0	451	10391
R-HSA-8874081	MET activates PTK2 signaling	1.00000000000378	3.78259001025131e-12	20	0	0	451	10391
R-HSA-418217	G beta:gamma signalling through PLC beta	1.00000000000378	3.78259001025131e-12	20	0	0	451	10391
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	1.00000000000378	3.78259001025131e-12	20	0	0	451	10391
R-HSA-6783783	Interleukin-10 signaling	1.00000000000405	4.04538407770501e-12	49	0	0	451	10391
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	1.00000000000405	4.04538407770501e-12	49	0	0	451	10391
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	1.00000000000469	4.69184912182209e-12	22	0	0	451	10391
R-HSA-166208	mTORC1-mediated signalling	1.00000000000469	4.69184912182209e-12	22	0	0	451	10391
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	1.00000000000469	4.69184912182209e-12	22	0	0	451	10391
R-HSA-77595	Processing of Intronless Pre-mRNAs	1.00000000000469	4.69184912182209e-12	22	0	0	451	10391
R-HSA-901032	ER Quality Control Compartment (ERQC)	1.00000000000469	4.69184912182209e-12	22	0	0	451	10391
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-209931	Serotonin and melatonin biosynthesis	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-203641	NOSTRIN mediated eNOS trafficking	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-391906	Leukotriene receptors	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8866423	VLDL biosynthesis	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-6785470	tRNA processing in the mitochondrion	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-5662702	Melanin biosynthesis	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-196819	Vitamin B1 (thiamin) metabolism	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-3000471	Scavenging by Class B Receptors	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-2161541	Abacavir metabolism	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-112307	Transmission across Electrical Synapses	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-1483226	Synthesis of PI	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-111463	SMAC binds to IAPs	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-69478	G2/M DNA replication checkpoint	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-446205	Synthesis of GDP-mannose	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-74713	IRS activation	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-1300652	Sperm:Oocyte Membrane Binding	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-111461	Cytochrome c-mediated apoptotic response	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-111448	Activation of NOXA and translocation to mitochondria	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8852405	Signaling by MST1	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-426048	Arachidonate production from DAG	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-68911	G2 Phase	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-111469	SMAC-mediated apoptotic response	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-157881	Cyclin B2 mediated events	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-70370	Galactose catabolism	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-1169092	Activation of RAS in B cells	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-561048	Organic anion transport	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-166187	Mitochondrial Uncoupling Proteins	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-1614517	Sulfide oxidation to sulfate	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-70350	Fructose catabolism	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-75157	FasL/ CD95L signaling	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-389599	Alpha-oxidation of phytanate	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8865999	MET activates PTPN11	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-167826	The fatty acid cycling model	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-71032	Propionyl-CoA catabolism	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8853383	Lysosomal oligosaccharide catabolism	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-390651	Dopamine receptors	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-444209	Free fatty acid receptors	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-167827	The proton buffering model	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-71262	Carnitine synthesis	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-114516	Disinhibition of SNARE formation	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-8875513	MET interacts with TNS proteins	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-112303	Electric Transmission Across Gap Junctions	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-427652	Sodium-coupled phosphate cotransporters	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	1.00000000000546	5.46368657858722e-12	5	0	0	451	10391
R-HSA-5602358	Diseases associated with the TLR signaling cascade	1.00000000000629	6.29207096938032e-12	24	0	0	451	10391
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	1.00000000000629	6.29207096938032e-12	24	0	0	451	10391
R-HSA-5260271	Diseases of Immune System	1.00000000000629	6.29207096938032e-12	24	0	0	451	10391
R-HSA-937041	IKK complex recruitment mediated by RIP1	1.00000000000629	6.29207096938032e-12	24	0	0	451	10391
R-HSA-191273	Cholesterol biosynthesis	1.00000000000629	6.29207096938032e-12	24	0	0	451	10391
R-HSA-8854691	Interleukin-19, 20, 22, 24	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-2243919	Crosslinking of collagen fibrils	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-156587	Amino Acid conjugation	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-419771	Opsins	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-2428933	SHC-related events triggered by IGF1R	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-2214320	Anchoring fibril formation	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-447041	CHL1 interactions	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-391908	Prostanoid ligand receptors	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-1296052	Ca2+ activated K+ channels	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-75094	Formation of the Editosome	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-189085	Digestion of dietary carbohydrate	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-1614558	Degradation of cysteine and homocysteine	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-110357	Displacement of DNA glycosylase by APEX1	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-163765	ChREBP activates metabolic gene expression	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-193634	Axonal growth inhibition (RHOA activation)	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-194002	Glucocorticoid biosynthesis	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-72200	mRNA Editing: C to U Conversion	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-159424	Conjugation of carboxylic acids	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-166665	Terminal pathway of complement	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-198693	AKT phosphorylates targets in the nucleus	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-1300642	Sperm Motility And Taxes	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-425986	Sodium/Proton exchangers	1.00000000000669	6.68654809358543e-12	9	0	0	451	10391
R-HSA-5334118	DNA methylation	1.000000000007	7.00319716142148e-12	66	0	0	451	10391
R-HSA-1483248	Synthesis of PIPs at the ER membrane	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-177539	Autointegration results in viral DNA circles	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-110331	Cleavage of the damaged purine	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-8875791	MET activates STAT3	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-977442	GABA A (rho) receptor activation	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-8849472	PTK6 Down-Regulation	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-77108	Utilization of Ketone Bodies	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-111446	Activation of BIM and translocation to mitochondria	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-844615	The AIM2 inflammasome	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5602680	MyD88 deficiency (TLR5)	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-175567	Integration of viral DNA into host genomic DNA	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-165181	Inhibition of TSC complex formation by PKB	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-1296067	Potassium transport channels	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-6806664	Metabolism of vitamin K	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-1614603	Cysteine formation from homocysteine	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-427589	Type II Na+/Pi cotransporters	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-351200	Interconversion of polyamines	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5602571	TRAF3 deficiency - HSE	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-163282	Mitochondrial transcription initiation	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5653890	Lactose synthesis	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-380615	Serotonin clearance from the synaptic cleft	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-111458	Formation of apoptosome	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-844455	The NLRP1 inflammasome	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-1307965	betaKlotho-mediated ligand binding	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-350864	Regulation of thyroid hormone activity	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-1299503	TWIK related potassium channel (TREK)	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5357572	Lysosomal glycogen catabolism	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-217271	FMO oxidises nucleophiles	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-139910	Activation of BMF and translocation to mitochondria	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-73927	Depurination	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-198745	Signalling to STAT3	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-379397	Enzymatic degradation of dopamine by COMT	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-3249367	STAT6-mediated induction of chemokines	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-193681	Ceramide signalling	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-265473	Trafficking of dietary sterols	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	1.000000000007	7.00418388110795e-12	3	0	0	451	10391
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000000702	7.01708223325914e-12	36	0	0	451	10391
R-HSA-111471	Apoptotic factor-mediated response	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-75158	TRAIL  signaling	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-174577	Activation of C3 and C5	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-448706	Interleukin-1 processing	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-429593	Inositol transporters	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-6814848	Glycerophospholipid catabolism	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-5652084	Fructose metabolism	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	1.00000000001073	1.07268623090022e-11	7	0	0	451	10391
R-HSA-1222449	Mtb iron assimilation by chelation	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-162589	Reverse Transcription of HIV RNA	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-169131	Inhibition of PKR	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5657655	MGMT-mediated DNA damage reversal	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1839120	Signaling by FGFR1 amplification mutants	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5602410	TLR3 deficiency - HSE	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-171286	Synthesis and processing of ENV and VPU	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-163316	Mitochondrial transcription termination	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-164516	Minus-strand DNA synthesis	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1483076	Synthesis of CL	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1222499	Response of Mtb to phagocytosis	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-2033515	t(4;14) translocations of FGFR3	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-389542	NADPH regeneration	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-2534343	Interaction With Cumulus Cells	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-140180	COX reactions	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-2408552	Methylation of MeSeH for excretion	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-162585	Uncoating of the HIV Virion	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5602415	UNC93B1 deficiency - HSE	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1839128	FGFR4 mutant receptor activation	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1855231	Synthesis of IPs in the ER lumen	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-3248023	Regulation by TREX1	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-164525	Plus-strand DNA synthesis	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-1300645	Acrosome Reaction	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	1.00000000001124	1.12431036702887e-11	1	0	0	451	10391
R-HSA-196757	Metabolism of folate and pterines	1.00000000001129	1.12929887273547e-11	18	0	0	451	10391
R-HSA-1912420	Pre-NOTCH Processing in Golgi	1.00000000001129	1.12929887273547e-11	18	0	0	451	10391
R-HSA-209776	Amine-derived hormones	1.00000000001129	1.12929887273547e-11	18	0	0	451	10391
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000001129	1.12929887273547e-11	18	0	0	451	10391
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	1.00000000001129	1.12929887273547e-11	18	0	0	451	10391
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000001129	1.12929887273547e-11	18	0	0	451	10391
R-HSA-69205	G1/S-Specific Transcription	1.00000000001129	1.12929887273547e-11	18	0	0	451	10391
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-1834941	STING mediated induction of host immune responses	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-418038	Nucleotide-like (purinergic) receptors	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-392517	Rap1 signalling	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-5686938	Regulation of TLR by endogenous ligand	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-190242	FGFR1 ligand binding and activation	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-5218859	Regulated Necrosis	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-5213460	RIPK1-mediated regulated necrosis	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-1170546	Prolactin receptor signaling	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-174403	Glutathione synthesis and recycling	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-918233	TRAF3-dependent IRF activation pathway	1.00000000001192	1.19192719570111e-11	16	0	0	451	10391
R-HSA-912694	Regulation of IFNA signaling	1.00000000001195	1.19535683926939e-11	26	0	0	451	10391
R-HSA-389948	PD-1 signaling	1.00000000001195	1.19535683926939e-11	26	0	0	451	10391
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000001195	1.19535683926939e-11	26	0	0	451	10391
R-HSA-73848	Pyrimidine metabolism	1.00000000001195	1.19535683926939e-11	26	0	0	451	10391
R-HSA-68884	Mitotic Telophase/Cytokinesis	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-111447	Activation of BAD and translocation to mitochondria	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-173623	Classical antibody-mediated complement activation	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-3371568	Attenuation phase	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-391903	Eicosanoid ligand-binding receptors	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-5682910	LGI-ADAM interactions	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	1.00000000001197	1.19686301500397e-11	15	0	0	451	10391
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-201688	WNT mediated activation of DVL	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-73929	Base-Excision Repair, AP Site Formation	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-70635	Urea cycle	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-139915	Activation of PUMA and translocation to mitochondria	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-430116	GP1b-IX-V activation signalling	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-428643	Organic anion transporters	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-2562578	TRIF-mediated programmed cell death	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-193697	p75NTR regulates axonogenesis	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-390450	Folding of actin by CCT/TriC	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-209968	Thyroxine biosynthesis	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-74259	Purine catabolism	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-6811555	PI5P Regulates TP53 Acetylation	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-1462054	Alpha-defensins	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-5663084	Diseases of carbohydrate metabolism	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-8875656	MET receptor recycling	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-110056	MAPK3 (ERK1) activation	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-2046105	Linoleic acid (LA) metabolism	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-159740	Gamma-carboxylation of protein precursors	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-196108	Pregnenolone biosynthesis	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-425381	Bicarbonate transporters	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-3215018	Processing and activation of SUMO	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-3785653	Myoclonic epilepsy of Lafora	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-8868766	rRNA processing in the mitochondrion	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-399997	Acetylcholine regulates insulin secretion	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-3229121	Glycogen storage diseases	1.00000000001284	1.28439761244939e-11	10	0	0	451	10391
R-HSA-429914	Deadenylation-dependent mRNA decay	1.00000000001501	1.5010403732808e-11	57	0	0	451	10391
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1.00000000001501	1.5010403732808e-11	57	0	0	451	10391
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000001526	1.52612205725823e-11	38	0	0	451	10391
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000001526	1.52612205725823e-11	38	0	0	451	10391
R-HSA-5689901	Metalloprotease DUBs	1.00000000001526	1.52612205725823e-11	38	0	0	451	10391
R-HSA-180585	Vif-mediated degradation of APOBEC3G	1.00000000001527	1.52730806642871e-11	55	0	0	451	10391
R-HSA-167287	HIV elongation arrest and recovery	1.00000000001564	1.56433859653123e-11	40	0	0	451	10391
R-HSA-156590	Glutathione conjugation	1.00000000001564	1.56433859653123e-11	40	0	0	451	10391
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000001564	1.56433859653123e-11	40	0	0	451	10391
R-HSA-109703	PKB-mediated events	1.00000000001564	1.56433859653123e-11	40	0	0	451	10391
R-HSA-69563	p53-Dependent G1 DNA Damage Response	1.00000000001632	1.63248954535625e-11	65	0	0	451	10391
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	1.00000000001632	1.63248954535625e-11	65	0	0	451	10391
R-HSA-165159	mTOR signalling	1.00000000001637	1.63720404599473e-11	39	0	0	451	10391
R-HSA-110329	Cleavage of the damaged pyrimidine	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-448424	Interleukin-17 signaling	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-977347	Serine biosynthesis	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-174430	Telomere C-strand synthesis initiation	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-6787450	tRNA modification in the mitochondrion	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-400451	Free fatty acids regulate insulin secretion	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-5358493	Synthesis of diphthamide-EEF2	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-73928	Depyrimidination	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-196836	Vitamin C (ascorbate) metabolism	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-8937144	Aryl hydrocarbon receptor signalling	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-1483115	Hydrolysis of LPC	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-444821	Relaxin receptors	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-70921	Histidine catabolism	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-68952	DNA replication initiation	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-804914	Transport of fatty acids	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-177128	Conjugation of salicylate with glycine	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-1483148	Synthesis of PG	1.00000000001639	1.63855895226925e-11	8	0	0	451	10391
R-HSA-73762	RNA Polymerase I Transcription Initiation	1.00000000001649	1.64901409532718e-11	48	0	0	451	10391
R-HSA-71182	Phenylalanine and tyrosine catabolism	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5625970	RHO GTPases activate KTN1	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-8875555	MET activates RAP1 and RAC1	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5655291	Signaling by FGFR4 in disease	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-193048	Androgen biosynthesis	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5690714	CD22 mediated BCR regulation	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-71288	Creatine metabolism	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-174490	Membrane binding and targetting of GAG proteins	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5661231	Metallothioneins bind metals	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-75072	mRNA Editing	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-189451	Heme biosynthesis	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-2470946	Cohesin Loading onto Chromatin	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-2514853	Condensation of Prometaphase Chromosomes	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-8851805	MET activates RAS signaling	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-3371378	Regulation by c-FLIP	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5660526	Response to metal ions	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-1059683	Interleukin-6 signaling	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-2485179	Activation of the phototransduction cascade	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-1839122	Signaling by activated point mutants of FGFR1	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-69416	Dimerization of procaspase-8	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5218900	CASP8 activity is inhibited	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-73614	Pyrimidine salvage reactions	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-5602498	MyD88 deficiency (TLR2/4)	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-196780	Biotin transport and metabolism	1.00000000001654	1.6541272818372e-11	11	0	0	451	10391
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-210745	Regulation of gene expression in beta cells	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-5654689	PI-3K cascade:FGFR1	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-500657	Presynaptic function of Kainate receptors	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-166786	Creation of C4 and C2 activators	1.0000000000168	1.68035486921129e-11	21	0	0	451	10391
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	1.00000000001691	1.69055457487085e-11	50	0	0	451	10391
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	1.00000000001691	1.69055457487085e-11	50	0	0	451	10391
R-HSA-167169	HIV Transcription Elongation	1.00000000001691	1.69055457487085e-11	50	0	0	451	10391
R-HSA-379726	Mitochondrial tRNA aminoacylation	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-5423646	Aflatoxin activation and detoxification	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-5205647	Mitophagy	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-3371571	HSF1-dependent transactivation	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-428930	Thromboxane signalling through TP receptor	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-5627123	RHO GTPases activate PAKs	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-5654693	FRS-mediated FGFR1 signaling	1.00000000001708	1.70800382324641e-11	23	0	0	451	10391
R-HSA-6783589	Interleukin-6 family signaling	1.00000000001724	1.72445404386553e-11	27	0	0	451	10391
R-HSA-211981	Xenobiotics	1.00000000001724	1.72445404386553e-11	27	0	0	451	10391
R-HSA-977606	Regulation of Complement cascade	1.00000000001724	1.72445404386553e-11	27	0	0	451	10391
R-HSA-901042	Calnexin/calreticulin cycle	1.00000000001724	1.72445404386553e-11	27	0	0	451	10391
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	1.00000000001724	1.72445404386553e-11	27	0	0	451	10391
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000001724	1.72445404386553e-11	27	0	0	451	10391
R-HSA-380994	ATF4 activates genes	1.00000000001724	1.72445404386553e-11	27	0	0	451	10391
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	1.00000000001753	1.75320513839917e-11	68	0	0	451	10391
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	1.00000000001845	1.84513763254995e-11	56	0	0	451	10391
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	1.00000000001845	1.84513763254995e-11	56	0	0	451	10391
R-HSA-69541	Stabilization of p53	1.00000000001845	1.84513763254995e-11	56	0	0	451	10391
R-HSA-381038	XBP1(S) activates chaperone genes	1.00000000001845	1.84513763254995e-11	56	0	0	451	10391
R-HSA-166663	Initial triggering of complement	1.00000000001994	1.9937219303828e-11	31	0	0	451	10391
R-HSA-8875878	MET promotes cell motility	1.00000000001994	1.9937219303828e-11	31	0	0	451	10391
R-HSA-73772	RNA Polymerase I Promoter Escape	1.00000000001994	1.9937219303828e-11	31	0	0	451	10391
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	1.00000000001994	1.9937219303828e-11	31	0	0	451	10391
R-HSA-114452	Activation of BH3-only proteins	1.00000000001994	1.9937219303828e-11	31	0	0	451	10391
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	1.00000000001994	1.9937219303828e-11	31	0	0	451	10391
R-HSA-1592389	Activation of Matrix Metalloproteinases	1.00000000002002	2.00229053544076e-11	33	0	0	451	10391
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1.00000000002007	2.00747398807948e-11	80	0	0	451	10391
R-HSA-192456	Digestion of dietary lipid	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-156711	Polo-like kinase mediated events	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-211935	Fatty acids	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-139853	Elevation of cytosolic Ca2+ levels	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-140534	Ligand-dependent caspase activation	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-5627117	RHO GTPases Activate ROCKs	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-189445	Metabolism of porphyrins	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-5625900	RHO GTPases activate CIT	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-3232118	SUMOylation of transcription factors	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-70221	Glycogen breakdown (glycogenolysis)	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-193639	p75NTR signals via NF-kB	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000002059	2.05938335564582e-11	17	0	0	451	10391
R-HSA-70263	Gluconeogenesis	1.00000000002093	2.09344385775672e-11	32	0	0	451	10391
R-HSA-73863	RNA Polymerase I Transcription Termination	1.00000000002093	2.09344385775672e-11	32	0	0	451	10391
R-HSA-209822	Glycoprotein hormones	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-8851680	Butyrophilin (BTN) family interactions	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-417957	P2Y receptors	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-211979	Eicosanoids	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-5689877	Josephin domain DUBs	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-5578768	Physiological factors	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-190373	FGFR1c ligand binding and activation	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-73621	Pyrimidine catabolism	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-176974	Unwinding of DNA	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-71064	Lysine catabolism	1.00000000002122	2.12215378555236e-11	12	0	0	451	10391
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	1.00000000002137	2.13727393619719e-11	60	0	0	451	10391
R-HSA-5387390	Hh mutants abrogate ligand secretion	1.00000000002137	2.13727393619719e-11	60	0	0	451	10391
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	1.00000000002181	2.18127065727301e-11	71	0	0	451	10391
R-HSA-109606	Intrinsic Pathway for Apoptosis	1.00000000002205	2.20532665347635e-11	44	0	0	451	10391
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	1.00000000002219	2.21904960425235e-11	29	0	0	451	10391
R-HSA-72086	mRNA Capping	1.00000000002219	2.21904960425235e-11	29	0	0	451	10391
R-HSA-5218920	VEGFR2 mediated vascular permeability	1.00000000002219	2.21904960425235e-11	29	0	0	451	10391
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000002219	2.21904960425235e-11	29	0	0	451	10391
R-HSA-166658	Complement cascade	1.00000000002267	2.26745278685981e-11	54	0	0	451	10391
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	1.00000000002267	2.26745278685981e-11	54	0	0	451	10391
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000002267	2.26745278685981e-11	54	0	0	451	10391
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	1.00000000002267	2.26745278685981e-11	54	0	0	451	10391
R-HSA-169911	Regulation of Apoptosis	1.00000000002267	2.26745278685981e-11	54	0	0	451	10391
R-HSA-69610	p53-Independent DNA Damage Response	1.00000000002267	2.26745278685981e-11	54	0	0	451	10391
R-HSA-167172	Transcription of the HIV genome	1.00000000002398	2.39839025686765e-11	77	0	0	451	10391
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	1.00000000002398	2.39839025686765e-11	77	0	0	451	10391
R-HSA-1236974	ER-Phagosome pathway	1.00000000002425	2.42526178172187e-11	85	0	0	451	10391
R-HSA-381042	PERK regulates gene expression	1.00000000002457	2.45701918457412e-11	30	0	0	451	10391
R-HSA-420092	Glucagon-type ligand receptors	1.00000000002457	2.45701918457412e-11	30	0	0	451	10391
R-HSA-1912408	Pre-NOTCH Transcription and Translation	1.00000000002457	2.45701918457412e-11	30	0	0	451	10391
R-HSA-381753	Olfactory Signaling Pathway	1.00000000002589	2.58850693524793e-11	435	0	0	451	10391
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	1.000000000026	2.59952356804941e-11	52	0	0	451	10391
R-HSA-3214842	HDMs demethylate histones	1.000000000026	2.59952356804941e-11	52	0	0	451	10391
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	1.000000000026	2.59952356804941e-11	52	0	0	451	10391
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	1.000000000026	2.59952356804941e-11	52	0	0	451	10391
R-HSA-171306	Packaging Of Telomere Ends	1.000000000026	2.59952356804941e-11	52	0	0	451	10391
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	1.000000000026	2.59952356804941e-11	52	0	0	451	10391
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	1.000000000026	2.59952356804941e-11	52	0	0	451	10391
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	1.0000000000262	2.61983585293795e-11	34	0	0	451	10391
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	1.0000000000262	2.61983585293795e-11	34	0	0	451	10391
R-HSA-390522	Striated Muscle Contraction	1.0000000000262	2.61983585293795e-11	34	0	0	451	10391
R-HSA-73847	Purine metabolism	1.0000000000262	2.61983585293795e-11	34	0	0	451	10391
R-HSA-354192	Integrin alphaIIb beta3 signaling	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-264876	Insulin processing	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-6803529	FGFR2 alternative splicing	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-174800	Chylomicron-mediated lipid transport	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-1266695	Interleukin-7 signaling	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	1.00000000002739	2.73903686536512e-11	28	0	0	451	10391
R-HSA-427413	NoRC negatively regulates rRNA expression	1.00000000002753	2.7527100579023e-11	108	0	0	451	10391
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-111957	Cam-PDE 1 activation	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-5626978	TNFR1-mediated ceramide production	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-189483	Heme degradation	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-6806942	MET Receptor Activation	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-193993	Mineralocorticoid biosynthesis	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-205025	NADE modulates death signalling	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-1566977	Fibronectin matrix formation	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-6799990	Metal sequestration by antimicrobial proteins	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-176417	Phosphorylation of Emi1	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-166662	Lectin pathway of complement activation	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-5336415	Uptake and function of diphtheria toxin	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-3065679	SUMO is proteolytically processed	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-3000484	Scavenging by Class F Receptors	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-390247	Beta-oxidation of very long chain fatty acids	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-5676934	Protein repair	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-428808	Na+-dependent glucose transporters	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-6793080	rRNA modification in the mitochondrion	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-5693548	Sensing of DNA Double Strand Breaks	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-5660668	CLEC7A/inflammasome pathway	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-500753	Pyrimidine biosynthesis	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-6787639	GDP-fucose biosynthesis	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-446199	Synthesis of Dolichyl-phosphate	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-1482798	Acyl chain remodeling of CL	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-190370	FGFR1b ligand binding and activation	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-2142700	Synthesis of Lipoxins (LX)	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-6798163	Choline catabolism	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-177135	Conjugation of benzoate with glycine	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-8849470	PTK6 Regulates Cell Cycle	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-1237112	Methionine salvage pathway	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-8851907	MET activates PI3K/AKT signaling	1.00000000002807	2.80659702994579e-11	6	0	0	451	10391
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	1.00000000002939	2.93856747243752e-11	51	0	0	451	10391
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	1.00000000002939	2.93856747243752e-11	51	0	0	451	10391
R-HSA-73854	RNA Polymerase I Promoter Clearance	1.00000000002954	2.95433738695549e-11	111	0	0	451	10391
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	1.00000000002954	2.95433738695549e-11	111	0	0	451	10391
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	1.00000000002967	2.96749181789363e-11	25	0	0	451	10391
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	1.00000000002967	2.96749181789363e-11	25	0	0	451	10391
R-HSA-1538133	G0 and Early G1	1.00000000002967	2.96749181789363e-11	25	0	0	451	10391
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	1.00000000002967	2.96749181789363e-11	25	0	0	451	10391
R-HSA-429947	Deadenylation of mRNA	1.00000000002967	2.96749181789363e-11	25	0	0	451	10391
R-HSA-69202	Cyclin E associated events during G1/S transition	1.00000000003026	3.02637252116864e-11	72	0	0	451	10391
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-3270619	IRF3-mediated induction of type I IFN	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-375281	Hormone ligand-binding receptors	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-1480926	O2/CO2 exchange in erythrocytes	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-432047	Passive transport by Aquaporins	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-140342	Apoptosis induced DNA fragmentation	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-2408517	SeMet incorporation into proteins	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-5210891	Uptake and function of anthrax toxins	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-211227	Activation of DNA fragmentation factor	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-350054	Notch-HLH transcription pathway	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-211999	CYP2E1 reactions	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-175474	Assembly Of The HIV Virion	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-74217	Purine salvage	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-171007	p38MAPK events	1.00000000003052	3.05237651906721e-11	13	0	0	451	10391
R-HSA-69615	G1/S DNA Damage Checkpoints	1.0000000000306	3.0601871724606e-11	67	0	0	451	10391
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000003143	3.14345731442513e-11	64	0	0	451	10391
R-HSA-3214858	RMTs methylate histone arginines	1.0000000000323	3.22959508190672e-11	79	0	0	451	10391
R-HSA-73864	RNA Polymerase I Transcription	1.00000000003338	3.33818148110427e-11	113	0	0	451	10391
R-HSA-381119	Unfolded Protein Response (UPR)	1.00000000003347	3.34696214388507e-11	92	0	0	451	10391
R-HSA-73777	RNA Polymerase I Chain Elongation	1.00000000003347	3.34696214388507e-11	92	0	0	451	10391
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	1.00000000003409	3.40907660355379e-11	90	0	0	451	10391
R-HSA-75953	RNA Polymerase II Transcription Initiation	1.00000000003456	3.45588820818065e-11	47	0	0	451	10391
R-HSA-73776	RNA Polymerase II Promoter Escape	1.00000000003456	3.45588820818065e-11	47	0	0	451	10391
R-HSA-167161	HIV Transcription Initiation	1.00000000003456	3.45588820818065e-11	47	0	0	451	10391
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	1.00000000003456	3.45588820818065e-11	47	0	0	451	10391
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	1.00000000003456	3.45588820818065e-11	47	0	0	451	10391
R-HSA-1912422	Pre-NOTCH Expression and Processing	1.00000000003456	3.45588820818065e-11	47	0	0	451	10391
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	1.00000000003456	3.45588820818065e-11	47	0	0	451	10391
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000003609	3.60946762322735e-11	70	0	0	451	10391
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	1.00000000003778	3.77812131869528e-11	61	0	0	451	10391
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	1.00000000003778	3.77812131869528e-11	61	0	0	451	10391
R-HSA-2142753	Arachidonic acid metabolism	1.00000000003778	3.77812131869528e-11	61	0	0	451	10391
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	1.00000000003778	3.77812131869528e-11	61	0	0	451	10391
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000004029	4.02873953008808e-11	53	0	0	451	10391
R-HSA-180534	Vpu mediated degradation of CD4	1.00000000004029	4.02873953008808e-11	53	0	0	451	10391
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	1.00000000004029	4.02873953008808e-11	53	0	0	451	10391
R-HSA-5619084	ABC transporter disorders	1.00000000004049	4.04935972300868e-11	69	0	0	451	10391
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	1.00000000004049	4.04935972300868e-11	69	0	0	451	10391
R-HSA-72163	mRNA Splicing - Major Pathway	1.00000000004108	4.10828384878132e-11	188	0	0	451	10391
R-HSA-72187	mRNA 3'-end processing	1.00000000004125	4.12464251881942e-11	63	0	0	451	10391
R-HSA-72172	mRNA Splicing	1.00000000004189	4.18876276697557e-11	196	0	0	451	10391
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	1.00000000004217	4.21700623677444e-11	58	0	0	451	10391
R-HSA-381070	IRE1alpha activates chaperones	1.00000000004217	4.21700623677444e-11	58	0	0	451	10391
R-HSA-5625740	RHO GTPases activate PKNs	1.00000000004388	4.38798442109148e-11	94	0	0	451	10391
R-HSA-3214815	HDACs deacetylate histones	1.00000000004388	4.38798442109148e-11	94	0	0	451	10391
R-HSA-5678895	Defective CFTR causes cystic fibrosis	1.00000000004517	4.51721418676977e-11	62	0	0	451	10391
R-HSA-5610780	Degradation of GLI1 by the proteasome	1.00000000004517	4.51721418676977e-11	62	0	0	451	10391
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	1.00000000004979	4.9789233568434e-11	91	0	0	451	10391
R-HSA-2299718	Condensation of Prophase Chromosomes	1.00000000004984	4.98433216713517e-11	75	0	0	451	10391
